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Orofacial Clefts  
Orofacial clefts are defined as congenital defects that are caused by complete or partial failure of the 
fusion of two or more of the following structures: the palatal shelves, the maxillary processes, the 
alveolar processes, the medial nasal processes, and the lateral nasal processes. This can lead to a 
variety of clefts, including clefts of the lip, alveolus, and the hard and soft palate. These clefts can 
either be isolated or combined, and they can be unilateral or bilateral (Berkowitz, 1994). A 
schematic drawing of a combined hard and soft palatal cleft is shown in figure 1. The incidence of 
orofacial clefts is approximately 1.5 in every 1000 newborn Dutch babies (Derijcke et al., 1996). In 
general, there is a predominance of girls in the cleft palate group, while the combined cleft lip and 
palate group comprises mainly boys (Berkowitz, 1994; Derijcke et al., 1996). Left-sided clefts are 
more common than bilateral clefts and right-sided clefts are the least common (Berkowitz, 1994). 
 
 
 
 
 
 
 
Figure 1: Schematic drawing of a cleft in both the hard and the soft palate. 
 The exact causes of orofacial clefts are not known, but factors that increase the risk include: 
genetic factors, insufficiencies in the maternal diet, maternal hormonal disturbances, illness and 
drug or alcohol abuse, and pollution (Habib, 1978; Berkowitz, 1994; Heidbüchel, 1997; Ten 
Tusscher et al., 2000; Van Rooij et al., 2003). Specifically, some of the clefts may be caused by 
excessive maternal intake of cortisone, insulin, vitamin A, aspirin or by a folic acid deficiency 
(Berkowitz, 1994; Van Rooij et al., 2003). The complications associated with orofacial clefts 
include feeding problems, loss of hearing, increased susceptibility to ear infections, impaired speech 
Future dental arch 
Lip 
Hard palate 
Soft palate 
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development, dental problems, and psychosocial problems (Eliason, 1991; Karling et al., 1993; 
Thornton et al., 1996). Beside these common complications, additional individual problems may 
occur, depending on the nature of the cleft and its severity. Because of this variety of complications 
the individual treatment modalities are chosen from a series of standardized protocols. The actual 
treatment involves in general a team of specialists, including pediatricians, plastic surgeons, 
orthodontists, oral surgeons, speech pathologists, social workers, and audiologists (Shah and Wong, 
1980; Kuijpers-Jagtman et al., 2000).   
 The goal of surgical repair of a cleft palate is to restore the anatomic integrity of the hard and 
soft palate, and the nasal mucosa. This results in an improvement of speech development, breathing, 
feeding and swallowing, with as little growth disturbances as possible. No consensus exists in the 
literature on the best approach to meet all goals (Van der Sloot, 2003; Henkel et al., 2004; Johnston 
et al., 2004). In the past, both soft and hard palate closure were performed between twelve and 
twenty-four months of age. Initially, this seemed to be a good compromise between speech and 
growth requirements. Later on, this technique was modified into an early repair of the soft palate to 
satisfy speech requirements, followed by a delayed repair of the hard palate to reduce growth 
inhibition (Schweckendiek and Doz, 1978; Friede and Enemark, 2001). To close the palatal cleft 
(palatoplasty), the modified Von Langenbeck’s bipedical flap method is often used (Trier, 1985; 
Ross, 1987; Murison and Pigott, 1992). The original technique was already described by 
Langenbeck in 1861. In the modified procedure, lateral incisions are made on both sides of the cleft 
and along the future dental arch, after which the mucoperiosteal flaps are mobilized and sutured in 
the midline (Trier, 1985). Consequently, this technique results in two lateral open wounds, in which 
denuded bone is present (figure 2). These wounds heal by secondary intention which is associated 
with the inhibition of maxillary growth and dento-alveolar development (Leenstra et al., 1995).  
 Experimental studies on animals were performed to investigate the iatrogenic effects of cleft 
palate repair (Kremenak and Searls, 1971; Freng, 1981; Wijdeveld et al., 1989). Such studies led to 
the conclusion that the denudation of shelf bone is a critical factor for maxillary and dento-alveolar 
growth inhibition (Kremenak et al., 1967; Wijdeveld et al., 1989). Histologic studies showed that 
both wound contraction and scar tissue formation are involved (Wijdeveld et al., 1987; Wijdeveld et 
al., 1991; Leenstra, 1997). 
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Figure 2: A schematic overview of the modified Von Langenbeck method for the closure of an isolated palatal cleft. 
Incisions are made along the future dental arch and on both sides of the cleft (A). The flaps are mobilized and sutured in 
the midline (B). The two lateral open wounds exposing denuded bone heal by secondary intention. 
 Many efforts have been made to prevent the iatrogenic effects of cleft palate surgery. Several 
studies describe modifications of the surgical techniques e.g. by changing the location of incisions 
or by the implantation of synthetic membranes (Leenstra et al., 1995; In de Braekt et al., 1995). 
Although some of these modifications slightly improved the outcome of surgery, they were not 
satisfactory.  In the last decade, many studies have focused on modulation of the outcome of the 
wound-healing process in order to reduce wound contraction and scarring (Rudolph, 1976; 
Desmouliere, 1995; Cornelissen et al., 2000; Hsu et al., 2000).  
 
Mechanisms of wound healing  
A wound is defined as a disruption of an anatomic structure and its function in any part of the body. 
Wound healing is a process aiming at the restoration of that structure and function. It is a 
complicated process that roughly can be divided into three subsequent, partly overlapping phases: 
inflammation, proliferation and tissue remodeling (Clark, 1996). First, a general overview of the 
wound-healing process in man is presented and some differences between intra-oral and dermal 
wound healing are discussed. In the subsequent sections the role of integrins and the heme 
oxygenase system are emphasized. 
 
B A 
Sutures 
Denuded bone 
Future dental arch 
Hard palate 
Incision lines 
Palatal cleft 
Soft palate 
  
Chapter 1 
 
 
 
 14 
Inflammation phase 
The first phase, the inflammation phase, starts immediately after wounding. Hemostasis occurs 
within minutes after initial injury, followed by an inflammatory response. Platelets are activated to 
seal the damaged blood vessels (table 1). Vasoconstriction occurs when platelets start to release 
vaso-constrictive factors. Platelets aggregate and then adhere to collagen, resulting in the formation 
of a temporary clot that covers the wound. These adhesion processes depend on integrin receptors 
on the cell surface (Albelda and Buck, 1990; Wehrle-Haller and Imhof, 2002). The hemostatic clot 
is stabilized by fibrin that is formed by the proteolysis of fibrinogen. This proteolysis is initiated by 
thrombin, a secretion product of platelets. The resulting fibrin mesh strengthens the platelet 
aggregate to form a stable haemostatic plug. Finally, platelets secrete several cytokines, like 
platelet-derived growth factor (PDGF), which is recognized as one of the first factors initiating the 
subsequent steps (Clark, 1996; Ehrlich and Krummel, 1996; Diegelmann and Evans, 2004).  
 During the inflammatory response, the permeability of the blood vessels increases, resulting in 
the extravasation of plasma and neutrophils (table 1) (Tomlinson and Ferguson, 2003). These 
neutrophils infiltrate the tissue and start to clean up the debris. Macrophages, attracted by the 
degradation products, contribute to the decontamination by phagocytosis (Diegelmann and Evans, 
2004). These neutrophils and macrophages also produce reactive oxygen species that can damage 
wound cells. Next to the classical enzymes superoxide dismutase and catalase, heme oxygenase 
protects wound cells against this oxidative stress (Hanselmann et al., 2001). Neutrophils and 
macrophages also secrete chemotactic factors and cytokines like fibroblast growth factor (FGF), 
epidermal growth factor (EGF), transforming growth factor beta (TGF-β) and interleukin-1 (IL-1), 
which are released in the wound area (Werner and Grose, 2003). Finally, as a part of the clean up 
process, fibrin is degraded by the fibrinolytic  system (Norris, 2003).  
 
Proliferation phase 
The second phase of the wound repair process, the proliferation phase, starts approximately four 
days after wounding and usually lasts until three weeks after wounding, depending on the size of 
the wound. This phase is characterized by the formation of granulation tissue, neo-vascularization, 
re-epithelialization, and wound contraction (Clark, 1996; Diegelmann and Evans, 2004). The 
formation of granulation tissue, starts after approximately four days and is a central event during the 
proliferation phase (Singer and Clark, 1999). Macrophages, fibroblasts and new blood vessels 
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invade the wound simultaneously. The macrophages provide a continuous source of cytokines 
necessary to stimulate fibroplasia and neo-vascularization. The fibroblasts produce new 
extracellular matrix to facilitate cellular ingrowth and the blood vessels transport oxygen and 
nutrients necessary to sustain cell metabolism (Singer and Clark, 1999). 
 Fibroblasts start to migrate into the wound and proliferate in response to fibronectin and growth 
factors like platelet derived growth factor (PDGF), FGF, and TGF-β , which are secreted by 
macrophages and neutrophils (Clark, 1996). After their appearance within the wound, fibroblasts 
start to secrete extracellular matrix components, such as collagen, elastin, fibronectin, and 
glycosaminoglycans, all constituents of the newly formed provisional matrix. The synthesis and 
deposition of collagen is one of the critical events in this phase. The main type of collagen produced 
during the proliferation phase is collagen type III (Clark, 1996). The collagen content is controlled 
by an interplay between the deposition of collagen and the degradation of collagen by collagenases 
(Stamenkovic, 2003).  
 Neo-vascularization is essential for sustaining the newly formed tissue. It is stimulated by 
macrophages and thrombocytes present in the wound. For instance, macrophages start to secrete 
vascular endothelial growth factor (VEGF), which is an inducer of neo-vascularization (Ogawa et 
al., 1999). This process is also controlled by thrombospondin 1 and 2 and anti-angiogenesis factors 
within the wound matrix (Velasco and Lange-Asschenfeldt, 2002).  
Neo-vascularization begins mainly at pre-existing vessels at the margins of the wound via 
sprouting, endothelial cell division, and the development of anastomoses. At the same time 
keratinocytes migrate from the wound edges over the granulation tissue and ultimately form an 
epithelium. This provides a seal against dehydration and infection. After re-epithelialization, the 
keratinocytes form new intercellular desmosomal junctions and hemidesmosomal junctions to the 
newly-formed basement membrane and they regain their original  stationary phenotype (Clark, 
1996).  
 The contraction of the wound tissue starts almost concurrently with collagen synthesis and is 
most prominent around one to two weeks post wounding (Grinnell, 1994). The maximal rate of 
contraction depends on the tissue strength and the dimensions of the wound. Contraction is defined 
as the centripetal movement of the wound edges that facilitates the closure of the wound (Peacock, 
1984). The process of wound contraction is initiated by fibroblasts which migrate from the 
surrounding of the wound (Darby et al., 1990). They generate mechanical tension during migration, 
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which triggers their differentiation into proto-myofibroblasts. A feature of a proto-myofibroblasts is 
their ability to generate contractile forces, however without the expression of α-smooth muscle 
actin (α-SMA) (Tomasek et al., 2002). Additionally, they are able to produce and organize 
fibronectin, and small fibronexi. Proto-myofibroblasts, present in early granulation tissue, 
differentiate into mature myofibroblasts in response to appropriate stimuli like transforming growth 
factor beta-1 (TGF-β1), ED-A fibronectin (ED-A FN), and mechanical tension (Tomasek et al., 
2002). Features of mature myofibroblasts are the expression of α-SMA in more extensively 
developed stress fibers, and the formation of large fibronexi. These mature myofibroblasts are 
present in late contracting granulation tissue (Tomasek et al., 2002). After re-epithelialization, 
mature myofibroblasts disappear through apoptosis and contraction ceases (Desmouliere, 1995; 
Funato et al., 1999; Moulin et al., 2000). 
 
Tissue remodeling phase 
The remodeling of the early granulation tissue starts approximately after two weeks and this process 
may continue indefinitely, but most of the tissue will be remodeled after approximately two years 
(table 1) (Rudolph et al., 1992). During this phase, collagen is synthesized, degraded, dramatically 
reorganized, and stabilized via molecular cross-linking (Diegelmann and Evans, 2004). Also the 
glycosaminoglycan hyaluronic acid is gradually replaced by proteoglycans, and fibronectin 
gradually disappears (Clark, 1996).  
 Matrix metalloproteinases and serine proteinases are secreted into the wound to degrade early 
type III collagen (Parks, 1999; Stamenkovic, 2003). These enzymes are produced by granulocytes, 
macrophages, fibroblasts, and epidermal cells, which are all present in the wound (Clark, 1996). 
Tissue inhibitors of metalloproteinases (TIMPs) are also produced by cells in the wound tissue 
counterbalance the MMPs (Stamenkovic, 2003).  
 Cytokines such as TGF-β, PDGF and IL-1 are important in regulating MMP and TIMP 
expression in vivo, but also the extracellular matrix itself may play an important regulatory role 
(Clark, 1996). Collagen type III is largely replaced by collagen I during remodeling. Water is 
gradually resorbed from the scar and, finally, the number of blood vessels declines. During this 
phase, most of the fibroblasts undergo apoptosis, resulting in a rather acellular scar (Clark, 1993; 
Messadi et al., 1999). Although the resulting scar tissue seldom achieves the strength of normal 
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tissue, it usually provides an acceptable alternative. In the case of wound healing after cleft palate 
repair, the scar tissue seems to be an important cause of growth disturbances. 
 
Table 1: Cellular involvement during wound healing. 
 
 
Fibroblasts, proto-myofibroblasts and mature myofibroblasts 
Fibroblasts, proto-myofibroblasts and mature myofibroblasts are the most important cells involved 
in wound contraction and subsequent scarring. During wound healing, fibroblasts migrate from the 
wound margins into the wound where they fulfill a variety of tasks (Clark, 1993). A majority of 
these fibroblasts will differentiate into proto-myofibroblasts under the influence of mechanical 
tension in the wound matrix (Tomasek et al., 2002). These proto-myofibroblasts will further 
differentiate into mature myofibroblasts after the appropriate stimuli of TGF-β, ED-A FN and 
mechanical tension. This information was used to develop a hypothetical scheme of the role of 
Phase in wound healing Subphase Days post injury Cells involved 
Inflammation Hemostasis 
 
Inflammation 
Immediate 
 
Day 1 – 4 
Platelets 
 
Neutrophils 
Mast cells 
Macrophages 
Proliferation Granulation tissue 
formation 
 
Migration and 
proliferation 
 
Neo-vascularization 
 
 
Re-epithelialization 
 
 
Wound contraction 
Day 4 - 21 
 
 
Day 4 – 21 
 
 
Day 4 – 21 
 
 
Immediate – Day 21 
 
 
Day 5 - 15 
Fibroblasts 
 
 
Macrophages 
Fibroblasts 
 
Endothelial cells 
Thrombocytes 
 
Keratinocytes 
 
 
Fibroblasts  
Proto-myofibroblasts 
Mature myofibroblasts 
Tissue remodeling Remodeling and scar 
formation 
Day 14 – 2 years Fibroblasts 
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Quiescent 
Fibroblast
Migratory Fibroblast
immature FAs
Proto-Myofibroblast
stress fibers (cytoplasmic actins)
mature FAs
Differentiated Myofibroblast
stress fibers (α-SMA)
supermature FAs (fibronexus)
(ED-A FN, tensin & vinculin)
TGFβ
platelets
leukocytes
cytokines
collagen 
synthesis
and compaction
by tractional 
forces
LOOSE 
COLLAGEN
WOUNDING
FIBRIN CLOT
LOOSE COLLAGEN
COMPACTED
COLLAGEN
APOPTOSIS
COLLAGEN 
under 
continuous
REMODELING
and SHORTENING
SHORTENED and 
CROSSLINKED COLLAGEN
ED-A FN
stretched
(active)
ED-A FN
folded
(inactive)
PDGF
TGFβ L-TGFβ
α-SMA
promoter
SRF
NORMAL DERMIS
RECONSTITUTED DERMIS
fibroblasts and myofibroblasts during wound healing (figure 3) (Hinz and Gabbiani, 2003). This 
hypothetical scheme is further explained in chapter 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Hypothetical scheme illustrating the differentiation from quiescent fibroblasts into differentiated mature 
myofibroblasts. The width and grey intensity of the pyramid represent the level of matrix tension (white = relaxed and 
grey = stressed), which is modulated continuously by proteins produced by fibroblast synthesis (dashed arrows) and 
contractile activity (dark arrows). The arrows left of the figure indicate changes. Stimulatory effects are indicated by 
black dotted arrows; arrow thickness grossly corresponds to the level of activity. Abbreviations: PDGF, platelet-derived 
growth factor; L-TGFβ, latent transforming growth factor β; SRF, serum response factor. Reprinted from Current 
Opinion in Biotechnology, Vol 14, Hinz and Gabbiani, Mechanisms of force generation and transmission by 
myofibroblasts, p538-46 © 2003 with permission from Elsevier. 
Differences between dermal and oral wound healing 
The wound-healing process differs between tissues. Oral wounds heal faster than skin wounds, and 
generally less scar tissue is formed in the oral region (Sciubba et al., 1978; Hakkinen et al., 2000). 
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It is hypothesized that factors present in the saliva and to a lesser extent in crevicular fluid might 
enhance the oral wound-healing process (Zelles et al., 1995; Playford and Macdonald, 1997; 
Hakkinen et al., 2000; Ishizaki et al., 2000). Growth factors, such as epidermal growth factor 
(EGF), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and 
insulin-like growth factor (IGF), which are all present in saliva have been described to enhance 
tissue repair in the oral region (Skaleric et al., 1997; Taichman et al., 1998; Fujisawa et al., 2003). 
However, most of the oral wound-healing studies focus on buccal, periodontal or gingival wounds 
or on cultured fibroblasts derived from these areas and not on palatal wounds or on palatal 
fibroblasts. In the palatal region, specific structural features seem to give rise to a different outcome 
of the wound-healing process. The palatal soft tissue consists of a rigid mucoperiosteum that is 
attached to the palatal bone. Healing of open wounds on the palate results in an additional periosteal 
osteogenic reaction. The resulting bone deposition leads to a tight anchorage of the scar to the 
palatal bone. This scar contributes to the impairment of maxillary growth and development of the 
dentition after palatoplasty (Wijdeveld et al., 1991). 
 
Integrins and wound healing 
Integrins are adhesion molecules that are present on the surface of nearly all cells. Integrins are a 
family of transmembrane glycoproteins that mediate cell-matrix and cell-cell adhesion (Hynes, 
1992; Etzioni, 1999). Adhesion is of principal importance for a cell because it enables intercellular 
communication, anchorage and migration, but also growth and differentiation (Ruoslahti, 1991). 
Consequently, integrins play key roles in all phases of wound healing (Yamada et al., 1996; 
Hakkinen et al., 2000).  
 
Integrins, structure and function 
Each integrin is composed of a non-covalently linked α and β subunit and is partly embedded in the 
plasma membrane (the transmembrane segment) (Ruoslahti, 1991; Hynes, 1992). Every subunit 
furthermore consists of a large extracellular part and a relatively short intracellular domain. 
Nowadays, eighteen α subunits and eight β subunits are identified, which can combine to twenty-
four different integrins (figure 4). The number of combinations appears to be restricted, because 
most α subunits are found to link to only one type of β subunit (Rojas and Ahmed, 1999; Hynes, 
2002). The molecular size of the α subunits varies between 120 and 210 kDa, while the β subunits 
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α1
   
α2
   
α3
   
α4
   
α5
   
α6
   
α7
   
α8
   
α9
   
α1 α1 αV
    
α αd
   
αL
    
αM
    
αX
β7 β4 β5 β6 β8
β1 β3 β2
αE
IIb    
vary between 95 and 130 kDa. The β4 subunit is an exception, because it is 220 kDa in size 
(Hemler, 1990; Tamura et al., 1990). The extracellular domain of each integrin can bind to certain 
extracellular matrix proteins and other ligands, while the cytoplasmic domain can link to the 
cytoskeleton. The linkage between this cytoplasmic domain and the cytoskeleton influences the 
ligand binding affinity of the extracellular domain (Diamond and Springer, 1994).   
 
 
 
 
 
Figure 4: Different associations of integrin subunits.  
Integrin-ligand interactions produce an “outside-in” signaling event in which the linkage of a ligand 
to the extracellular domain triggers intracellular pathways that alter cellular processes such as gene 
regulation, proliferation, and apoptosis. For such an “outside-in” signaling clustering of integrins 
and the formation of focal adhesions is a prerequisite. This phenomenon is illustrated by the 
observation that synovial fibroblasts, which are grown on fibronectin-coated plates, show an 
induction of matrix metalloproteinase expression (Huhtala et al., 1995; Rojas and Ahmed, 1999). 
“Inside-out” signaling, on the other hand, occurs when an activated cell sends a signal from the 
inside of the cell through the cytoplasmic domain of the integrin to change the extracellular domain 
conformation. This may have a positive or negative effect on the integrin-ligand binding. Such 
“inside-out” signaling is illustrated by the observation that integrin α2β1 is  either inactive, can act 
as a receptor for collagen, or as a receptor for collagen and laminin, depending on the intracellular 
signals (Schwartz et al., 1995). 
 Several types of integrin ligands have been described: extracellular matrix proteins like 
collagens, fibrinogen, fibronectin, and laminins, other adhesion molecules like ICAM’s and 
VCAM’s, coagulation factors, fibrinolytic factors, and the complement factor C3b (Elangbam et al., 
1997; Stupack and Cheresh, 2002). In addition, some bacterial and viral proteins have also been 
found to interact with integrins (Nemerow and Stewart, 2001; Hauck, 2002). The Arg-Gly-Asp 
(RGD) sequence is required for ligand binding of many integrins (Ruoslahti and Pierschbacher, 
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1987). Such an RGD sequence is found in many adhesive extracellular matrix proteins, including 
collagens, fibronectin, vitronectin, osteopontin, thrombospondin, fibrinogen, and von Willebrand 
factor (Ruoslahti and Pierschbacher, 1987). The binding capacity depends on the actual tertiary 
structure of the recognition site. Also, small natural and synthetic RGD peptides are able to bind to 
many integrins and thereby prevent the binding of the cell to the matrix. The binding of some 
integrins is highly specific (e.g. α5β1 only binds to fibronectin), while others bind to several ligands 
(e.g. α3β1 binds to collagen IV, fibronectin, and laminin) (Albelda and Buck, 1990; Clark and 
Brugge, 1995).  
 Integrins form clusters on the cell membrane after activation, resulting in focal adhesion 
complexes, which show a large increase in binding strength  (Jockusch et al., 1995; Lee and 
Jacobson, 1997; Wehrle-Haller and Imhof, 2002). Such clusters of integrin-ligand complexes serve 
as signaling centers that regulate cell activities. Focal adhesion complexes often consist of more 
than 20 different proteins, such as focal adhesion kinase (FAK), paxillin and tensin (Horwitz, 1997). 
 
Integrins in wound healing  
Integrins have been found on the surface of most cells involved in the different phases of the 
wound-healing process.  
 
Inflammation phase  
Immediately after injury, activated αIIbβ3 integrins on platelets act as a receptor for other platelets 
and extracellular matrix components such as fibrin, vitronectin, von Willebrand factor VIII, and 
thrombospondin (Clark, 1996). These interactions contribute to platelet aggregation and clot 
formation. Furthermore, integrins play an important role during the inflammation process. The 
activation of β2-integrins on the surface of circulating leukocytes mediates their binding to 
endothelial cells (Springer, 1990). Integrins also promote leukocyte extravasation from the 
vasculature into the surrounding tissues (De Fougerolles et al., 2000).  
 
Proliferation phase 
Once the proliferation phase has started, integrins are involved in neo-vascularization. In vitro 
studies show that the integrin αvβ3 promotes endothelial cell migration on provisional matrix 
proteins (Leavesley et al., 1993). During the migration of fibroblasts into the wound, they display a 
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“migratory” phenotype, characterized by a diffuse distribution of β1 integrins over the cell 
membrane. These integrins are hardly organized into focal adhesions (Clark, 1996). When 
migration has ceased, wound contraction starts and the fibroblasts form a contractile cytoskeleton 
(Welch et al., 1990). During wound contraction, α1β1, α2β1, and α5β1 are involved in the contact of 
the contracting (myo)fibroblasts with the extracellular matrix, allowing the contractile forces to be 
transmitted over the wound (Hemler, 1990; Welch et al., 1990; Schiro et al., 1991; Horwitz, 1997; 
Racine-Samson et al., 1997). Several in vitro studies using a collagen gel contraction model support 
the idea that these integrins are involved in wound contraction (Schiro et al., 1991; Carver et al., 
1995; Jokinen et al., 2004; Kondo et al., 2004). Moreover, integrin α1β1 plays an important role in 
collagen gel contraction (Carver et al., 1995) and integrin α2β1 mediates both reorganization and 
contraction of collagen matrices by human fibroblasts (Schiro et al., 1991). During re-
epithelialization, also wound keratinocytes change their phenotype. The normal path of 
differentiation (vertical) is replaced by a horizontal migratory activity (Graber et al., 1999). The 
α2β1, α3β1 and α6β4 integrins loose their basal distribution, due to the loss of collagen type IV from 
the basal membrane after wounding. The αvβ5 integrin is replaced by αvβ6 integrin, and, in contrast 
to intact epithelium, integrin α5β1 is expressed (Larjava et al., 1993; Clark et al., 1996; Graber et 
al., 1999). This
 
integrin, which can bind to fibronectin, is the most important integrin for 
keratinocyte migration during re-epithelialization (Kim et al., 1992). 
 
Tissue remodeling phase 
During the remodeling phase a strong up-regulation of integrins α1β1 and α2β1 has been found. The 
latter, however, is only transient (Noszczyk et al., 2002). These integrins mediate the interaction 
between the (myo)fibroblasts and collagen I, the main component of scar tissue (Hemler, 1990; 
Gotwals et al., 1996). In knockout mice, in which α1–integrins were disabled, wound healing was 
strongly impaired, pointing towards a strong involvement of this integrin subunit (Pozzi et al., 
2000). Surprisingly, mice deficient in the α2 subunit showed undisturbed wound healing. This 
indicates that other integrins or non-integrin receptors compensated for the loss of α2β1 integrin 
function (Mercurio, 2002). 
 Most fibroblasts undergo apoptosis during the remodeling phase, resulting in a rather acellular 
scar. Integrin receptors may also play an important role in this event (Buckley et al., 1998; 
Giancotti and Ruoslahti, 1999; Stupack and Cheresh, 2002).  
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Heme oxygenase and wound healing 
Increasing evidence is pointing towards an important role for heme and its degrading enzyme heme 
oxygenase in wound healing. In the early stages of wound healing, the heme oxygenase system 
protects the cells in the wound area against oxidative stress (Liu et al., 2000; Hanselmann et al., 
2001; Philippidis et al., 2004). There are also indications that heme is involved in the modulation of 
integrin function (Liu et al., 2000). Some evidence points towards a role of heme oxygenase in the 
prevention of fibrosis in certain organs (Li et al., 2003; Morse, 2003). In the following paragraphs, 
the role of heme and heme oxygenase in the wound-healing process will be briefly discussed.  
 
Heme oxygenase 
Heme oxygenase (HO) is the rate-limiting enzyme in the catabolism of heme. It is secreted by a 
variety of cells, such as fibroblasts (Andoh et al., 2004). It breaks down the porphyrin ring of heme 
to yield equimolar amounts of biliverdin, free iron (Fe2+) and carbon monoxide (CO). Biliverdin is 
rapidly converted into bilirubin by biliverdin reductase. The heme-derived oxidant, iron, is directly 
sequestered and inactivated by CO-induced ferritin (Vogt et al., 1995). CO causes vasodilatation, 
inhibits platelets aggregation and suppresses the production of cytokines, whereas 
biliverdin/bilirubin exerts potent antioxidant actions (Nakagami et al., 1993; Dore et al., 1999; 
Johnson et al., 1999).  
 To date, three isoforms of HO have been identified: HO-1 (also known as heat-shock protein 32 
or hsp32), HO-2, and HO-3 (Cruse and Maines, 1988; Maines, 1997; McCoubrey et al., 1997). 
These isoforms are products of different genes and differ greatly in tissue distribution and 
regulation. They have a molecular weight of approximately 32 kDa, 36 kDa and 33 kDa, 
respectively. Under normal physiological conditions, most cells express low or undetectable levels 
of HO-1, while HO-2 and HO-3 are constitutively expressed (Cruse and Maines, 1988; McCoubrey 
et al., 1997; Maines, 2000). However, HO-1 is strongly induced following various stressful stimuli, 
including heavy metals, endotoxins, hyperoxia, heat shock, ischemia, radiation, cytokines, and its 
substrate heme, and in pathological conditions.  
 
Heme oxygenase in wound healing 
Wounds are associated with hemorrhage, hemolysis, and cell damage, which result in a local 
accumulation of free heme proteins and heme. The most well-known function of HO in wound 
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healing is its cytoprotective action in the inflammatory phase, which is mediated via the breakdown 
products of heme (Hanselmann et al., 2001). Biliverdin and bilirubin function as a potent 
antioxidant system, whereas CO mediates vasodilatation via cyclic guanosine monophosphate 
(cGMP) induction (Siow et al., 1999). Furthermore, the iron that is released from heme by HO-1 
activity, further enhances ferritin synthesis and thereby inhibits iron-catalyzed production of 
reactive oxygen species (Balla et al., 1992). Over-expression of HO-1 in endothelial cells has been 
shown to protect from heme- and hemoglobin-mediated toxicity and is associated with increased 
tolerance of cells to ischemia and trauma in a variety of tissues (Abraham et al., 1995; Amersi et al., 
1999). Interestingly, HO-1 over-expression has been demonstrated to down-modulate adhesion 
molecules and to diminish leukocyte adhesion to the vascular endothelium both in vitro and in vivo 
(Hayashi et al., 1999; Wagener et al., 1999; Vachharajani et al., 2000; Rucker et al., 2001; Wagener 
et al., 2001).   
 A more hypothetical, anti-fibrotic function of HO in wound healing can be inferred from 
studies on liver and pulmonary fibrosis (Li et al., 2003; Morse, 2003). HO-1 was detected in liver 
biopsy specimens from cirrhotic patients, both in macrophages and myofibroblasts within the 
fibrotic septa. In vitro studies with hepatic myofibroblasts showed that the anti-fibrotic effects of 
prostaglandin J2 are mediated by upregulation of HO-1 (Li et al., 2003). These effects include an 
inhibition of proliferation of myofibroblasts and of procollagen type I mRNA expression. A similar 
role of HO-1 and the products of enzymatic heme breakdown is suggested in pulmonary fibrosis 
(Morse, 2003). It is not known up to now whether HO-1 also exerts anti-fibrotic effects during 
wound healing in skin or mucosa. 
 
Aim 
Wound contraction and subsequent scar tissue formation is thought to be a main cause of the 
maxillary and dento-alveolar growth inhibition observed after cleft palate surgery. A reduction in 
wound contraction and scar tissue formation might prevent these iatrogenic effects. To achieve this, 
different approaches have been chosen in the past. Nowadays, a main approach is to interfere with 
fibroblast activity, since these cells play a key role during wound contraction and scar tissue 
formation. Integrins are crucial in these processes and are therefore chosen as the main focus of our 
studies. A reduction of wound contraction and scarring might eventually be achieved by the 
modulation of integrin function.  
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The specific aims of the present study are: 
 
• To review the role of (myo)fibroblasts in palatal wound healing and to deduce targets for 
intervention (Chapter 2). 
• To isolate fibroblasts populations from subsequent stages in palatal wound healing and 
to characterize their expression of integrins and cytoskeletal proteins in vitro  
 (Chapter 3).  
• To confirm the existence of different fibroblasts populations in vivo by the analysis of 
expression of integrins and cytoskeletal proteins during wound healing (Chapter 4). 
• To compare the adhesion and migration characteristics of fibroblast populations from 
subsequent stages in palatal wound healing, and to relate these to the expression of the 
β1 subunit and vinculin (Chapter 5). 
• To analyze the role of heme oxygenase during palatal wound healing (Chapter 6). 
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Abstract 
The surgical closure of orofacial clefts is considered to impair maxillary growth and dento-alveolar 
development. Wound contraction and subsequent scar tissue formation during healing of these 
surgical wounds, contribute largely to these growth disturbances. The potential to minimize wound 
contraction and subsequent scarring by clinical interventions depends on the surgeon’s knowledge 
of the events responsible for these phenomena. Fibroblasts initiate wound contraction, but proto-
myofibroblasts and mature myofibroblasts are by far the most important cells in this process. 
Myofibroblasts are characterized by their cytoskeleton, which contains alpha-smooth muscle actin. 
Additionally, their contractile apparatus contains bundles of actin microfilaments and associated 
contractile proteins, such as non-muscle myosin. This contractile apparatus is thought to be the 
major force-generating element involved in wound contraction. After closure of the wound, the 
myofibroblasts disappear by apoptosis, and a less cellular scar is formed. A reduction of contraction 
and scarring might be obtained by inhibition of myofibroblast differentiation, stimulation of their 
de-differentiation, stimulation of myofibroblast apoptosis, or impairment of myofibroblast function. 
In this review, we will discuss all of these possibilities, which ultimately may lead to a better 
outcome of cleft palate surgery.  
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Introduction 
Orofacial clefts are defined as congenital defects in which the fusion between two or more of the 
following structures has failed: the palatal shelves, the maxillary prominences, and the medial nasal 
prominences. The clefts are surgically closed to restore the integrity of the oral and nasal cavity, and 
to allow normal feeding and speech development. A modified Von Langenbeck method is often 
used for palatoplasty, the initial surgical repair of the palate (Ross, 1987). Incisions are made on 
both sides of the cleft and adjacent to the alveolar bone, and the mucoperiosteal flaps are mobilized 
and sutured together in the midline. As a consequence, this technique results in lateral open wounds 
with denuded bone. Healing of these wounds is associated with the disadvantageous effects on 
maxillary growth and dento-alveolar development often seen in cleft palate patients. Many 
alternative methods for palatoplasty have been developed, but growth disturbances still occur 
(Millard, 1976). Two different but related wound-healing events - namely, wound contraction and 
scar tissue formation - contribute largely to these undesirable consequences (Kremenak, 1984; 
Wijdeveld et al., 1987a; Wijdeveld et al., 1991). Wound contraction reduces the size of the defect, 
but it also induces substantial scarring, ultimately resulting in the disadvantageous effects on growth 
(Wijdeveld et al., 1987b; Wijdeveld et al., 1991). A reduction of wound contraction and subsequent 
scarring is therefore desirable. 
 Fibroblasts play an important role in both processes (Grinnell, 1994; Clark, 1996; Badid et al., 
2000). They display a considerable degree of inter- and intra-site heterogeneity in phenotype and 
activity (Irwin et al., 1994; Lekic et al., 1997). Differences in migration, integrin expression, cell 
proliferation, and collagen synthesis by fibroblasts obtained from different phases of wound healing 
have been reported (Finesmith et al., 1990; Fries et al., 1994; Irwin et al., 1994; Badid et al., 2000; 
Van Beurden et al., 2003). A specialized fibroblast type, involved in wound contraction, is the 
myofibroblast. Its major characteristic is the expression of alpha-smooth-muscle actin (α-SMA). 
Myofibroblasts are present in organs with a high remodeling capacity, such as the kidneys, the 
lungs, and the periodontal ligament (Gabbiani, 1994; Desmouliere and Gabbiani, 1996; Gabbiani, 
1998; Lorena et al., 2002; Tomasek et al., 2002) or during increased remodeling, such as in growth, 
development, inflammatory responses, and the contraction of healing wounds (Squier and 
Kremenak, 1980; Gabbiani, 1992). In contrast, hardly any myofibroblasts are present in tissues with 
a low remodeling activity, as in normal dermis (Squier and Kremenak, 1980; Cornelissen et al., 
2000b; Van Beurden et al., 2003).  
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 Myofibroblasts were first described in 1971 (Gabbiani et al., 1971). Since then, the role of 
myofibroblasts has been intensively studied (Desmouliere, 1995; Desmouliere and Gabbiani, 1996; 
Powell et al., 1999; Moulin et al., 2000; Hinz et al., 2001; Van Beurden et al., 2003). 
Myofibroblasts cause the extracellular matrix to contract (Clark, 1996), and are involved in the 
regulation of proliferation and differentiation of epithelial, vascular, and neurogenic cells (Saunders 
and D'Amore, 1992; Yamagishi et al., 1993). This review will focus on the role of myofibroblasts 
in wound contraction during wound healing after palatoplasty. The factors involved in the 
differentiation of fibroblasts into myofibroblasts will be emphasized. Understanding the biology of 
these factors might be a starting point for the development of strategies to reduce undesired 
contraction and subsequent scarring. 
 
Wound healing  
Wound healing can be divided into three subsequent, partly overlapping, phases, namely, 
inflammation, proliferation, and tissue remodeling (Clark, 1996). Following injury, vasoconstriction 
reduces hemorrhage and favors platelet aggregation. Almost concurrently, vasodilatation enables 
inflammatory cells to enter the site of injury and clean the wound. Neutrophils and macrophages 
migrate into the wound to prevent invasion and proliferation of micro-organisms (Ehrlich and 
Krummel, 1996). Platelet aggregation and coagulation result in the formation of a provisional fibrin 
clot that covers the wound. (Clark, 1996; Ehrlich and Krummel, 1996). 
 Second, the proliferation phase starts with the migration of fibroblasts into the wound area and 
their propagation. These fibroblasts start to produce granulation tissue components, such as 
fibronectin, collagen, and hyaluronic acid (Clark, 1996). Some fibroblasts differentiate into 
myofibroblasts, which are principally responsible for tissue contraction, but also produce 
extracellular matrix components (Sappino et al., 1990; Grinnell, 1994; Ehrlich and Krummel, 
1996). In skin wounds, myofibroblasts are abundantly present up to two weeks post-wounding 
(Greenhalgh, 1998; Huang et al., 2003). Simultaneously, re-epithelialization occurs by proliferation 
and migration of epithelial cells from the wound edges. Soon after re-epithelialization, wound 
contraction stops, and myofibroblasts start to disappear, probably through apoptosis (Desmouliere 
et al., 1995; Clark, 1996; Huang et al., 2003).  
 Third, during the remodeling phase, the number of blood vessels declines, and apoptosis of 
fibroblasts results in scar tissue with a low cell density (Clark, 1996). Ultimately, the scar contains 
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only a few fibroblasts with a well-developed rough endoplasmic reticulum (Gabbiani, 1994). In 
pathological situations, such as hypertrophic scars, myofibroblasts may persist (Sappino et al., 
1990; Ehrlich et al., 1994; Spyrou and Naylor, 2002).  
 Unlike adult skin, early fetal skin heals without wound contraction and scar tissue formation 
(Moulin et al., 2001). A low ratio of transforming growth factor (TGF)β1,2 to TGFβ3 seems to cause 
this phenomenon (Moulin et al., 2001). Interestingly, mice lacking the TGFβ1 antagonist TGFβ3 
develop a cleft palate (Nawshad et al., 2004). Furthermore, myofibroblasts hardly occur in early 
fetal wounds (McCluskey and Martin, 1995), while wounds of later gestational age show a 
temporary increase in the number of myofibroblasts (Schor et al., 1996). Fetal wounds are also 
characterized by the absence of clot formation and inflammatory reactions. Taken together, at an 
early gestational age, the adult wound-healing process is not yet fully developed, which precludes 
wound contraction and scar tissue formation. At a later gestational age, these specific features of 
early fetal wounds disappear. 
 
Dermal versus oral wound healing 
A general observation is that wounds in the oral mucosa heal faster and with less scarring than do 
dermal wounds (Hakkinen et al., 2000), although the opposite is also claimed (Nooh and Graves, 
2003). The cause of this difference is not completely understood, but saliva, leucocytes, growth 
factors, and specific fibroblast subpopulations seem to be involved (Noguchi et al., 1991; Hormia et 
al., 1993; Varshney et al., 1997; Taichman et al., 1998; Stephens et al., 2001; Lepekhin et al., 
2002).  
 Saliva provides a unique environment favoring wound healing (Hakkinen et al., 2000). Saliva-
treated cutaneous wounds have a reduced inflammatory reaction, faster epithelial coverage, and a 
faster connective tissue regeneration (Zelles et al., 1995; Varshney et al., 1997; Kagami et al., 
2000; Ohshima et al., 2002). Desalivated oral wounds contain fewer myofibroblasts than do saliva-
treated wounds, and a delayed peak in their number (Bodner and Dayan, 1995). As a result, wound 
contraction and granulation tissue formation are delayed in desalivated rats (Hutson et al., 1979; 
Bodner et al., 1991). It appears that moisture and ionic strength are not the primary factors 
promoting wound healing (Zelles et al., 1995). More likely, growth factors in saliva - such as 
epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), basic fibroblast growth 
factor (bFGF), and insulin-like growth factor (IGF) - enhance tissue repair (Skaleric et al., 1997; 
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Taichman et al., 1998; Fujisawa et al., 2003). Lower levels of macrophages, neutrophils, and T-
cells are present in oral wounds than in skin wounds (Szpaderska et al., 2003). Furthermore, oral 
wounds contain fewer pro-inflammatory factors such as TGFβ1 and interleukin-6 (IL-6) (Bodner 
and Dayan, 1995; Hakkinen et al., 2000; Szpaderska et al., 2003). In vitro studies have shown that 
oral fibroblasts possess a higher capability to cause a collagen lattice to contract than do dermal 
fibroblasts (Stephens et al., 1996; Stephens et al., 2001; Sukotjo et al., 2003). In the same in vitro 
model, oral fibroblasts produce higher levels of matrix metalloproteinase-2 (MMP-2) and reduced 
levels of tissue inhibitors of metallo proteinases (TIMPs) (Stephens et al., 2001).  
 The fibroblast phenotype differs substantially between anatomical sites (Castor et al., 1962; 
Moulin et al., 1998; Lee and Eun, 1999; Chipev and Simon, 2002). Different fibroblast 
subpopulations are also present in oral and dermal tissues. Intra-oral fibroblasts generally exhibit a 
more fetal-like phenotype with a remodeling capacity higher than that of dermal fibroblasts (Sloan, 
1991; Irwin et al., 1994; Stephens et al., 2001). Dermal and oral fibroblasts secrete different types 
and amounts of glycosaminoglycans (GAGs) (Bronson et al., 1988). Also, differences in 
migrational behavior (Lepekhin et al., 2002), adhesional properties (Palaiologou et al., 2001), 
expression of extracellular matrix receptors (Palaiologou et al., 2001), and response to growth 
factors like TGFβ 1 (Lee and Eun, 1999) have been reported. However, all the above findings are 
from studies on fibroblasts derived from buccal, periodontal, or gingival wounds. Studies on palatal 
fibroblasts are lacking. On the palate, specific structural features give rise to a different outcome of 
the wound-healing process. The palatal soft tissue is a rigid mucoperiosteum that is attached to the 
palatal bone. The healing of open wounds on the palate after cleft palate closure results in an 
additional periosteal osteogenic reaction, which tightly anchors the scar tissue to the palatal bone. 
This immobile scar impairs maxillary growth and development of the dentition after palatoplasty 
(Wijdeveld et al., 1991). 
 Thus, oral wound healing differs from dermal wound healing in several aspects. The faster 
wound-healing rate and the decreased scar formation indicate a more fetal type of wound healing. 
These differences are caused by the local environment and specific fibroblast subpopulations. In 
spite of these favorable characteristics, the specific features of palatal wound healing are 
responsible for the growth disturbances observed after cleft palate repair. 
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Wound contraction 
The first concept of wound contraction was postulated in 1971 (Gabbiani et al., 1971). It was based 
on the involvement of myofibroblasts. Wound contraction is achieved by the concerted action of 
many myofibroblasts (Desmouliere and Gabbiani, 1996), and is mediated by many cell-cell and 
cell-matrix contacts, resulting in a re-arrangement or shortening of the collagen fibrils (Welch et al., 
1990). The second concept (Ehrlich and Rajaratnam, 1990) states that the locomotion of normal 
fibroblasts leads to the contraction of a wound. It states that fibroblasts do not act in a coordinated 
manner, but that the tractional forces of many individual fibroblasts are responsible for wound 
contraction.  
 Recently, a combination of these two concepts has been advocated by Tomasek et al. (2002), 
who state that migrating fibroblasts initially exert tractional forces on the surrounding collagen 
matrix. This mechanical tension stimulates fibroblasts to differentiate into proto-myofibroblasts by 
the development of stress fibers (Tomasek et al., 2002). Fibroblasts under tension via the 
extracellular matrix also express TGFβ1 (Varedi et al., 1997). Proto-myofibroblasts generate 
contractile forces without the expression of α-SMA. They are also able to synthesize and organize 
fibronectin, and to form small fibronexi. Proto-myofibroblasts can differentiate into mature 
myofibroblasts in response to specific factors, like TGFβ1, ED-A fibronectin (ED-A FN), and 
mechanical tension (Tomasek et al., 2002). In the cornea, keratocytes seem to differentiate directly 
into myofibroblasts (Jester et al., 2002). Mature myofibroblasts express α-SMA in elaborate stress 
fibers, and form of large fibronexi. These differentiated myofibroblasts are present in late 
contracting granulation tissue (Tomasek et al., 2002). After closure of the wound, mature 
myofibroblasts disappear through apoptosis (Desmouliere et al., 1995; Funato et al., 1999; Moulin 
et al., 2000) or by de-differentiation (Desmouliere, 1995).  
 
Definition, origin, and characterization of the myofibroblast  
The simplest definition of a myofibroblast is that it is a fibroblast with smooth muscle cell-like 
features (Powell et al., 1999). Although the characteristics of myofibroblasts are well-described, 
there is no consensus about their origin. Based on morphological observations, it was postulated 
that myofibroblasts are derived from smooth muscle cells (Fisher et al., 1978; Sottiurai et al., 1978; 
Shum and McFarlane, 1988). However, this concept was rejected on the basis of 
immunocytochemical studies (Schurch et al., 1984; Eddy et al., 1988). Other concepts state that 
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myofibroblasts develop directly from mesenchymal cells (Dominguez-Malagon, 1993), epithelial 
cells (Bariety et al., 2003), pericytes (Lindahl et al., 1997), or circulating fibrocytes (Abe et al., 
2001; Metz, 2003). The most widely accepted concept is that myofibroblasts originate from 
fibroblasts (Gabbiani et al., 1971; Gabbiani and Badonnel, 1976; Gabbiani et al., 1976; Gokel and 
Hubner, 1977; Ariyan et al., 1978; Grinnell, 1994; Masur et al., 1996; Gabbiani, 2003). In healing 
wounds, an influx of fibroblasts from the surrounding tissue is observed. These fibroblasts 
differentiate into myofibroblasts after the appropriate stimuli (Schmitt-Graff et al., 1994).  
 Myofibroblasts are characterized by their cytoskeleton, which contains α-SMA, an actin 
isoform also present in smooth muscle cells (Darby et al., 1990; Desmouliere and Gabbiani, 1996; 
Gabbiani, 1998; Tomasek et al., 2002; Gabbiani, 2003). Additionally, their contractile apparatus 
contains bundles of actin microfilaments and associated contractile proteins, such as non-muscle 
myosin. This contractile apparatus is the major force-generating element involved in wound 
contraction (Desmouliere, 1995), and it is also found in cultured fibroblasts (Powell et al., 1999; 
Tomasek et al., 2002; Hinz and Gabbiani, 2003). The actin-containing stress fibers terminate in the 
fibronexus, which is a specialized transmembrane adhesion complex that links cytoplasmatic actin 
to extracellular fibronectin fibrils through integrins (Singer et al., 1984; Eyden, 1993; Powell et al., 
1999). This provides a mechano-transduction system, which transmits the forces generated by the 
stress fibers to the extracellular matrix (inside-out signaling) (Tomasek et al., 2002). In contrast, 
extracellular signals may induce an intracellular response (outside-in signaling) (Burridge and 
Chrzanowska-Wodnicka, 1996; Tomasek et al., 2002). Connections between myofibroblasts are 
established via adherence and gap junctions. The nuclei of myofibroblasts have multiple 
indentations (Darby et al., 1990; Valentich et al., 1997; Powell et al., 1999). Ordinary fibroblasts 
lack all of these characteristics (Eyden, 1993; Powell et al., 1999). 
 Until recently, myofibroblasts were divided into six different subtypes, based on 
immunohistochemical staining of cytoskeletal proteins (Gabbiani, 1994; Desmouliere and Gabbiani, 
1996; Desmouliere et al., 1997). In this classification, one of the myofibroblast subtypes is α-SMA-
negative (Sappino et al., 1990). Currently, it is thought that myofibroblasts should be classified into 
only two types (Hinz and Gabbiani, 2003). The first type, the proto-myofibroblast is partly 
differentiated and contains actin stress fibers but no α-SMA. This cell type also produces 
intracellular fibronectin and possesses small fibronexi (Tomasek et al., 2002; Hinz and Gabbiani, 
2003). The second type, expresses α-SMA and is considered to be the mature myofibroblast, 
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characterized by an extensive network of stress fibers and large fibronexi (Tomasek et al., 2002; 
Hinz and Gabbiani, 2003). 
 
Factors regulating myofibroblast differentiation  
Factors involved in the differentiation of fibroblasts into proto-myofibroblasts, and subsequently 
into mature myofibroblasts, are summarized in figure 1. Most factors directly or indirectly influence 
the expression of α-SMA, and are therefore involved only in the differentiation of proto-
myofibroblasts into mature myofibroblasts.  
 
Factors regulating the differentiation of fibroblasts into proto-myofibroblasts 
Mechanical tension generated by migrating fibroblasts promotes the assembly of stress fibers 
characteristic of the proto-myofibroblast (Tomasek et al., 2002; Hinz and Gabbiani, 2003). The 
increasing numbers of fibroblasts in the wound area secrete new collagen and fibronectin. The 
orientation of the cells and fibers within this matrix is parallel to the wound surface and along the 
lines of tension (Hinz et al., 2001). The fibroblasts exert small tractional forces on the newly 
formed matrix, reinforce cell-matrix contacts, develop intracellular contractile stress fibers, and, 
hence, become proto-myofibroblasts (Hinz and Gabbiani, 2003). The proto-myofibroblast 
phenotype is maintained by the continuous interaction between cell-generated tension and the 
reaction of a substratum that is sufficiently stiff to resist this force (Hinz and Gabbiani, 2003). 
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 Mechanical tension  
 PDGF 
 TGFβ1   
 Mechanical tension 
 ED-A FN  
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 Integrins  
 Low cell density  
 
 
 
 IFNγ    
 bFGF  
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 High cell density  
 
 
F 
proto-MF 
     mature MF 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The myofibroblast differentiation model.  indicates a stimulation of differentiation and  an inhibition of 
differentiation. Abbreviations: F = fibroblast; proto-MF = proto-myofibroblast; mature MF = mature myofibroblast; 
PDGF = platelet derived growth factor; TGF-β = transforming growth factor β; ED-A FN = ED-A (EIIIA) variant of 
fibronectin; GM-CSF = granulocyte/macrophage-colony-stimulating factor; IFN-γ = interferon-γ; bFGF = basic 
fibroblast growth factor; PGE2 = prostaglandin E2.  
 
 The role of platelet-derived growth factor (PDGF) in myofibroblast differentiation (Bostrom et 
al., 1996; Lindahl et al., 1997) is restricted to the differentiation of fibroblasts into proto-
myofibroblasts, since it does not induce the expression of α-SMA (Tomasek et al., 2002). However, 
PDGF might be important for the differentiation of keratocytes into myofibroblasts (Jester et al., 
2002). In conclusion, mechanical tension is a major factor promoting the differentiation of 
fibroblasts into proto-myofibroblasts, and PDGF might also be involved. 
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Factors promoting the differentiation of proto-myofibroblasts into mature myofibroblasts  
Mechanical tension, TGFβ1, and ED-A FN (a variant of fibronectin) are key players in the 
differentiation of proto-myofibroblasts into mature myofibroblasts (Tomasek et al., 2002; Gabbiani, 
2003; Phan, 2003). TGFβ1 stimulates the expression of ED-A FN and α-SMA, and it increases the 
assembly of stress fibers and focal adhesions both in vitro and in vivo (Borsi et al., 1990; 
Desmouliere et al., 1993; Ronnov-Jessen and Petersen, 1993; Yokozeki et al., 1997; Vaughan et al., 
2000).  
 ED-A FN is a specific variant of fibronectin that includes the splice segment ED-A, which is 
expressed only during early embryogenesis (Ffrench-Constant, 1995; Xia and Culp, 1995; Serini et 
al., 1998) and wound healing (Tomasek et al., 2002). During early embryogenesis, ED-A FN does 
not induce the differention of mature myofibroblasts because TGFβ1 is absent (Whitby and 
Ferguson, 1991). Therefore, the role of ED-A FN in myofibroblast differentiation is restricted to 
post-natal wound healing. Myofibroblasts preferentially bind to ED-A FN via the integrins α9β1 and 
α4β1 (Liao et al., 2002; Muro et al., 2003). In the presence of ED-A FN and TGFβ1 the 
myofibroblast phenotype is lost when mechanical tension is removed (Hinz et al., 2001). Thus, the 
differentiation of proto-myofibroblasts into mature myofibroblasts is stimulated by an interplay 
between TGFβ1 and ED-A FN in the presence of mechanical tension (Serini et al., 1998; Vaughan 
et al., 2000). 
 Other factors may also contribute to the differentiation of proto-myofibroblasts into mature 
myofibroblasts. Granulocyte-macrophage colony-stimulating factor (GM-CSF) seems to induce the 
synthesis of α-SMA in vivo (Rubbia-Brandt et al., 1991; Feugate et al., 2002), but not when it is 
added to cultured fibroblasts (Rubbia-Brandt et al., 1991). This suggests that GM-CSF stimulates 
the clustering of macrophages in vivo, which, in turn express TGFβ1 that stimulates the expression 
of α-SMA (Serini and Gabbiani, 1999). Indeed, the appearance of myofibroblast in vivo is often 
preceded by a cluster-like accumulation of macrophages (Vyalov et al., 1993; Serini and Gabbiani, 
1999). Heparin induces α-SMA in vitro (Desmouliere et al., 1992), but, in vivo, it requires tumor 
necrosis factor (TNF)-α (Desmouliere et al., 1992; Schmitt-Graff et al., 1994).  
 Integrins are also involved in the differentiation of proto-myofibroblasts into mature 
myofibroblasts (Dugina et al., 2001). The expression of the fibronectin receptor α5β1 increases 
concurrently with the increase in α-SMA in differentiating myofibroblasts (Masur et al., 1996; 
Masur et al., 1999). In fact, large clusters of this integrin are present in the fibronexi of mature 
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myofibroblasts (Dugina et al., 1998; Masur et al., 1999; Dugina et al., 2001). The binding of αvβ1, 
αvβ3, and αvβ5 integrins to vitronectin inhibits the differentiation of mature myofibroblasts (Scaffidi 
et al., 2001). Function-blocking monoclonal antibodies against these integrins induce the expression 
of α-SMA and its organization into stress fibers, which increases the contraction of collagen lattices 
(Scaffidi et al., 2001). The absence of cell-cell contacts also induces the differentiation into mature 
myofibroblasts. This is observed if fibroblasts are plated at a low density (Masur et al., 1996). The 
absence of cell-cell contacts is thought to cause an increase in the number of TGFβ receptors, 
resulting in an increase in the expression of α-SMA by TGFβ (Rizzino et al., 1988).  
 Cytokines that inhibit myofibroblast differentiation include interferon-γ (IFN-γ) (Hansson et 
al., 1989), bFGF (Schmitt-Graff et al., 1994; Spyrou and Naylor, 2002), and prostaglandin E2 
(PGE2) (Kolodsick et al., 2003). Both in vitro and in vivo, IFN-γ decreases α-SMA expression 
(Pittet et al., 1994; Spyrou and Naylor, 2002). Furthermore, IFN-γ decreases collagen lattice 
contraction by dermal or palatal fibroblasts (Moulin et al., 1998; Yokozeki et al., 1999). Also, 
bFGF inhibits the differentiation of myofibroblasts in vitro (Schmitt-Graff et al., 1994) and in vivo 
(Spyrou and Naylor, 2002; Kanda et al., 2003). Furthermore, bFGF induces apoptosis in 
myofibroblasts from rat palatal mucosa (Funato et al., 1997). Finally, PGE2 inhibits the TGFβ1-
induced expression of α-SMA in primary fetal and adult lung fibroblasts (Kolodsick et al., 2003). 
 In conclusion, mechanical tension is essential for the conversion of fibroblasts into proto-
myofibroblasts. The interplay between mechanical tension, TGFβ1 and ED-A FN largely regulates 
the differentiation of proto-myofibroblasts into mature myofibroblasts (Tomasek et al., 2002).  
 
Factors reducing wound contraction 
The reduction of wound contraction during intra-oral wound healing after cleft palate surgery might 
be achieved by the inhibition of differentiation of myofibroblasts, either by reducing “stimulatory 
factors” or by stimulating “inhibitory factors”. The stimulation of de-differentiation or apoptosis, or 
the impairment of myofibroblast function, is another possible approach.  
  
Inhibition of factors that induce myofibroblast differentiation  
The absence of TGFβ1 in fetal wounds is related to a reduced differentiation of myofibroblasts 
(Nodder and Martin, 1997; Moulin et al., 2001; Tomasek et al., 2002). This leads to less wound 
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contraction and scar formation. Elimination of TGFβ1 might therefore prevent wound contraction 
and scarring and has been studied extensively. Most of these studies report a strong reduction in α-
SMA and therefore a reduction in mature myofibroblasts (Shah et al., 1992; Arora and McCulloch, 
1999; Hinz et al., 2003). Neutralizing antibodies against TGFβ1 significantly inhibit collagen lattice 
contraction by palatal scar fibroblasts (Yokozeki et al., 1997). These antibodies also prevent scar 
formation during dermal wound healing (Shah et al., 1992). Wounds treated with anti-TGFβ1 
showed a lower inflammatory response and less deposition of extracellular matrix in the early 
stages of wound healing (Shah et al., 1999).  
However, in the later stages anti-TGFβ1 inhibits myofibroblast apoptosis (Funato et al., 1997; 
Funato et al., 1999), leading to a  prolonged presence of mature myofibroblasts. This might result in 
increased wound contraction and scar tissue formation. Due to this biphasic role of TGFβ1 during 
wound healing, its elimination may induce new problems, and proper timing of such treatment will 
be essential.  
 Another treatment modality might be the blocking of ED-A FN, which is essential for the 
differentiation of proto-myofibroblasts into mature myofibroblasts (Balza et al., 1988; Serini et al., 
1998). An antibody against ED-A FN specifically blocked the TGFβ1-triggered expression of α-
SMA and collagen type I in cultured fibroblasts (Serini et al., 1998). Therefore, the elimination of 
ED-A FN is a promising approach to improve the outcome of wound healing. Another advantage of 
ED-A FN is that it is present only in embryos and in wound tissues, which reduces the risk of side 
effects (Kornblihtt et al., 1996; Serini and Gabbiani, 1999; De Wever and Mareel, 2002). The 
relaxation of tension in collagen lattices reduces α-SMA, ED-A FN, and TGFβ1 levels (Arora and 
McCulloch, 1999; Hinz and Gabbiani, 2003). This indicates that ED-A FN and TGFβ1 are required 
for the expression of α-SMA, but tension is also a prerequisite. Since  in vivo releasing of tension is 
difficult, the feasibility of this technique for the modulation of wound healing is questionable.  
 
Stimulation of factors that inhibit myofibroblast differentiation 
The application of IFN-γ results in a decreased expression of α-SMA, both in vitro and in vivo 
(Pittet et al., 1994; Schmitt-Graff et al., 1994; Moulin et al., 1998; Cornelissen et al., 2000a). 
Moreover, intralesional injection of IFN-γ decreases the expression of α-SMA in patients with 
hypertrophic scars and Dupuytren’s disease, which are both characterized by persisting 
myofibroblasts (Pittet et al., 1994). Also, bFGF inhibits the differentiation of fibroblasts into 
  
Myofibroblasts in palatal wound healing 
 
 
 
49 
myofibroblasts, both in vivo and in vitro (Finesmith et al., 1990; Spyrou and Naylor, 2002). The 
application of bFGF to a wound results in a tissue architecture more closely resembling that of the 
normal uninjured situation (Spyrou and Naylor, 2002). PGE2  is another inhibitory factor for 
myofibroblast differentiation (Zhu et al., 2001; Kolodsick et al., 2003) and collagen lattice 
contraction in vitro (Zhu et al., 2001). However, the in vivo administration of PGE2 often causes 
severe side-effects, such as diarrhea, lethargy, and flushing (Paralkar et al., 2003). From the above 
data, we conclude that bFGF and IFN-γ are the prime candidates for reducing the expression of α-
SMA in myofibroblasts (Moulin et al., 1998).  
 
Stimulation of apoptosis 
Myofibroblasts disappear by apoptosis after closure of a wound (Desmouliere, 1995; Desmouliere 
et al., 1995). A reduction of wound contraction might therefore be achieved by the stimulation of 
myofibroblast apoptosis (Fesus et al., 1991). In palatal wound healing in the rat,  the number of 
myofibroblasts peaks in the second week after wounding occurs. This coincides with a peak number 
of apoptotic cells (Van Beurden et al., 2003). The stimulation of myofibroblast apoptosis by TGFβ1 
and bFGF might thus reduce the contraction of palatal wounds (Funato et al., 1999). However, as 
discussed before, TGFβ1 has a biphasic role during palatal wound healing in the rat. Early in wound 
healing, it stimulates the differentiation of myofibroblasts and after re-epithelialization it stimulates 
the apoptosis of myofibroblasts (Funato et al., 1997; Funato et al., 1999). bFGF also stimulates 
myofibroblast apoptosis (Funato et al., 1997; Funato et al., 1999). Moreover, the application of a 
mixture of TGFβ1 and bFGF had a synergistic effect (Funato et al., 1997; Funato et al., 1999). 
Apoptosis can also be stimulated by covering granulation tissue with a vascularized flap (Darby et 
al., 2002), or by a disruption of cell-matrix interactions (Frisch and Screaton, 2001). Loss of 
integrin-mediated cell adhesion initiates the response (Frisch and Francis, 1994) and can be 
provoked by RGD-containing peptides (Hadden and Henke, 2000). However, the use of small 
fibronectin peptides deserves caution since all integrin-mediated cell-matrix interactions may be 
disrupted. 
 
Impairment of myofibroblast function 
Impairment of myofibroblast function might be achieved by the modification of integrins on the cell 
surface. Integrins mediate the mutual contacts among myofibroblasts, and the contacts between 
  
Chapter 2 
 
 
 
 
50 
myofibroblasts and the surrounding matrix (van der Flier and Sonnenberg, 2001). The integrins 
α1β1, α2β1, α5β1 (Horwitz, 1997), and α8β1 (Levine et al., 2000) thus allow for the transmission of 
contractile forces through the wound (Racine-Samson et al., 1997). The binding of antibodies to 
these integrins might reduce wound contraction by preventing matrix contraction, or by preventing 
myofibroblasts differentiation (Arora et al., 1999). However, the same integrins on other cell types 
will also be blocked. Local application of the antibodies and proper timing of the treatment might 
reduce some of these side-effects. 
 Integrin function can also be modified with peptides containing the Arg-Gly-Asp (RGD) 
sequence. This sequence is a major recognition site for integrins (Arnaout et al., 2002). Since the 
integrin-mediated cell attachment also regulates fibroblast differentiation, simple RGD peptides 
might be used to prevent the appearance of myofibroblasts. A drawback of RGD peptides is that 
they may also affect other cell types, which causes unwanted side-effects. However, the 
performance of RGD peptides can be enhanced by stereochemical changes, which influence their 
efficiency and specificity (Williams, 1992). In conclusion, RGD peptides may reduce the 
attachment of myofibroblasts to the matrix, and thereby diminish wound contraction. This is 
supported by the inhibition of retinal pigment epithelial cell-mediated collagen lattice contraction 
by a disintegrin (Yang et al., 1997). However, the use of natural or artificial peptides containing the 
RGD sequence may cause severe side-effects.  
 
Other techniques  
Several other techniques with a possible beneficial effect on wound healing have been studied. 
They influence different aspects of the wound-healing process and include low-level laser therapy 
(In de Braekt et al., 1991), biodegradable membranes (In de Braekt et al., 1991; In de Braekt et al., 
1992), matrix substitutes (Fujioka and Fujii, 1997) and modified surgical techniques (Leenstra et 
al., 1995; Noguchi et al., 2003). The covering of the wound with a vascularized flap or a tissue-
engineered product may also reduce wound contraction (Darby et al., 2002; Von den Hoff et al., 
2006). Fetal surgery might be an option, since fetal wounds have been shown to heal without 
scarring. However, it is questionable whether this technique should be used in the treatment of non-
life threatening congenital anomalies (Weinzweig et al., 1999), of which the pre-natal cleft 
diagnosis is rather inaccurate. Additionally, the ethical problems related to  fetal repair of clefts 
have not yet been solved (Molsted, 1999). 
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Concluding remarks 
The surgical closure of a cleft palate is considered to impair maxillary growth and dento-alveolar 
development (Ross, 1987; Wijdeveld et al., 1991). Both wound contraction and scarring contribute 
greatly to these undesirable effects of surgery (Wijdeveld et al., 1987a; Wijdeveld et al., 1991). 
This review focuses on the role of myofibroblasts during the oral wound-healing process, and, more 
specifically, on their role in wound contraction. The reduction of wound contraction might improve 
the outcome of the oral wound-healing process. Recently, it has been described that fibroblasts 
initially differentiate into proto-myofibroblasts and subsequently into mature myofibroblasts, both 
of which contribute to wound contraction (Tomasek et al., 2002; Gabbiani, 2003). Several factors 
that regulate these differentiation pathways are now known. Some of them might be promising as 
targets for therapeutical intervention and are described in this review. Table 1 summarizes these 
possible treatment modalities. Some of them seem to be feasible for therapeutic intervention, while 
others have too many disadvantages. The application of TGFβ inhibiting factors is often described 
as a promising tool to reduce the differentiation of fibroblasts into mature myofibroblasts. However, 
due to its bivalent role in wound healing, the application of this cytokine is not without a risk. 
Among the more promising growth factors are IFN-γ and bFGF, because both factors have been 
shown to inhibit the differentiation of proto-myofibroblasts into mature myofibroblasts, both in vivo 
and in vitro. Blocking of ED-A FN seems to be most promising, because the risk of side effects will 
be negligible, since it is expressed excusively during wound healing. Future studies should focus on 
the topical application of these promising substances, or on their incorporation into suitable carrier 
materials. Recently it was shown that cells originating from the bone marrow also contribute to 
wound healing and possibly also to fibrosis (Fathke et al., 2004; Ishii et al., 2005). This might offer 
new prospects for therapy. 
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Table 1: Different treatment modalities and their clinical feasibility. 
 
Treatment Modality Feasibility 
Neutralize stimulatory factors 
TGF-β1 
ED-A FN 
Mechanical tension 
 
+ 
++ 
- 
 
Apply inhibiting factors 
IFN-γ 
bFGF 
TGF-β + bFGF 
PGE2 
 
 
+ 
+ 
+ 
- 
 
Others 
Apoptosis induction 
Antibodies 
RGD-peptides 
 
 
- 
- 
- 
Abbreviations: TGF-β1 = transforming growth factor β1; ED-A FN = ED-A 
(EIIIA) variant of fibronectin; IFN-γ = interferon-γ; bFGF = basic fibroblast 
growth factor; PGE2 = prostaglandin E2. -: not feasible, +: promising, ++: 
most promising. 
 
 Most of the research on myofibroblasts has been performed on skin, although some research on 
oral mucosa has also been published. The differences and similarities between wound healing in the 
dermis and that in the oral cavity are discussed in this review. The most remarkable differences are 
that wounds in the oral mucosa heal faster and with less scarring than do dermal wounds. In spite of 
this, the specific features of the palatal mucoperiosteum give rise to extensive wound contraction 
and scar tissue formation. This knowledge should be borne in mind for the development of 
therapeutic interventions to improve the outcome of cleft palate surgery. 
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Abstract 
The objective of this study was to characterize fibroblasts at sequential time points during intra-oral 
wound healing in the rat. Experimental wounds were made at several time points in the 
mucoperiosteum of the palate of 35-day-old Wistar rats. Fibroblasts were cultured from the biopsies 
under standard conditions for the same number of passages. The expression of the integrin subunits 
α1, α6, and β1; and the intermediate filaments a-smooth-muscle actin and vimentin were analyzed 
by flow cytometry. Western blot analysis was performed at 0, 8, and 60 days postwounding to 
confirm the expression of both intermediate filaments. The phenotypic profiles of fibroblasts 
cultured from subsequent stages in the wound-healing process differed considerably. We conclude 
that distinct fibroblast phenotypes can be isolated from different stages in wound healing. These 
phenotypes remained stable during in vitro culturing. In addition, cryosections of the wound areas 
were made at identical time points and were immunohistochemically stained for the same antigens. 
The immunohistochemical staining correlated well to the flow-cytometric data. These results 
suggest the occurrence of multiple subpopulations of fibroblasts with a specialized function during 
wound healing. We hypothesize that undesirable consequences of wound healing might be 
prevented through the modulation of specific fibroblast subpopulations. 
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Introduction 
Following injury, the wound-healing process consists of subsequent phases involving inflammation, 
granulation tissue formation, and tissue remodeling (Clark, 1996). The deposition of a fibrin clot 
and the onset of an acute inflammation (Ehrlich and Krummel, 1996) characterize the initial phase. 
The transition to granulation tissue starts with the migration of fibroblasts out of the wound margins 
into the wound. The fibroblasts attach to the provisional matrix and start to produce granulation 
tissue components. The matrix of this relatively loose tissue mainly consists of fibronectin, 
collagen, and hyaluronic acid (Clark, 1996). Simultaneously, reepithelialization occurs by the 
proliferation and migration of epithelial cells from the wound edges. A specialized population of 
differentiated fibroblasts, the myofibroblasts, appears during this second phase. These cells express 
smooth muscle cytoskeleton proteins (α-smooth muscle actin [α-SMA] in particular) and are 
involved in the production of extracellular matrix (ECM) and in tissue contraction (Desmouliere 
and Gabbiani, 1996; Gabbiani, 1998). In the third phase of wound repair, fibroblasts remodel the 
ECM, leading to a rather acellular scar (Clark, 1996).  
 Fibroblasts obviously play a crucial role during several stages of the wound-healing process. 
The α-SMA-positive myofibroblast is a fibroblast subtype that has been studied intensively 
(Gabbiani et al., 1971; Skalli et al., 1986; Desmouliere et al., 1992). This fibroblast subtype is 
present in the granulation tissue during the contraction of the wound. The transition of fibroblasts to 
myofibroblasts strongly supports the hypothesis of fibroblast plasticity (Schmitt-Graff et al., 1994). 
However, a prolonged presence of myofibroblasts in the wound might lead to fibrocontractive 
diseases (Desmouliere et al., 1992).  
 Phenotypical differences in fibroblasts, cultured from dermis, articular tissues, mesothelial 
surfaces, and mucoperiosteum have been reported (Castor et al., 1962). Fibroblast heterogeneity has 
also been shown for human skin fibroblast clones differing in collagen synthesis (Botstein et al., 
1982), for human skin fibroblasts varying in the ability to respond to prostaglandin E2 (Korn, 
1985), and for their differences in cell surface markers as analyzed by flow cytometry (Phipps et al., 
1989).  
 Fibroblast functions such as migration, wound contraction, and matrix remodeling strongly 
depend on their contact with the ECM. This contact is mediated by a specialized group of adhesion 
molecules, the integrins. Integrins are a family of transmembrane glycoproteins that mediate cell–
ECM and cell–cell adhesion. Each integrin is composed of a noncovalently linked α and β subunit. 
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The classification of integrins is based on their β-subunit (Ruoslahti, 1991; Hynes, 1992; Horwitz, 
1997). Integrin receptors are found on the surface of most cells involved in wound healing. 
Immediately after injury, αIIbβ3 integrin mediates the interactions between platelets and ECM 
components such as fibrin, vitronectin, von Willebrand-factor VIII, and thrombospondin (Clark, 
1996). During granulation tissue formation, integrins are required for neovascularization and 
fibroblast migration (Clark, 1990). During wound contraction, α2β1 (Hemler, 1990; Schiro et al., 
1991) and α5β1 (Welch et al., 1990) are involved in the contact of the fibroblasts with the ECM. 
These integrins allow the contractile forces to be transmitted over the wound. Both α-SMA and 
vimentin are required for the generation of these contractile forces. During reepithelialization, 
keratinocytes use integrins for attachment to and migration over the granulation tissue. The 
expression of α6β4 is thought to be unique for keratinocytes and is required for anchoring basal 
keratinocytes to the basement membrane (Sonnenberg et al., 1991; Clark, 1996). During the 
remodeling phase, α1β1 and α2β1 mediate the interaction between the fibroblasts and collagen I, the 
main element of scar tissue (Hemler, 1990).  
 The purpose of this study was to determine phenotypic differences between fibroblasts cultured 
from biopsy specimens obtained during subsequent stages in wound healing, and to compare these 
results to immunohistochemical stainings of wound sections. We analyzed the expression of three 
integrin subunits, α1, α6, and β1, and the intermediate filaments α-SMA and vimentin in cultured 
fibroblasts and in wound biopsy specimens. A recently established model for intra-oral wound 
healing in the rat was used (Cornelissen et al., 1999).  
 
Materials and methods 
Animals 
A total of 70 5-week-old male Wistar rats (Harlan, Zeist, The Netherlands) were used. The rats 
weighed 119 ± 9 g and had been acclimatized to the animal facility for 1 week before the start of the 
experiments. All animals were kept under normal laboratory conditions and were fed ad libitum. 
The experiments were approved by the Board for Animal Experiments of the Radboud University 
Nijmegen Medical Centre.  
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Intra-oral wounding and preparation of wound tissue 
The rats were divided into two weight-matched groups before initial wounding (t = 0 days). Both 
groups consisted of 35 rats and were intended for fibroblast culture and immunohistochemistry, 
respectively. All rats were anesthetized with an intraperitoneal injection of 0.4 ml/kg body weight 
fentanyl and fluanisone (Hypnorm®, Janssen-Cilag, Beerse, Belgium). Full-thickness excisional 
wounds were made in the mucoperiosteum of the hard palate between the second molars using a 3-
mm biopsy punch. The initial wounds included the submucosa and at least one of the two 
neurovascular bundles (Cornelissen et al., 1999). The wounded rats were medicated postoperatively 
with a subcutaneous injection of 0.1 mg/kg body weight buprenorphine (Temgesic®, Schering-
Plough, Brussels, Belgium) as an analgesic. Animals were euthanized with a mixture of 
CO2/Carbogene at 3, 5, 8, 15, 30, 60, and 90 days after initial wounding. A total of 35 rats, five per 
time point, were used for culturing fibroblasts and immunohistochemical analysis, respectively. 
Three-millimeter biopsy specimens were obtained for fibroblast culture, and for 
immunohistochemical analysis, 4-mm biopsy specimens were obtained to include the wound 
margins. These samples were immediately immersed in OCT compound (Tissue-Tek, Sakura 
Finetek Europe, Zoeterwoude, The Netherlands), frozen in liquid nitrogen, and stored at -80°C.  
 
Primary fibroblast cultures 
Biopsy specimens were transported in sterile phosphate buffered saline solution (PBS), washed 
extensively, cut into at least 20 small pieces, and placed into a single well of a 24-well culture plate 
containing Dulbecco’s Modified Eagle’s Medium (DMEM) with 25 mm 4-(2-hydroxyethyl)-1-
piperazine-ethanesulfonic acid (HEPES), sodium pyruvate, 1000 mg/l glucose and pyridoxine 
supplemented with 10% fetal bovine serum (FBS) and 100 U/ml penicillin, and 100 μg/ml 
streptomycin (all from Gibco Life Technologies Ltd, Paisley, Scotland). The tissue explants were 
left undisturbed for 1 week in the incubator (37°C, 5% CO2) to allow the outgrowth of fibroblasts. 
After 7 days, the cultures were trypsinized with 0.25% trypsin (Gibco) in DMEM and transferred to 
a 25-cm2 culture flask (Nalge Nunc Int. Corp., Naperville, IL). Cultures were successively passaged 
to one and three 75 cm2 culture flasks. Finally, cell cultures were frozen (0.5 x 106 cells per vial) in 
7.5% dimethyl sulfoxide (DMSO, ICN Biomedicals Inc., Aurora, OH) in culture medium and stored 
in liquid nitrogen until use. Cultured cells were Von Willebrand-factor VIII– and cytokeratin 10–
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negative, excluding the possibility of a fibroblast population mixed with endothelial cells and 
keratinocytes.   
 
Flow cytometry 
Frozen fibroblast suspensions were quickly thawed and washed to remove DMSO. Cells were 
cultured in a 25-cm2 culture flask, and at 90% confluence cells were passaged to 75 cm2 culture 
flasks. At 90% confluence, cells were harvested by trypsinization and single-cell suspensions were 
prepared. Approximately 105 cells were washed in 0.5% PBSA (0.5% bovine serum albumin 
[Sigma Chemical Co., Saint Louis, MO] in PBS with 0.05% NaN3) and incubated for 30 minutes at 
4°C with primary antibody. The following primary antibodies were used: rabbit-anti-rat α1 (anti-CD 
49a); rabbit-anti-rat β1 (anti-CD 29, both a gift of Dr. Löster, Berlin, Germany) and mouse-anti-rat 
α6 (anti-CD 49f, Instruchemie, Hilversum, The Netherlands). The cells were successively washed 
with PBSA and incubated with secondary antibody for 30 minutes at 4°C. A goat-anti-rabbit 
fluorescein isothiocyanate (FITC; Sigma) was used for polyclonal antibodies and a goat-anti-mouse 
FITC (Sigma) for monoclonal antibodies. After washing with PBSA, cells were analyzed on a 
FACScan flow cytometer (Becton Dickinson, Oxnard, CA). Color emission analysis was performed 
using a band pass filter for FITC-labeled probes. Gates were set to exclude debris. At least 3000 
cells were scanned and displayed as cell count versus log-fluorescence intensity. The relative size of 
the positive population was determined from these graphs. The mean fluorescence intensity of the 
positive population was calculated by subtraction of the control sample (without primary antibody) 
from the mean fluorescence intensity of the total population. For each time point, fibroblast cultures 
of five rats were analyzed in duplicate, averaged, and plotted as mean ± standard error of the mean 
(SEM).  
 The intracellular intermediate filaments required additional treatment before flow-cytometric 
analysis. Single-cell suspensions were treated as above with the addition of a fixation step (1.0% 
paraformaldehyde in PBSA for 20 minutes at 0°C) and a permeabilization step (0.1% Saponin 
[Sigma] in PBSA for 20 minutes at 0°C) after the first washing procedure. The following antibodies 
against intermediate filaments were used: a mouse-anti-human α-SMA (Sigma) and a rabbit-anti-
human vimentin (a gift of K. Maass, Nijmegen, The Netherlands). 
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Western blotting 
Fibroblasts were lysed according to the method of Pagan and coworkers (Pagan et al., 1999). After 
washing in PBS, the cells were incubated with lysis buffer (10 mm Tris/HCl with 140 mM NaCl, 
1.5 M KCl, 5 mM EDTA, 0.5% Triton X-100 and 1 mM phenylmethylsulfonyl fluoride, pH 7.6) for 
30 minutes at 4°C. The lysate was removed and the remaining insoluble residue was scraped off and 
resuspended in the same buffer. This suspension was centrifuged (2500 g, 30 minutes, 4°C) and the 
pellet was washed in PBS. After centrifugation of the suspension (3000 g, 10 minutes, 4°C), the 
pellet was resuspended in PBS with 1 mM phenylmethylsulfonyl fluoride and stored at -20°C. 
Before use, the cell lysate was quickly thawed, heated (95°C, 5 minutes), cooled down, and mixed 
gently. Protein concentrations of the cell lysates were determined with the Bradford assay (Pierce, 
Rockwell, IL) and the same amount of protein was loaded on each lane. Polyacrylamide gel 
electrophoresis was performed under reducing conditions, using a 10% gel with 0.1% sodium 
dodecyl sulfate and a Tris-HCl buffer on a Minigel system (BioRad Laboratories, Hercules, CA). 
Proteins were electrophoretically transferred onto a nitrocellulose membrane (BioRad) in a Trans-
Blot cell (Biorad) at 400 mA for 1 hour. Membranes were blocked overnight in 3% PBSA and 
incubated for 1 hour at room temperature with the primary antibodies. The following antibodies 
were used: a mouse-anti-human α-SMA (Sigma), a rabbit-anti-human vimentin, and a mouse-anti-
human vimentin (Biogenex, San Ramon, CA).  
 After washing, the alkaline phosphatase-conjugated secondary antibody was added for 1 hour. 
The blots were developed with the Enhanced ChemoLuminescence system (ECL; Amersham 
Pharmacia Biotech., Buckinhamshire, UK). Scanning densitometry was performed on a Gel-Doc 
2000 system (BioRad). 
 
Immunohistochemistry 
Ten serial cryosections (4 μm) were obtained from the center of each biopsy specimen. The 
cryosections were fixed in 100% acetone for 10 minutes and washed in PBS with 0.05% Tween 20 
(PBST, Sigma). To block endogenous peroxidase activity, the sections were treated for 20 minutes 
with 3% H2O2 in PBST. After rinsing in PBST, the sections were incubated with 5% bovine serum 
albumin in PBST for 20 minutes to prevent nonspecific binding. The excess was tipped off and the 
sections were incubated with primary antibody overnight at 4°C (anti-integrins and anti-vimentin) 
or 1 hour at room temperature (anti-α-SMA). After washing with PBST, the secondary antibodies 
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were added for 60 minutes at room temperature. Biotinylated donkey-anti-mouse immunoglobulin 
(Jackson Immunoresearch, West Grove, PA) was used for the α6 integrin anti-monoclonal antibody 
and peroxidase-conjugated goat-anti-mouse for the monoclonal antibodies against α-SMA and 
vimentin. Biotinylated goat-anti-rabbit immunoglobulin (Chemicon International Inc., Temecula, 
CA) was used for all polyclonal antibodies. Subsequently, avidin/biotin horseradish peroxidase 
macromolecular complex (ABC kit, Vector laboratories, Burlingame, CA) was added for 30 
minutes for the biotinylated antibodies. Peroxidase activity was visualized by incubation with 3,3’-
diaminobenzidine tetrahydrochloride (SigmaFast, Sigma). The staining was enhanced by incubating 
the sections for 10 minutes in 0.5% CuSO4 in saline. Sections were counterstained with Dellafield’s 
hematoxylin, dehydrated, and mounted in DPX (Brunschwig chemie, Amsterdam, The 
Netherlands). In negative controls, the primary antibody or both primary and secondary antibodies 
were omitted. All controls were negative and showed no background staining. The level of staining 
in the submucosa of three rats at each time point was evaluated on a 4-point scale as follows: very 
high=3, high=2, low=1 and absent=0. The sections were evaluated independently by two 
investigators (H.v.B and P.S.) and expressed as mean score ± standard error of the mean. 
 
Results 
Fibroblasts were cultured under standard conditions from wound biopsy specimens taken at several 
time points after wounding. The expression of integrin subunits α1, β1, and α6 and both intermediate 
filaments was analyzed by flow cytometry. The mean fluorescence intensity and the size of the 
positive population were plotted against time for each antigen (figure 1).  
 
Flow-cytometric analysis of integrin expression 
The mean fluorescence intensity of the fibroblasts cultured from day 0 biopsy specimens and 
stained for integrin subunit α1 was 16 (figure 1A, dashed line). A peak was observed at 5 days 
postwounding (PW), after which the fluorescent intensity returned to its initial level at 90 days PW. 
About 53% of the day 0 fibroblasts were positive for α1 (figure 1A, solid line). This percentage 
decreased to 21% at 3 days PW, after which it increased and showed a peak of 56% at 5 and 8 days 
PW. A maximum of 62% was observed at 30 days PW. Finally, the percentage of positive cells 
decreased slowly to about the initial level at 90 days PW.  
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 The initial mean fluorescence intensity after staining for integrin subunit β1 was 148 (figure 1B, 
dashed line). Successively, the fluorescence intensity increased to 5 days PW, decreased strongly to 
day 30 PW, and increased to a second peak at 60 days PW. About 75% of the day 0 cells expressed 
the β1 subunit, increasing to a peak of 94% at 30 days PW (figure 1B, solid line). The size of the 
positive population at 90 days PW (65%) was slightly smaller than that at day 0.  
 The mean fluorescence intensity after staining for the α6 integrin subunit showed less change 
than that for the α1 and β1 subunits (figure 1C, dashed line), although similar fluctuations were 
observed during the first 2 weeks PW. The fluorescence intensity at day 0 was slightly lower than at 
90 days PW, without any obvious peak levels in between. The size of the positive population 
fluctuated between 53% at 15 days PW and 77% at 60 days PW (figure 1C, solid line). The size of 
the initial positive population correlated to that at day 90.  
 A dynamic period in the expression of all three integrin subunits was found during the first 2 
weeks PW. The high standard errors during this period were probably due to variations between 
rats. 
 
Flow-cytometric analysis of the expression of intermediate filaments 
The mean fluorescence intensity of the fibroblasts cultured from biopsies taken at day 0 was very 
low after staining for α-SMA (figure 1D, dashed line). The intensity successively increased to a 
maximum at day 8 and decreased through 90 days PW. The majority of the fibroblast population 
(81%) was positive for α-SMA at day 0 (figure 1D, solid line), decreasing to 35% at 3 days PW. A 
peak level of 74% was observed at 8 days PW, after which the size of the population progressively 
decreased to 36% at 90 days PW.  
 The initial mean fluorescence intensity after staining for vimentin was remarkably low, with a 
value of 3 (figure 1E, dashed line). Hereafter, the fluorescence intensity increased rapidly to a peak 
at 8 and 15 days PW, after which the intensity returned to a low level at 30 days PW. After day 30, 
the fluorescence intensity increased slightly to 90 days PW. Eight percent of the day 0 fibroblasts 
were positive for vimentin, increasing to 76% between 8 and 15 days PW (figure 1E, solid line). 
Finally, the size of the positive population decreased to 48% at 90 days PW.  
 To summarize the flow-cytometric data, phenotypic profiles were plotted for three time points 
(0, 8, and 60 days PW, figure 2). Because of problems with the vimentin antibody, these data were 
omitted from the phenotypic profile (see western blot analysis). The fluorescence intensities at day 
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0 were set at 100% and the intensities of day 8 and 60 were plotted relative to day 0. The expression 
of the integrin subunit α1 and α-SMA showed considerable differences between the three cell 
populations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flow-cytometric analysis of cultured fibroblasts on a FACScan flow cytometer. At least 3000 cells were 
scanned and displayed as cell count versus log-fluorescence intensity. The relative size of the positive population was 
determined from these graphs (solid line). The mean fluorescence intensity of the positive population was calculated by  
subtraction of the control sample from the mean fluorescence intensity of the total population (dashed line). Fibroblasts 
were stained for the integrin subunits α1 (A), β1 (B), and α6 (C) and the actin filament α-SMA (D) and intermediate 
filament vimentin (E). For each time point, fibroblast cultures of five rats were analyzed in duplicate, averaged, and 
plotted as mean ± SEM. 
10
30
50
70
90
10
30
50
70
90
T im e (days)
0 20 40 60 80 100
0
40
80
120
160
200
240
10
30
50
70
90
-
-
-
-
-
-
-
 
Fl
uo
re
sc
en
ce
 in
te
ns
ity
 --
---
--
10
30
50
70
90
_
_
_
_
_
_
 
Pe
rc
en
ta
ge
 o
f p
os
iti
ve
 c
el
ls
 _
__
10
30
50
70
90
80
120
160
200
240
280
 
10
30
50
70
90
200
600
1000
1400
1800
2200
10
30
50
70
90
A 
B 
C 
D 
E 
α1 
β1 
α6 
α-SMA 
Vim 
  
Chapter 3 
 
 
 
 78 
 
 
  
 
 
 
 
Figure 2: Phenotypic profiles of fibroblasts based on data obtained from figure 1. The fluorescence intensity at day 0 
was set at 100% and the profiles of day 8 and 60 were plotted relative to day 0. The  expression of α1 integrin subunit 
and α-SMA varied considerably in the three cell populations. 
Western blot analysis of both intermediate filaments  
To verify the flow-cytometric data of days 0, 8, and 60, the intracellular content of both 
intermediate filaments was analyzed by western blotting (figure 3). The expression of α-SMA was 
nearly undetectable at day 0, very high at 8 days PW, and a little less at 60 days PW. Obviously, 
these results qualitatively correlated with the flow-cytometric results (figure 1D). Because the initial 
vimentin expression found with flow cytometry (determined with a polyclonal antibody) was 
extremely low, we verified the expression with the same antibody by western blot analysis. In 
contrast, the expression of vimentin was equal at days 0, 8, and 60 PW (figure 3). Consequently, we 
used a monoclonal antibody, which was not yet available at the time of the flow-cytometric 
analysis, to confirm the expression found with the polyclonal antibody. The vimentin expression in 
western blotting was similar for both antibodies (figure 3). Because of the contradiction between the 
data of flow cytometry and western blotting, we regarded the flow cytometric data at day 0 as not 
reliable and omitted them from the profiles (figure 2). 
 
Immunohistochemical analysis of integrin subunits and intermediate filaments   
Immunohistochemical analysis was performed on wound biopsy specimens taken at subsequent 
time points in wound healing. The wound biopsy specimens included the complete mucoperiosteum 
(figure 4). The level of staining was evaluated on a 4-point scale for each antibody and summarized 
in table 1. An overview of representative immunohistochemical micrographs, stained for the 
integrin subunit α1 and both intermediate filaments, is shown in figure 4. These micrographs 
originated from biopsy specimens obtained at 0, 8, and 60 days PW. 
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Figure 3: Western blot analysis of the intermediate filaments. Analysis was performed with a monoclonal antibody 
(mAb) against α-SMA (A), a mAb against vimentin (B) and a polyclonal antibody (pAb) against vimentin (C) at 0, 8, 
and 60 days PW. The expression of α-SMA was negligible at day 0, very strong at 8 days PW, and slightly weaker at 60 
days PW. The expression of vimentin determined with the monoclonal antibody and the polyclonal antibody was 
similar and showed a comparable expression at days 0, 8, and 60 PW. 
 In general, integrin subunit α1 expression was found in the vascular structures in the 
mucoperiosteum (figure 4, A–C) and in inflammatory cells present during the first 5 days of the 
wound-healing process (not shown). In normal palatal mucoperiosteum (day 0), the level of staining 
of the α1-positive fibroblasts was 1.67 (table 1). A peak in the level of staining was observed 
between 5 and 8 days PW (2.75), after which the level successively decreased to 30 days PW and 
increased to a second peak at 90 days PW. The immunohistochemical staining of integrin subunit 
α1 agreed weakly with the flow-cytometric results; however, the maximum level of staining 
occurred at the same time point.  
 The antibody against the β1 subunit gave an overall membrane labeling of fibroblasts during all 
time points in wound healing (data not shown). Furthermore, anti-β1 integrin reacted with vascular 
endothelia and gave an evenly distributed labeling of epithelial cells (not shown). The level of 
staining at day 0 amounted to 1.5 and increased to 2.5 at 8 days PW (table 1). A second peak was 
observed at 30 days PW (3.0). The correlation between the immunohistochemical data and the 
number of positive cells found with flow cytometry was high (table 1). Corresponding peaks were 
observed at 8 and 30 days PW.  
 In general, the α6 integrin subunit showed intense expression in the first two or three layers of 
the epithelium and in vascular endothelia of the connective tissue. Surprisingly, most connective 
tissue fibroblasts also expressed this subunit. The antibody against the α6 subunit showed stable 
fibroblast labeling during wound healing (not shown), although a small peak was observed at 15 
58 kDa 
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days PW (table 1). The level of staining at day 0 was similar to that at 90 days PW. The 
immunohistochemical data correlated well with the flow-cytometric data (table 1).  
 
Intermediate filaments 
Anti-α-SMA antibodies reacted with vascular structures in the mucoperiosteum (figure 4, d–f). No 
α-SMA staining was observed in fibroblasts of the normal palatal mucoperiosteum (table 1). 
Fibroblasts showed α-SMA expression from 3 days PW (0.7) and the level of staining increased to 
a maximum at 8 days PW (3.0). The level of staining decreased rapidly after closure of the wound, 
although some positive cells were still found at 90 days PW. The immunohistochemical data 
correlated well with the flow-cytometric data. The western blot data also correlated with the 
immunohistochemical data (figure 3).  
 The monoclonal antibody was used for the vimentin staining because this antibody was more 
specific than the polyclonal antibody and gave less background staining. This antibody showed an 
overall and intense cytoskeletal staining of fibroblasts (figure 4, G–I). In addition, vimentin was 
expressed by vascular cells in the mucoperiosteum (figure 4, G–I).  
Successively, the level of staining decreased after wounding (day 3), increased to a maximum at 15 
(3.0) and 30 (3.0) days PW, and decreased slightly to 1.8 at 90 days PW (table 1). A good 
correlation was observed between the intensity of the vimentin bands in western blotting and the 
level of staining in immunohistochemistry (figure 3). 
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Figure 4: Immunohistochemical staining of wound biopsy specimens. Wound sections stained for the integrin subunit 
α1 (A–C), and the intermediate filaments α-SMA (D–F) and vimentin (G–H) at 0, 8 and 60 days PW are shown. (A–C) 
Palatal mucoperiosteum stained for integrin subunit α1 at 0 (A), 8 (B), and 60 (C) days PW. The number of α1-positive 
cells was high during all three time points in wound healing. In addition to fibroblasts, the antibody reacted with 
vascular structures (arrows) in the mucoperiosteum. (D–E) α-SMA staining of the palatal mucoperiosteum at 0 (D), 8 
(E) and 60 (F) days PW. No α-SMA staining was found in the fibroblasts at day 0, however, the antibody reacted with 
vascular structures in the submucosa (arrow). An intense staining of cells was observed in the granulation tissue of the 
healing wound at 8 days PW. At 60 days PW, the submucosa showed a very low α-SMA staining. (G–I) Vimentin 
staining of the palatal mucoperiosteum at 0 (G), 8 (H), and 60 (I) days PW. An intense staining of fibroblasts was 
observed at day 0, 8 and 60, with the strongest staining at 8 days PW. In addition, vimentin was localized in the 
vascular structures of the submucosa. E = epithelium, M = submucosa, and arrows indicate vascular structures. Bar 
represents 50 μm. 
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 Table 1: Level of immunohistochemical staining of wound sections. 
 
Staining intensity 
 
Fibroblast marker Initial Peak End Correlation with flow 
cytometry * 
day 0 day 5 day 90 
α1 
1.67 ± 0.41 2.83 ± 0.20 2.67 ± 0.41 
+ 
day 0 day 30 day 90 β1 
1.50 ± 0.50 3.00 ± 0.50 2.50 ± 0.00 
+ + 
 
day 0 day 15 day 90 
α6 
1.83 ± 0.20 2.33 ± 0.20 1.83 ± 0.20 
+ + 
 
day 0 day 8 day 90 
α-SMA 
0.00 ± 0.00 3.00 ± 0.00 0.67 ± 0.41 
+ + + 
 
day 0 day 15, 30 day 90 
Vim 
2.25 ± 0.25 3.00 ± 0.00 1.75 ± 0.25 
+ 
 
The level of staining in the submucosa of three rats at each time point was evaluated on a 4-point scale as 
follows: very high = 3, high = 2, low = 1, and absent = 0. The sections were evaluated independently by 
two investigators and expressed as mean ± SEM. In particular, the level of staining of the integrin subunits 
β1, α6 and α-SMA correlated highly with the flow-cytometric results. 
*Correlation with flow cytometry (+ + +) very high (+ +) high (+) low ( ) absent.  
 
 
Discussion 
Although fibroblasts are traditionally described as static cells providing maintenance and support 
for tissues (Sempowski et al., 1995), there is accumulating evidence showing that fibroblasts are 
dynamic cells occurring in functionally and morphologically heterogeneous subpopulations. The 
origin of wound fibroblasts is unclear, although they have been proposed to originate from the 
wound margins or from a subpopulation of resident connective tissue fibroblasts (Hakkinen and 
Larjava, 1992). The wound-healing process involves changes of these cells from quiescent to 
proliferating cells and subsequently to migratory, ECM-producing and contracting cells (Hakkinen 
et al., 2000). Clark has also suggested that fibroblasts undergo phenotypic changes to accomplish 
these various tasks (Clark, 1988).  
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 Several studies on cultured fibroblasts also support the existence of fibroblast subpopulations. 
Early work on the heterogeneity of fibroblasts was done by Castor and coworkers (Castor et al., 
1962). They found metabolic differences between mesothelial fibroblasts and fibroblasts of skin, 
articular tissues, and periosteum. Mesothelial fibroblasts showed less proliferative activity and a 
higher production of uronic acid–containing mucopolysaccharides compared to the other fibroblast 
types. In addition to these in vitro differences between fibroblasts from distinct anatomical sites, 
some studies also point toward the existence of fibroblast subpopulations within the same tissue. 
Elias and coworkers detected three distinct populations of human lung fibroblasts, although these 
subpopulations did not retain their discrete phenotypes after prolonged culture (Elias et al., 1987). 
Cultured granulation fibroblasts from both chronically inflamed periodontal lesions and healing 
wounds gave rise to subpopulations differing in morphology and growth potential (Hakkinen and 
Larjava, 1992).  
 Fibroblasts from normal dermis, reparative granulation tissue, and mature scars differed 
considerably in the level of matrix synthesis in vitro (Bertolami and Bronson, 1990). In our study, 
we show the presence of distinct fibroblast phenotypes in fibroblasts cultured from biopsies taken at 
subsequent time points in wound healing. The cultured fibroblasts differed in the expression of a 
panel of integrin subunits and intermediate filaments. Sempowski and coworkers postulated that in 
vitro differences between fibroblasts must be considered carefully, because culture artifacts may be 
involved (Sempowski et al., 1995). To minimize the risk of culture artifacts, we used identical 
culture conditions for all fibroblast populations. In addition, we verified the stability of the 
fibroblast phenotypes during prolonged culture. The fibroblasts showed no significant changes in 
expression of the markers up to eight passages, based on flow cytometry (data not shown). Schor 
and coworkers observed a similar phenotypic stability up to seven passages of subpopulations of 
papillary gingival fibroblasts (Schor et al., 1996). The phenotypic profile of the fibroblasts cultured 
from biopsies taken at day 0 was used as a reference for the profiles from fibroblasts taken at 
subsequent time points (figure 2). The phenotypic profiles comprised the integrin subunits α1, β1 
and α6 and the intermediate filament α-SMA. The intermediate filament vimentin showed an 
extremely low expression level in day 0 fibroblasts based on flow cytometry. However, western 
blotting showed a much higher expression level, similar to that of day 8 and 60. This suggests that 
the accessibility of the epitope and/or the affinity of the vimentin antibody may vary substantially 
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between the two experimental techniques. Therefore, the vimentin data were not included in the 
profiles.  
 The day 0 tissue represents normal, unwounded mucosa. In this tissue, fibroblasts are 
surrounded by a matrix that contains collagen as a major component. The α1 subunit was highly 
expressed on fibroblasts cultured from this time point.  
 The α1 subunit is probably present in the collagen receptor α1β1, which is the only known 
dimer containing the α1 subunit (Kagami et al., 1999). The β1 subunit was also highly expressed on 
day 0 fibroblasts. The α1β1 integrin is, at least in part, responsible for the interaction between 
fibroblasts and the surrounding matrix (Carver et al., 1995) and is also suggested to be involved in 
the regulation of collagen synthesis (Gardner et al., 1999). The β1 subunit can also associate with 
several other α subunits (Yasoshima et al., 2000). Our data further show the presence of the integrin 
subunit α6 on day 0 fibroblasts. This was also found in tissue sections of day 0 biopsies. Conflicting 
data have been reported on the presence of α6 on fibroblasts (Hynes, 1992; Jasiulionis et al., 1996; 
Yamada et al., 1996; Graber et al., 1999; Pirila et al., 2001). We propose that, in the connective 
tissue, α6 integrins may function as a fibroblast receptor for laminin. The day 0 fibroblasts also 
express α-SMA, although at a very low level. This was also found for fibroblasts from normal 
periodontal tissues (Arora and McCulloch, 1994; Arora and McCulloch, 1999). In conclusion, day 0 
fibroblasts resemble quiescent cells, that maintain the normal ECM.  
 Day 8 of the wound-healing process is the time of maximum contraction of the wound in this 
model (Cornelissen et al., 2000). The flow-cytometric profile of fibroblasts cultured from day 8 
tissue differed remarkably from that of day 0 fibroblasts. Particularly, the expression of the integrin 
subunit α1 and of α-SMA were increased. This was also found for the immunohistochemical 
expression of both markers in day 8 tissue. Several other authors have also found an increased 
expression of α1 integrin subunit during wound contraction (Carver et al., 1995; Racine-Samson et 
al., 1997). This increased level of α1 at 8 days PW is suggested to be related to wound contraction. 
α-SMA was highly expressed by day 8 fibroblasts. α-SMA is expressed in myofibroblasts, which 
are involved in the contraction of the wound tissue (Clark, 1996). Our immunohistochemical data 
confirm these findings. In conclusion, both integrin subunit α1 and α-SMA expression are increased 
in day 8 fibroblasts. Day 8 fibroblasts seem to be in an activated state, in contrast with the more 
quiescent fibroblasts obtained at day 0. The activated fibroblast phenotype appears to be maintained 
during in vitro culture.  
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 Day 60 is well within the remodeling phase of wound healing and scar tissue is already present 
(Yasoshima et al., 2000). The expression of α1 integrin subunit in day 60 fibroblasts had returned to 
a normal level. Furthermore, the expression of α-SMA in these fibroblasts had decreased but was 
still higher than in day 0 fibroblasts. It seems that day 60 fibroblasts had only partly returned to a 
quiescent state, which might be related to the development of scar tissue.  
 In general, our results indicate that multiple subpopulations of fibroblasts can be obtained from 
subsequent time points in wound healing. The characteristics of these subpopulations were 
maintained during prolonged in vitro culture. The expression of several important markers varied 
strongly in the subpopulations, which might be related to the functions of these fibroblasts in wound 
healing. Up to 90 days PW the expression profile of cultured fibroblasts did not return to normal, 
which might explain the development of scar tissue. We suggest that the modulation of specific 
fibroblast subpopulations might improve the outcome of the wound-healing process. 
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Abstract 
Wound healing after cleft palate surgery is often associated with impairment of maxillary growth 
and dento-alveolar development. Wound contraction and scar tissue formation contribute strongly 
to these effects. In vitro studies have revealed that fibroblasts isolated during different phases of 
palatal wound healing show phenotypical differences. They change from a quiescent to an activated 
state and then partly back to a quiescent state. In this study, we evaluated the existence of fibroblast 
phenotypes at several time-points during palatal wound healing in the rat. Based on cytoskeletal 
changes (α-SMA, vimentin, vinculin), integrin expression (α1, α2, αv, and β1) and changes in 
cellularity, we conclude that phenotypically different fibroblast populations are also present during 
in vivo wound healing. α-SMA and the integrin subunits α1 and αv were significantly up-regulated, 
and vinculin was significantly down-regulated, at early time-points compared to late time-points in 
wound healing. These changes point to an activated fibroblast state early in wound healing. Later in 
wound healing, these activated fibroblasts return only partially to the unwounded situation. These 
results strongly support the idea that different fibroblast populations with specific phenotypes occur 
in the course of palatal wound healing. 
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Introduction 
The closure of a palatal cleft usually results in two lateral open wounds, in which denuded bone is 
apparent. Healing of these wounds is associated with the inhibition of maxillary growth and dento-
alveolar development (Ross, 1987), which, to a large extent, is caused by wound contraction and 
scar tissue formation (Wijdeveld et al., 1991). Specific inhibition of these processes might diminish 
the iatrogenic effects of palatal surgery. In an earlier in vitro study we cultured fibroblasts isolated 
during different phases of palatal wound healing in the rat. Their phenotype appeared to change 
during wound healing, from quiescent at 0 days post wounding (PW), to activated at 8 days PW 
and, finally, showing a partial return to the original state at 60 days PW (Van Beurden et al., 2003). 
If the in vivo phenotypes are comparable to those observed in vitro, their modulation may improve 
the outcome of the wound-healing process. Therefore, this study aimed to analyse protein 
expression patterns in wound biopsies, harvested during different phases of wound healing. 
Changes in the cytoskeleton, expression of integrins, and the cellularity during palatal wound 
healing were also characterized.  
 
Cytoskeletal markers: α-Smooth muscle actin (α-SMA) belongs to the actin microfilament system 
and enables myofibroblasts to generate forces during the contraction of granulation tissue 
(Gabbiani, 1992). The intermediate filament vimentin also contributes to these contractile forces 
(Coleman and Lazarides, 1992). Vinculin is a constituent of the cellular focal adhesion complex 
(FAC) and is part of the link between integrins and the cytoskeleton, and is thus involved in focal 
adhesion-mediated processes during wound healing (Bailly, 2003).  
 
Integrins: The integrin subunits α1 and α2 combine uniquely with the subunit β1 to form the 
integrins α1β1 and α2β1. These integrins serve mainly as receptors for collagen and therefore may 
play a role during wound contraction and tissue remodelling (Clark, 1996; Racine-Samson et al., 
1997; Singer and Clark, 1999). The integrin subunit αv is able to combine with several β subunits. 
These combinations mainly serve as receptors for vitronectin and fibronectin (Gailit and Clark, 
1994). The presence of fibronectin-binding αv integrins (αvβ1 and αvβ3) is mainly confined to the 
granulation phase, whereas the vitronectin-binding αv integrins (αvβ3 and αvβ5) are present during 
all phases of wound healing (Hintner et al., 1991; Clark, 1996; Noszczyk et al., 2002).  
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Cellularity: We determined the level of apoptosis and the DNA content in the biopsies to analyse 
changes in cellularity during wound healing. Apoptosis is probably the main process by which the 
cellularity of a wound decreases, resulting in a relatively acellular scar (Desmouliere and Gabbiani, 
1996).  
 The combined analyses of these markers at different time-points during palatal wound healing 
would yield information on the sequential occurrence of phenotypically different fibroblast 
subpopulations. This information might be useful as a starting point for improving the outcome of 
the wound-healing process after cleft palate repair. 
 
Materials and methods 
Animals 
Fifty male Wistar rats were used. Their mean weight was 147 ± 9 g, and they were acclimatized to 
the animal facility 1 wk before starting the experiments. All animals were housed under normal 
laboratory conditions, and chow and water were provided ad libitum. The experiments were 
approved by the Board for Animal Experiments of the Radboud University Medical Centre, 
Nijmegen.   
 
Intra-oral wounding and sampling 
All rats were 35 days old at the start of the experiment. The rats were divided into two weight-
matched groups of 25 animals. Group 1 was used for biochemical and western blot analyses and 
group 2 was used for immunohistochemical analyses. At 0 days PW, all rats were anesthetized and 
palatal mucoperiosteal wounds were made with a 3 mm biopsy punch. At 5, 8, 15, 30, and 60 days 
PW, 5 animals from both groups were killed. Respectively, 3 mm biopsies (group 1) or 4-mm 
biopsies (group 2) were taken, the latter also including the wound margins. Group 1 biopsies were 
homogenized and group 2 biopsies were embedded in OCT compound (Tissue-Tek, Sakura Finetek 
Europe, Zoetermeer, the Netherlands), after which both were stored at -80°C. 
 
Biochemistry 
Protein concentrations in the homogenized biopsies were determined by using the bicinchoninic 
acid (BCA) assay (Pierce, Rockwell, IL, USA). The DNA concentration in the same samples was 
determined by using the PicoGreen DNA quantitation kit (Molecular Probes, Leiden, the 
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Netherlands). The DNA/protein ratio was used as a measure of cell density and expressed as ng of 
DNA per μg of protein.  
 
Antibodies 
The primary antibodies used during the experiments are summarized in table 1. 
 
Table 1: Antibodies used in the experiments. 
 
Primary antibody* Origin ** WB IC 
Mouse-anti-rat integrin subunit α1  Instruchemie  + 
Hamster-anti-rat integrin subunit α2 BD Biosciences Pharmingen  + 
Mouse-anti-human integrin subunit αv BD Transduction labs +  
Mouse-anti-human integrin subunit β1 BD Transduction labs  + 
Mouse-anti-human α-SMA Sigma + + 
Mouse-anti-human vimentin Biogenex + + 
Mouse-anti-human vinculin Sigma +  
Abbreviations: WB = western blotting, IC = immunohistochemistry, α-SMA = alpha-smooth-muscle 
actin.*All antibodies against human antigens showed cross-reactivity with rat antigens. 
**Instruchemie, Delfzijl, Netherlands; BD Biosciences Pharmingen, Oxnard, CA, USA; BD 
Transduction Labs, Oxnard, CA, USA; Sigma, Saint Louis, MO, USA; Biogenex, San Ramon, CA, 
USA. 
 
 
Western blotting 
Biopsy specimens of palatal wound tissues were homogenized in cold modified RIPA buffer [9.10 
mM Na2HPO4, 1.48 mM NaH2PO4, 150 mM NaCl, 1% (wt/vol) Triton-X-100; 1 mM activated 
NaVO4, 1mM freshly added phenylmethylsulphonyl fluoride (PMSF); pH set to 7.4], in a 
homogenizer (Pro 200; Pro Scientific, Monroe, CT, USA). After centrifugation (20 min at 11,000 
g), the supernatant was collected and stored until use. All samples were standardized based on 
protein concentration. A sample of pooled homogenates served as an interassay control. Sodium 
dodecyl sulphate–polyacrylamide gel electrophoresis (SDS–PAGE) was performed under Laemmli 
conditions (Laemmli, 1970), using a 7.5% gel on a Minigel III system (Biorad, Hercules, CA, 
USA). The primary antibodies used are summarized in table 1. Blots were developed by using the 
enhanced chemiluminescence (ECL) system (Amersham Pharmacia Biotech., Little Chalfont, 
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Bucks., UK). The intensity of the bands was assessed by scanning densitometry on a Gel-Doc 2000 
system (Biorad).  
 
Immunohistochemistry  
Serial cryosections, with a thickness of 4 μm, were obtained from the centre of each biopsy 
specimen and stained as described previously (Van Beurden et al., 2003). Briefly, the cryosections 
were fixed in acetone for 10 min then washed in phosphate-buffered saline (PBS) containing 0.05% 
(wt/vol) Tween 20 (PBST; Sigma, St Louis, MO, USA). To block endogenous peroxidase activity, 
the sections were treated for 20 min with PBST containing 3% (vol/vol) H2O2. After rinsing in 
PBST, the sections were incubated for 20 min with PBST containing 5% (wt/vol) bovine serum 
albumin (BSA) to prevent non-specific binding. The excess was tipped off and the sections were 
incubated with primary antibody (see table 1 for an overview of the primary antibodies used) 
overnight at 4°C. After washing unbound antibody with PBST, secondary antibody was added for 
60 min at room temperature. Peroxidase activity was visualized by incubation with 3,3’-di-
aminobenzidine tetrahydrochloride (DAB; SigmaFast; Sigma). The staining was enhanced by 
incubating the sections for 10 min in saline containing 0.5% (wt/vol) CuSO4. Sections were 
counterstained with Dellafield’s haematoxylin, dehydrated and mounted in DPX (Brunschwig 
Chemie, Amsterdam, the Netherlands). In negative controls, the primary antibody, or both primary 
and secondary antibodies, were omitted. All controls were negative and showed no significant 
background staining. The number of positive cells was evaluated on a 4-point scale as follows: none 
= 0; few = 1; moderate = 2; many = 3. For each antigen, 10 serial sections of 3 different rats per 
time-point were evaluated independently by 2 investigators. The estimated scores of the 3 series of 
sections were averaged, yielding the mean score per time-point.   
 
Apoptosis 
Ten serial cryosections, obtained from the centre of each biopsy specimen, were fixed in 3% 
(vol/vol) paraformaldehyde (PFA) and incubated in permeabilization buffer [PBS containing 0.1% 
(wt/vol) Triton-X-100 and 0.1% (wt/vol) sodium citrate] for 2 min on ice. Hereafter, sections were 
incubated with a TdT-mediated biotin–dUTP nick-end labelling (TUNEL) reaction mix 
(fluorescein-labelled d-UTP and terminal transferase; Boehringer Mannheim, Mannheim, Germany) 
for 30 min at 37°C. After stopping the TUNEL reaction, nuclei were counterstained with 7.5  
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μg/ml-1 propidium iodide in PBS. The sections were examined on a fluorescence microscope. 
Sections that were preincubated with 200 μg ml-1 DNAse (Boehringer Mannheim) served as 
positive controls. The number of apoptotic cells was evaluated on a 4-point scale as follows: none = 
0; few = 1; moderate = 2; many = 3. The sections of each rat (n = 3) per time-point were evaluated 
independently by two investigators. The estimation of the number of apoptotic cells was expressed 
as the mean score per time-point.  
 
Statistics 
After square-root transformation to obtain normality, a one-way analysis of variance (anova) was 
used for the western blot and DNA data. A Kruskal–Wallis one-way anova on ranks was used for 
the immunohistochemical and apoptosis data. Where data were significant, posthoc comparisons 
were made by using a Student-Newman-Keuls test. After pooling early (5, 8, 15 days PW) and late 
(30, 60 days PW) wound-healing data, the Student’s t-test was performed. For all statistics, a P-
value of less than 0.05 was considered statistically significant. 
 
Results  
Western blotting 
The concentration of protein observed in biopsies obtained at different time-points was plotted 
relative to that of unwounded tissue (0 days PW) (figure 1). The concentration of α-SMA (figure 
1A) was significantly lower at 5 and 60 days PW than at 0 days PW. In the time-period between 5 
and 60 days PW, the concentration of α-SMA was lower than at 0 days PW, but this was not 
significant. The concentration of α-SMA at 60 days PW was only 20% of that at 0 days PW. After 
pooling early (5, 8, 15 days PW) and late (30, 60 days PW) wound-healing data, no significant 
differences were observed.  
 The concentration of vimentin (figure 1B) was significantly increased at 8, 15, 30, and 60 days 
PW vs. 0 days PW. The maximum concentration of vimentin was observed at 15 days PW, after 
which it showed a decrease, but the level still remained higher than that observed at 0 days PW. 
After pooling of early (5, 8, 15 days PW) and late (30, 60 days PW) wound-healing data, no 
significant differences were observed.  
 The concentration of vinculin (figure 1C) was significantly reduced at 5 and 15 days PW; at 
subsequent time-points the concentration of vinculin increased significantly to return to the level 
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observed at 0 days PW. After pooling early (5, 8, 15 days PW) and late (30, 60 days PW) wound-
healing data, the concentration of vinculin appeared to be significantly lower early during the 
wound-healing process. 
 The integrin αv subunit concentration (figure 1D) increased immediately after wounding to 
reach a maximum at 15 days PW; however, no significant changes between individual time-points 
were found. After pooling of early (5, 8, 15 days PW) and late (30, 60 days PW) wound-healing 
data, the concentration of the integrin αv subunit was significantly higher early during wound 
healing.  
 Finally, an overview of all patterns is plotted in figure 1E. The differences between the 
concentration of vimentin and the integrin subunit, αv, during wound healing were the most 
pronounced. The concentration of both types of protein reached a maximum at 15 days PW.   
 
Immunohistochemistry 
The results of the immunohistochemical scores are plotted as the mean of the estimated scores 
(figure 2). The number of α-SMA-positive fibroblasts (figure 2A) was significantly higher at 5, 8, 
and 15 days PW compared to that observed in unwounded tissue (0 days PW). The number of 
positive cells peaked at 8 days PW, then decreased up to 60 days PW, to a level similar to that 
observed at 0 days PW. After pooling early (5, 8, 15 days PW) and late (30, 60 days PW) wound-
healing data, the number of α-SMA-positive fibroblasts was significantly higher early in wound 
healing.  
 The number of vimentin-positive fibroblasts (figure 2B) tended to increase from 5 days PW 
onwards, reaching a maximum between 15 and 30 days PW, after which they returned to the level 
observed at 0 days PW. These changes, however, were never significant. There were also no 
significant differences between early (5, 8, 15 days PW) and late (30, 60 days PW) wound-healing 
data.  
 Although the number of integrin subunit α1-positive fibroblasts (figure 2C) did not show any 
significant change, the number of positive cells tended to be higher at ≈ 5–8 days PW than at 0 days 
PW, after which they showed a gradual decrease to starting levels. After pooling early (5, 8, 15 days 
PW) and late (30, 60 days PW) wound-healing data, the number of α1-positive fibroblasts was 
found to be significantly higher early in wound healing.  
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 The number of α2 subunit-positive fibroblasts (figure 2D) was significantly higher at 8 days 
PW than at 0 days PW. At other time-points, no significant differences, relative to 0 days PW, were 
observed. After pooling early (5, 8, 15 days PW) and late (30, 60 days PW) wound-healing data, no 
significant differences were observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Western blotting of tissue homogenates. Western blot analyses of α-SMA (A), vimentin (B), vinculin (C), αv 
(D), and an overview of all expression levels in the tissue homogenates (E). Panel E is a summary of the expression 
levels plotted in panels A, B, C and D. The data in panels A–E represent the mean value ± standard error of the mean 
(SEM) of at least 4 rats. Protein expression is expressed as a percentage of the unwounded rats. *Difference vs. 0 days 
post wounding (PW) (P < 0.05). 
 
 The number of β1 subunit-positive fibroblasts (figure 2E) did not show any significant 
differences vs. 0 days PW. After pooling early (5, 8, 15 days PW) and late (30, 60 days PW) 
wound-healing data, no significant differences were observed.  
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 Finally, an overview of the patterns is plotted in figure 2F. The changes in the number of α-
SMA and vimentin-positive fibroblasts during wound healing were most pronounced. Both 
cytoskeletal proteins showed a maximum expression at 8 days PW, as determined by 
immunohistochemical analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Immunohistochemistry of tissue biopsies. Immunohistochemical analyses of α-SMA (A), vimentin (B), α1 
(C), α2 (D), β2 (E), and an overview of all expression levels in the sections (F). Panel F is a summary of the results 
plotted in panels A, B, C, D and E. The data in panels A–E represent the mean scores ± standard error of the mean 
(SEM) of 5 rats. *Difference vs. 0 days post wounding (PW) (P < 0.05). 
Changes in cellularity during wound healing 
The cell density and the number of apoptotic cells are plotted in figure 3. Although no significant 
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a maximum at the 8–15 days PW time-point, after which it decreased to the level observed at 0 days 
PW. There were no significant differences in cellularity between the early phase (5, 8, 15 days PW) 
and the late phase (30, 60 days PW) of wound healing. The number of apoptotic cells was very low 
in unwounded tissue and showed an increase, after wounding, to reach a maximum at ≈15 days PW, 
after which it decreased to the level observed at 0 days PW . The number of apoptotic cells was 
significantly higher early (5, 8, 15 days PW) rather than later (30, 60 days PW) in wound healing. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Changes in cellularity during wound healing. Bars represent the mean apoptosis score ± standard error of the 
mean (SEM), based on 10 sections of 3 rats per time-point. The line represents the cell density, expressed as DNA per 
μg of protein ± standard error of the mean (SEM), based on the analysis of 5 rats per time-point. No significant 
differences over time were observed. 
Discussion 
In the course of wound healing the fibroblast phenotype changes. One of the main changes observed 
is the concentration of α-SMA. Initially, a marked decrease in α-SMA was observed in tissue 
homogenates. These homogenates contained wound tissue, including α-SMA-positive blood 
vessels. Therefore, it is possible that the decrease in α-SMA is caused by the removal of large blood 
vessels containing α-SMA, together with the biopsy. Hereafter, neovascularization and the influx of 
α-SMA positive myofibroblasts in wound tissue resulted in an increase, but the concentration of  
α-SMA remained lower than in unwounded tissue. Immunohistochemical analysis carried out after 
α-SMA staining of the biopsies was solely focused on the α-SMA-positive fibroblasts. It showed a 
significant increase in α-SMA, from 5 to 15 days PW, followed by a significant decrease up to 60 
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days PW. These results correspond with the appearance of myofibroblasts during wound 
contraction, followed by their disappearance during tissue remodelling, as described in the literature 
for dermal fibroblasts (Desmouliere et al., 1992; Grinnell, 1994; Clark, 1996). The disappearance of 
the myofibroblasts from 15 days PW onwards probably corresponds to the high apoptosis score at 
this time-point.  
 The vimentin concentration was significantly increased at 8 days PW in tissue homogenates; 
however, the number of vimentin-positive fibroblasts, as determined by immunohistochemical 
analysis, did not change significantly during wound healing. This difference can be explained by the 
substantial influx of non-fibroblast vimentin-positive cells, such as macrophages and endothelial 
cells, present early in wound healing. The invasion of these non-fibroblastic vimentin-positive cells 
might have caused the high concentration of vimentin in tissue homogenates (Clark, 1996; Ehrlich 
and Krummel, 1996; Valgeirsdottir et al., 1998). However, it is also possible that the increase of 
vimentin in tissue homogenates early in wound healing is caused by an increase in the concentration 
of vimentin per cell, rather than by an increase in the number of vimentin-positive cells. This 
suggestion is supported by the scant change in cellularity observed during that time-period.  
 The concentration of vinculin, which is used as a measure for focal adhesions, is high in 
unwounded tissue, significantly lower early in wound healing, and high at later time-points in 
wound healing. Dynamic, migrating cells have fewer focal adhesions than quiescent cells, which 
display a strong adhesion (Huttenlocher et al., 1995; Murphy-Ullrich, 2001). Therefore, the present 
data point to a high cell mobility early in wound healing and a reduced mobility late in wound 
healing.  
 Besides vinculin, integrins are a major constituent of the focal adhesions. They mediate the 
contact between the cells and the surrounding extracellular matrix and are strongly involved in 
processes such as migration, adhesion, proliferation, and differentiation (Maheshwari et al., 2000; 
Wehrle-Haller and Imhof, 2003). The present study shows a significant increase in the number of 
α1-positive and α2-positive fibroblasts early in wound healing. This is probably related to wound 
contraction and matrix remodeling, as both subunits, as part of α1β1 and α2β1 integrins, are strongly 
implicated in these processes (Clark, 1996; Jenkins et al., 1999; Aukhil, 2000; Cooke et al., 2000; 
Szulgit et al., 2002). Furthermore, we observed a significant increase in the amount of αv early in 
wound healing compared to late in wound healing. This increased amount might be related to the 
increased migration of fibroblasts early in wound healing, as αvβ1 and αvβ3 integrins can act as 
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receptors for fibronectin, which is very important for fibroblast migration early in wound healing 
(Kim et al., 1992; Gailit and Clark, 1994; Horiba and Fukuda, 1994; Graber et al., 1999). Noszczyk 
et al. also observed a significant increase in the concentration of αv early in the primary intention 
healing of skin wounds (Noszczyk et al., 2002). We did not observe significant differences in the 
number of β1-positive cells, although the number of positive fibroblasts tended to increase with 
time. This might be caused by an increase of non-collagen-binding integrins, such as α5β1, because 
the concentration of collagen-binding integrins α1β1 and α2β1 decreased late in wound healing.  
 Apart from the changing patterns of cytoskeletal proteins and integrins, it is also obvious that 
the cellularity of the wound matrix is higher than in normal tissue and that it changes during 
healing. We observed a maximum cell density at around 8–15 days PW. This corresponds with the 
time of maximum granulation tissue formation. During this period, endothelial cells, 
myofibroblasts, and, in particular, fibroblasts are responsible for tissue formation through 
proliferation and the production of collagen (Clark, 1996). After fulfilling their function, the 
majority of cells will probably disappear as a result of apoptosis. We indeed observed the highest 
number of apoptotic cells to occur at around 15 days PW, after which it showed a decrease, but not 
to the 0 days PW level. This indicates that in these wounds, the transition between granulation 
tissue and the development of scar tissue starts at around 15 days PW and lasts until at least 60 days 
PW, which is in agreement with the findings of Desmouliere et al. (Desmouliere and Gabbiani, 
1996).  
 The present data indicate two important periods of change in the amount of protein present 
during palatal wound healing. Early in wound healing we observed an up-regulation of cytoskeletal 
markers and integrins, and a down-regulation of vinculin, pointing to an activated and more mobile 
state of the fibroblasts. Later in wound healing, the amount of the different proteins only partly 
returned to the level observed in unwounded tissue. This indicates that true healing is not achieved, 
which might account for the formation of scar tissue. These results strongly support the idea that 
different fibroblast populations with specific phenotypes occur in the course of palatal wound 
healing. Furthermore, we conclude from the different patterns that palatal wound healing is largely 
comparable to dermal wound healing. Therefore, it is probable that these different fibroblast 
subpopulations also exist during dermal wound healing. 
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Abstract 
Cleft palate patients often show mid-facial growth impairment after surgical closure of the defect. 
This is a consequence of palatal wound healing, and more specifically of wound contraction and 
scar tissue formation. Cells of the fibroblast lineage are responsible for these processes and they 
display different phenotypes in the course of the wound-healing process. The aim of this study was 
to analyze the in vitro adhesion and migration of wound fibroblasts, isolated during the palatal 
wound-healing process in the rat. Additionally, we analyzed the expression of β1 integrins and 
vinculin, being the key players in adhesion and migration.  Palatal fibroblasts from age-matched 
controls were analyzed to measure the effects of normal aging. Palatal fibroblasts from unwounded 
tissue showed a low migratory behavior  (< 25 μm), a strong capability to adhere (>80%) and a low 
expression of β1 integrins and vinculin. In contrast, fibroblasts obtained from healing palatal 
wounds were highly migratory (> 200 μm) coupled to a weak capability to adhere (<65%) and a 
high expression of vinculin and β1 integrins. This demonstrates that the palatal wound-healing 
process induces a change in fibroblast phenotype from “quiescent” to “activated”, which persists in 
vitro.  
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Introduction 
Cleft palate patients often show mid-facial growth impairment after surgical closure of the cleft 
(Ross, 1987). Animal experimental studies led to the conclusion that the denudation of shelf bone is 
a critical factor for maxillary and dento-alveolar growth inhibition (Kremenak et al., 1967; 
Wijdeveld et al., 1989). Histological studies showed that both wound contraction and scar tissue 
formation are involved in this inhibition (Wijdeveld et al., 1987; Wijdeveld et al., 1991; Leenstra, 
1997). Wound contraction and scar tissue formation strongly contribute to these unwanted effects 
(Wijdeveld et al., 1987; Wijdeveld et al., 1991), which are caused by fibroblasts and myofibroblasts 
(Clark, 1996). We have previously reported that palatal fibroblasts show different phenotypes in 
subsequent phases of the wound-healing process (Van Beurden et al., 2003; Van Beurden et al., 
2005). These differences seem to coincide with changes in the functions of fibroblasts and 
myofibroblasts during wound contraction and scar tissue formation. For these functions, adequate 
adhesion and migration is essential.  
 Cell migration is enabled by the continuous formation of cytoplasmic protrusions at the leading 
edge of the cell, and controlled retraction of adhesive contacts at its rear. Simultaneously, focal 
adhesions (FA’s) at the leading edge provide dynamic links of the cytoskeleton to the substrate in 
order to anchor the protrusions (Holly et al., 2000). Main components of FA’s are β1 integrins and 
vinculin. The β1 integrins provide a link between the actin cytoskeleton and the extracellular matrix 
during migration and adhesion (Hynes, 1992; Holly et al., 2000). Vinculin is present in the intra-
cellular part of an FA (DePasquale and Izzard, 1987; Zieske et al., 1989). Therefore, β1 integrins 
and vinculin are used as markers for FA’s. 
 Many studies have been performed on the adhesion and migration of dermal fibroblasts in 
relation to wound healing (Boemi et al., 1999; Park et al., 2001; Reed et al., 2001; Li et al., 2004). 
However, only few studies deal with the adhesion and migration of oral mucosal or periodontal 
fibroblasts (Al-Khateeb et al., 1997; Stephens et al., 2001; Lepekhin et al., 2002) and no 
experimental data at all are available on palatal fibroblasts. The aim of the present study was to 
describe differences in the in vitro adhesion and migration between fibroblasts from unwounded 
tissue and fibroblasts from early and late phases of palatal wound healing. Additionally, the 
expression of β1 integrins and vinculin is analyzed by western blotting. The results provide 
evidence of functional changes in fibroblast populations during the progression of palatal wound 
healing. The characterization of the processes that take place during palatal wound healing will 
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hopefully lead to a clinical treatment modality that interferes in the wound healing circumventing 
the unwanted side effects of palatal wound healing.  
 
Materials and methods 
Animals 
A total of 13 35-day-old male Wistar rats were used. All animals were acclimatized in the animal 
facility for one week before the start of the experiments. The animals were kept under normal 
laboratory conditions and pellets of chow (Hope Farms, Woerden, Netherlands) and water were 
offered ad libitum. The experiments were approved by the Board for Animal Experiments of the 
Radboud University Nijmegen Medical Centre, The Netherlands.  
 
Palatal wounding 
Prior to wounding, ten rats were anaesthetized with an intraperitoneal injection of 2.7 ml/kg 
bodyweight FFM-mix (0.079 mg/ml fentanyl citrate (Janssen Animal Health, Beerse, Belgium), 2.5 
mg/ml fluanisone (Janssen Animal Health) and 2.5 mg/ml midazolam (Rosteoclasthe, Mijdrecht, 
Netherlands). In each rat a full-thickness excisional wound was made in the mucoperiosteum of the 
hard palate between the molars using a 3-mm biopsy punch. The biopsies were used as day 0 
unwounded controls (d0con). The wounds were allowed to heal for 8 (d8, n=5) or 60 days (d60, 
n=5). After this period, the animals were sacrificed with a mixture of CO2/Carbogene. 
Subsequently, 3-mm biopsies were obtained from the wound area. Additionally, three control rats 
with the same age as the day 60 experimental rats (d60con, n=3) were included in the study, to 
control for possible age-effects. Also from these control rats full-thickness biopsies were taken with 
a 3-mm biopsy punch, as described above.  
 
Primary fibroblast cultures 
Each biopsy was transported in sterile Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco Life 
Technologies Ltd, Paisly, Scotland). The biopsies were washed extensively and cut into at least 20 
small pieces, which were placed into a single well of a 24-well culture plate. The culture medium 
contained DMEM supplemented with 10% fetal bovine serum (FBS, Gibco), 100 U/ml penicillin 
(Gibco), and 100 μg/ml streptomycin (Gibco). The tissue explants were left undisturbed for one 
week in a humidified incubator (37ºC, 5% CO2) to allow the outgrowth of fibroblasts. At 90% 
  
Chapter 5 
 
 
 
 112 
confluency, the cells were trypsinized with 0.25% trypsin in 0.2 g/l EDTA in Hanks’ Balance Salt 
Solution (Hanks’BSS; Gibco) and transferred to a 25 cm2 culture flask (Nalge Nunc Int. Corp., 
Naperville, IL, USA). The cells were successively passaged to one and three 75 cm2 culture flasks. 
At 90% confluency, the cells were trypsinized, pooled and frozen in 7.5% dimethyl sulfoxide (ICN 
Biomedicals Inc., Aurora, OH, USA) in culture medium and stored in liquid nitrogen. All cell 
cultures were tested negative by immunohistochemistry for Von Willebrand Factor VIII and 
cytokeratin 10, which excludes the possible presence of endothelial cells and/or keratinocytes. At 
this point, batches of the following fibroblast populations were available for the experiments: 8 days 
post wounding (PW) (d8, n=5), 60 days PW (d60, n=4), day 0 controls (day0con, n=4) and day 60 
controls (d60con, n=3). 
 
Migration assay  
Batches of d8 (n=5), and d60 (n=4), d0con (n=4) and d60con (n=3) fibroblasts were quickly 
thawed, resuspended and seeded in a 75 cm2 culture flask. At 90% confluency, the fibroblasts were 
harvested by trypsinization. Prior to the migration experiments, 24-wells plates were incubated for 4 
hours with 2.6 μg/cm2 rat tail collagen (Serva, Serva Electrophoresis GmbH, Heidelberg, Germany) 
in Phosphate Buffered Saline (PBS). Excess collagen was removed by washing with PBS. The 
fibroblast batches were seeded in the collagen coated 24-wells plates and cultured until confluency. 
Migration was assessed by using the scratch assay (Ridgway et al., 2005). Experiments were 
performed in fourfold. Then, two diagonal scratches per well were made using a standard yellow 
pipette tip. This produced a scratch of 843 μm and the width appeared to differ only marginally 
between experiments. This procedure did not damage the collagen coating, as determined with an 
Azan staining in parallel experiments. After removal of the detached cells by gently washing with 
PBS, the adherent cells were incubated in culture medium for 20 hours to allow migration into the 
scratch. Subsequently, the cells were fixed for 30 min in 3% paraformaldehyde in PBS and stained 
with 0.1 % crystal violet for 25 min. Finally, cell migration into the scratch was analyzed with a 
Leica MZ12 microscope equipped with a digital camera (Leica Microsystems, Rijswijk, 
Netherlands). A grid was applied over the scratch and at about 80 predetermined gridlines the 
distance traveled by the cells on the gridline was determined using Qwin computer software 
(Leica). The mean migration was calculated as the mean difference between the original width of 
the scratch (843 ± 9 μm) and the migrated distance after 20 hours and expressed in μm. 
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Cell adhesion assay 
Batches of d8 (n=2), d60 (n=2), d0con (n=2) and d60con (n=2) fibroblasts were quickly thawed, 
resuspended and seeded in 75 cm2 culture flasks. At 90% confluency, fibroblasts were harvested by 
trypsinization, suspended in PBS and labeled with 25 μg/ml calcein-AM (Molecular Probes, 
Eugene, OR, USA) for 30 min at 37 ºC. Hereafter, the cells were centrifuged (400 g, 5 minutes, 4 
ºC) and resuspended in medium with serum (Gibco). The cells (30,000 cells/well) were seeded in 
triplicate in 96-well flat bottom Maxisorp plates (Nunc, Roskilde, Denmark) that were precoated for 
4 hours with 2.6 μg/cm2 rat tail collagen (Serva) in PBS. The cells were allowed to attach for 10, 20, 
30, or 40 minutes at 37 ºC, after which the non-adherent cells were gently washed away with 0.5 % 
BSA in TSM (150 mM NaCl, 10 mM TRIS-HCL, 2 mM MgCl2, 1 mM CaCl2, pH 8.0). The 
adherent cells were lysed with 100 μl lysis buffer (50 mM TRIS, 0.1 % SDS) and the fluorescence 
was quantified on a cytofluorometer (Perseptive Biosystems, Framingham, MA, USA).  Non-
washed controls were included to determine the fluorescence of the total cell population. The results 
of the measurements are expressed as the mean percentage ± SD of adhering cells of triplicate 
wells. 
 
Western blotting 
Culture flasks (75 cm2) were pre-coated with collagen by incubation for at least 4 hours with 2.6 
μg/cm2 rat tail collagen (Serva) in PBS. Excess collagen was removed with PBS. Batches of d8 
(n=3), d60 (n=3) and d0con (n=3) fibroblasts were quickly thawed and cultured in 75 cm2 culture 
flasks. At 90% confluency, fibroblasts were harvested by trypsinization and seeded in non-coated 
wells (NCW) or in collagen coated wells (CCW) in 24-well plates and cultured until confluency. 
After washing in PBS, the cells were incubated with lysis buffer (10 mM TRIS-HCl; 140 mM NaCl, 
1.5 M KCl, 5 mM EDTA, 0.5% Triton X-100 and 1 mM PMSF, pH 7.6) for 30 minutes at 4 ºC and 
the lysate was centrifuged (16000 g, 10 minutes, 4 ºC) (Pagan et al., 1999). The supernatant was 
stored at -20 ºC until use.  
 After quickly thawing, the supernatant was heated (95 °C, 5 minutes), cooled down and mixed 
gently. Polyacrylamide gel electrophoresis was performed under reducing conditions, using a 10% 
gel with 0.1% SDS and a TRIS-HCl buffer on a Minigel system (Biorad, Hercules, CA, USA). A 
pool of cell lysates was used as a reference sample. Thereafter, proteins were electrophoretically 
transferred onto a nitrocellulose membrane (Biorad) in a Trans-Blot cell (Biorad) at 400 mA for 1 
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hour. Membranes were blocked in 3% PBSA (1 hour, RT) and incubated overnight with primary 
antibodies at 4 ºC. The following antibodies were used: a mouse-anti-human integrin β1 subunit 
(BD Transduction Laboratories, Lexington, KT, USA) and a mouse-anti-human vinculin (Sigma, 
ST Louis, MI, USA). A mouse-anti-pan-actin antibody (Cedarlane, Oakfield, CN) was used to 
calibrate the amount of cells in the samples. After washing, an alkaline phosphatase-conjugated 
goat-anti-mouse secondary antibody (BD Transduction Laboratories) was added for 1 hour. The 
blots were developed with the ECL (Enhanced ChemoLuminescence) system (Amersham 
Pharmacia Biotech., Little Chalfont, UK). The intensity of the bands was assessed by scanning 
densitometry on a Gel-Doc 2000 system (Biorad). 
 
Statistics 
A one-way analysis of variance (ANOVA) was used to compare the migration in the d8, d60, d0con 
and d60con batches. Post-hoc comparisons were made by Student-Newman-Keuls tests. A p-value 
of less than 0.05 was considered statistically significant.  
 A two-way ANOVA was used for the adhesion experiments using the different batches and the 
adhesion time as independent variables. Post-hoc comparisons were made by Student-Newman-
Keuls tests.  A p-value of less than 0.05 was considered statistically significant.  
 Two-way ANOVA’s were used to analyze the expression of integrin β1-subunit and vinculin, 
using coating (NCW, CCW) and cell batch as independent factors. In case normality or equal 
variance failed, a Mann Whitney Rank Sum test was performed. Post-hoc comparisons were made 
by Student-Newman-Keuls tests. A p-value of less than 0.05 was considered statistically significant. 
 
Results 
Migration assay 
Figure 1 shows representative examples of a scratch after 20 hours of incubation for batches of d8 
(A), d60 (B), d0con (C), and d60con (D) fibroblasts. The mean migrations into the scratches and 
their SD's are plotted in figure 2. The mean migration for d8 fibroblasts (n=5) was 238 ± 88 μm, for 
d60 fibroblasts (n=4) 382 ± 65 μm, for d0con fibroblasts (n=4) 28 ± 65 μm and for d60con 
fibroblasts (n=3) 146 ± 11 μm. One-way-ANOVA showed a difference in the migration between 
the batches, and post-hoc analysis showed that the mean migration of the d60 batch was 
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significantly higher than that of the d0con batch. The differences between the other batches were 
not significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Appearance of the scratch after 20 hours of incubation of A: d8, B: d60, C: d0con, and D: d60con fibroblasts.  
Bars represent 1mm. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: The mean migration ± SD for the different cell populations. * Indicates a significant difference from d0con 
fibroblasts.  
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Adhesion assay 
Batches of d8 (n=2), d60 (n=2), d0con (n=2) and d60con (n=2) fibroblasts were left to adhere and 
spread on collagen-coated 96-well plates for 10 to 40 minutes. The fibroblast adhesion was 
expressed as a percentage of the total cell number ± SD. The two-way-ANOVA indicated no 
substantial effect of adhesion time on adhesion, but significant effects between the cell batches 
collected at different time points after wounding. Post-hoc analysis showed that the average 
adhesion of the d0con batch was significantly higher than that from the d8, d60, and the d60con 
fibroblasts. After pooling the data from each batch, the d0con fibroblasts showed an average 
adhesion of 85.1 ± 2.4%, the d8 fibroblasts of 65.2 ± 5.6%, the d60 fibroblasts of 51.8 ± 6.0%, and 
the d60con fibroblasts of 67.8 ± 2.3% (figure 3).  
 
 
 
 
  
 
 
 
 
 
 
 
Figure 3: Adhesion of d8, d60, d0con and d60con fibroblasts on collagen. The adhesion profile of the d8, d60 and 
d60con are significantly different from the d0con. The results are expressed as the mean percentage ± SD of adhering 
cells of triplicate wells.  
The expression of β1 integrins and vinculin  
The expression of the β1 integrins was determined in the d0con, d8 and d60 batches on non-coated 
(NCW) and collagen-coated wells (CCW) (figure 4A). The Mann Whitney Rank Sum test showed 
no significant effect of the substrate on the expression of β1 integrins, nor a significant difference 
between the batches regarding the expression of β1 integrins. The β1 expression on CCW tended to 
be higher in the d8 and d60 batches than in the d0con batch, although these differences were not 
significant. Actin was used as internal control for different protein loading of the individual lanes 
(figure 5). 
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Figure 4: Expression of β1 integrins (A) and vinculin (B), determined on d0con, d8, and d60 fibroblasts by western 
blotting. Cells were cultured on non-collagen-coated (NCW) and collagen-coated (CCW) wells. * Indicates a significant 
difference with d60 fibroblasts within the same coating batch. # Indicates a significant difference between cells on the 
same coating. 
 The expression of vinculin was determined in the d0con, d8 and d60 batches on NCW and 
CCW (figure 4B). Two-way-ANOVA showed an effect of the substrate on the expression of 
vinculin. Post-hoc analysis showed a significant higher vinculin expression in the d60 batch on 
CCW than on NCW. Furthermore, significant differences between the batches collected at different 
time points after wounding were encountered. This could be attributed to the significantly higher 
expression of vinculin in the d60 batch on CCW than in the d8 and the d0con batches on the same 
substrate. 
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Figure 5: Western blot of vinculin (upper row) and actin (lower row) of d8 fibroblasts. Lane 1-3 show the results 
obtained for cells grown on non-collagen coated wells (NCW). Lane 4-6 represent the results obtained with cells grown 
on collagen coated wells (CCW). Lane 7 shows the result obtained with an control lysate. 
Discussion 
In order to characterize fibroblast populations during palatal wound healing, the in vitro migration 
and adhesion of fibroblasts obtained at 8 days PW and 60 days PW was determined. Fibroblasts 
from unwounded controls obtained at 0 and 60 days after the start of the experiment have been 
included to analyze the influence of normal aging. The expression of vinculin and β1 integrins was 
also included, since they are important mediators of fibroblast migration and adhesion through their 
presence in focal adhesions (Critchley, 2000). 
 Control fibroblasts obtained at day 0 and day 60 showed the same migration, indicating that 
their migration did not change with normal aging. The wound fibroblasts, however, tended to show 
more migration than the control fibroblasts. This difference was only significant for the 60 days PW 
fibroblasts. It suggests an increasing migration during the wound-healing process. From literature it 
is known that the migration of fibroblasts depends on their origin: differences in the migration 
between fetal and adult fibroblasts have been related to the expression of migration stimulating 
factor (MSF) (Schor and Schor, 1987; Irwin et al., 1994; Park et al., 2001), different migration 
activity has been described for gingival and skin fibroblasts (Irwin et al., 1994). Also, the substrate 
has an effect on the migration of fibroblasts (Dean and Blankenship, 1997). However, differences in 
fibroblast migration in subsequent phases of wound healing have not been recognized up to now. 
 The adhesion of day 60 control fibroblasts was significantly less than that of day 0 control 
fibroblasts, pointing towards an age-dependent decrease. Our data also suggest a decrease in 
adhesion capability caused by wound healing, since 8 days PW and 60 days PW fibroblasts adhered 
significantly less than day 0 controls. However, this was not conclusive as no significant difference 
was found between wound fibroblasts and day 60 controls. The results of the migration and 
adhesion assays suggest that a weak or moderate adhesion, as found for 8 and 60 days PW 
fibroblasts, favors migration, whereas a strong adhesion, as found for day 0 controls, tends to 
  
In vitro migration and adhesion 
 
 
 
 119 
immobilize the cells (Dunlevy and Couchman, 1993; Ruoslahti and Obrink, 1996; Wehrle-Haller 
and Imhof, 2003b).  
  Focal adhesions are important for fibroblast migration and adhesion (Albelda and Buck, 1990; 
Dunlevy and Couchman, 1993) and therefore changes in the expression of focal adhesion proteins 
were expected during wound healing. Indeed, if collagen was available as a ligand for FA’s, a 
significant higher vinculin expression was observed in 60 days PW fibroblasts than in 8 days PW 
fibroblasts and day 0 controls. Vinculin expression  is highest in d60 fibroblasts (d0<d8<d60), 
likewise migration is highest for d60 fibroblasts (d0<<d8<d60). The expression of the integrin β1-
subunit was the highest in d60 fibroblast (do<<d60<d8). Since the migration data and the 
expression data follow the same trend,  vinculin and β1 integrins, besides other adhesion molecules, 
are involved in the migration of palatal wound fibroblasts over a collagen substrate, which is in 
agreement with studies on dermal fibroblasts (Hood and Ceheresh, 2002; Bailly, 2003; Wehrle-
Haller and Imhof, 2003a). Our observation that β1 integrins and vinculin are linked with fibroblast 
migration and adhesion adds to previous reports on the role of β1 integrins (Greiling and Clark, 
1997; Kagami et al., 1999; Reed et al., 2001) and vinculin (Dunlevy and Couchman, 1993; Bailly, 
2003) in these processes.  Finally, our data support that collagen is a suitable substrate for fibroblast 
migration (Park et al., 2001; Reed et al., 2001; Gaudet et al., 2003).  
 The results of this study indicate that normal palatal fibroblasts and wound fibroblasts differ in 
phenotype. These characteristics are maintained during in vitro culture. Normal fibroblasts in vitro 
showed a stronger adhesion, a lower migration capability, and a lower expression of FA proteins 
compared to fibroblasts collected from wounded tissue. Contrarily, wound fibroblasts in vitro show 
a weaker adhesion, a higher migration capability, and a higher expression of FA proteins. The 
normal fibroblasts thus have a quiescent phenotype while the wound fibroblasts seem to have a 
more activated phenotype. We have shown similar differences in the expression of integrins and 
cytoskeletal markers in cultured wound fibroblasts by flow cytometry (Van Beurden et al., 2003). 
During the first 60 days of wound healing, the fibroblast phenotype did not return to normal, which 
shows that the fibroblast remains in an activated state for at least this period.  
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Abstract 
When cells are injured they release their contents, resulting in a local accumulation of free heme 
proteins and heme. Here, we investigated the involvement of heme and its degrading enzyme heme 
oxygenase (HO) in the inflammatory process during wound healing. We observed that heme 
directly accumulates at the edges of the wound after inflicting a wound in the palate of Wistar rats. 
This coincided with an increased adhesion molecule expression and the recruitment of leukocytes. 
To prove that heme is responsible for the recruitment of leukocytes, heme was administered 
intradermally 24 hours prior to injury. A clear heme-induced influx of both macrophages and 
granulocytes was observed. When examining the HO isoforms, HO-1 and HO-2, we found that HO-
2 was present in the entire submucosa. Surprisingly, we observed also that HO-1 is significantly 
expressed in the epithelium of both the mucosa and the skin of animals without wounds. On 
inflammation, HO-1 expression increased, particularly in infiltrating cells during the resolution 
phase of inflammation. Interestingly, we observed that heme-induced influx of leukocytes was 
highly elevated after pharmacologic inhibition of HO activity. These observations suggest that the 
heme-HO system is closely involved in the control of wound healing. Our results demonstrate that 
the local release of heme may be a physiologic trigger to start inflammatory processes, whereas HO-
1 antagonizes inflammation by attenuating adhesive interactions and cellular infiltration.  
Moreover, the basal level of HO expression in the skin may serve as a first protective environment 
against acute oxidative and inflammatory insults.  
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Introduction 
The skin, consisting of an epidermal and a dermal layer divided by the stratum basale, forms a 
versatile organ with highly adaptive properties. In addition to the various homeostatic mechanisms, 
the skin has to cope continuously with changes in the external environment, such as oxidative 
insults, heat, cold, UV radiation, and injury (Cross et al., 1998; Dubertret, 2000). The skin 
microenvironment changes dramatically after injury (Clark, 1996; Chettibi and Ferguson, 1999; 
Cooper, 1999; Dressler et al., 2000). One of the earliest changes in the skin after wounding is the 
release of modified, denatured tissue proteins. This may result from the direct effect of the trauma or 
by proteolysis following lysosomal rupture. Wounds are associated with severe hemorrhage, 
hemolysis, and cell injury and may result in a local accumulation of free heme proteins and heme.  
 Heme and heme proteins play a crucial role in diverse biologic processes and are present in 
every human cell. We and others have recently shown that free heme also possesses several pro-
oxidative and proinflammatory properties (Balla et al., 1991; Wagener et al., 1997; Wagener et al., 
1999; Wagener et al., 2001; Jeney et al., 2002). It induces the expression of adhesion molecules and 
causes vascular permeability and leukocyte infiltration (Wagener et al., 2001).  
 Wound healing consists of a complex series of processes to stop and prevent blood loss, to kill 
possible intruding pathogens, and to restore the site of injury (Chettibi and Ferguson, 1999; Hunt et 
al., 2000). In chronic wounds, resolution of inflammation is interrupted, resulting in continuous 
influx of inflammatory cells and subsequently exacerbation of cellular injury.  
 It is well accepted that bacterial products, such as lipopolysaccharide (LPS) or CpG-containing 
DNA, initiate inflammatory processes. However, non-open wounds, such as contusions, do not 
involve invasion of pathogens, but nevertheless result in inflammatory processes and wound 
healing. This may be explained by the local release of heme and heme proteins at the site of injury. 
Elevated levels of free heme may act as a "danger signal" and initiate a wide range of 
proinflammatory signals to recruit and alert the immune system.  
 In the resolution phase of inflammation, heme and other proinflammatory signals need to be 
neutralized. Interestingly, heme oxygenase 1 (HO-1), the heme-degrading enzyme, is one of the 
major acute-phase proteins that are induced on stress (Abraham et al., 1988; Maines, 1997).  
 HO expression represents an important mechanism of protective response to a wide variety of 
cellular stresses (Abraham et al., 1988). HO is the enzyme that converts heme into 
biliverdin/bilirubin, iron, and carbon monoxide (CO) (Tenhunen et al., 1968; Abraham et al., 1988).  
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There are currently 3 isoforms of HO described. HO-2 and, to a lesser extent, the recently 
discovered HO-3 isoenzyme are predominantly constitutively expressed and function mainly in 
normal heme capturing and metabolism (Braggins et al., 1986; McCoubrey et al., 1997). The 
inducible HO-1 isoform is known to function in a wide range of processes that could be important in 
the resolution phase of wound healing, such as amelioration of inflammation, proliferation, and 
protection against apoptosis (Willis, 1995; Brouard et al., 2000; Duckers et al., 2001). These actions 
are likely mediated via the downstream effector molecules of HO. Biliverdin and bilirubin function 
as a potent antioxidant system, whereas CO mediates vasodilation via cyclic guanosine 
monophosphate (cGMP) induction (Siow et al., 1999). Furthermore, the iron, released from heme by 
HO-1 activity, enhances ferritin synthesis and thereby renders it inactive by sequestering (Balla et 
al., 1992). In this regard, overexpression of HO-1 in endothelial cells has been shown to protect 
from heme- and hemoglobin-mediated toxicity and is associated with increased tolerance of cells to 
ischemia and trauma in a variety of tissues (Abraham et al., 1995; Amersi et al., 1999; Yang et al., 
1999). Interestingly, HO-1 overexpression has been demonstrated to down-modulate inflammatory 
adhesion molecules and to diminish leukocyte adhesion to the vascular endothelium on 
proinflammatory stimuli both in vitro and in vivo (Hayashi et al., 1999; Wagener et al., 1999; 
Vachharajani et al., 2000; Rucker et al., 2001; Wagener et al., 2001).  
 Here, we hypothesize that HO alleviates the inflammatory process present after wounding and 
provides protection against further injurious insults. To investigate this hypothesis, we examined the 
role of the heme-HO system on adhesion molecule expression and leukocyte recruitment during 
wound healing in rat oral mucosa.  
 
Materials and Methods 
Porphyrin solutions 
The following porphyrins were used: hemin (Sigma Chemical, St Louis, MO) and tin (stannic) 
mesoporphyrin (SnMP; Porphyrin Products, Logan, UT). At low concentrations, SnMP acts as a 
potent and selective competitive inhibitor of HO activity in vitro and in vivo (Kappas et al., 2001). 
All porphyrin solutions were freshly prepared as previously described (Chernick et al., 1989). In 
short, hemin was dissolved together with Trizma base in a 0.1 M NaOH solution and diluted in 
saline (Braun Melsungen, Melsungen, Germany). Next, the pH was adjusted to pH 8 with HCl. The 
solution was then filter-sterilized, protected from light, and directly used. The heme solution was 
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negative for the presence of endotoxin contamination as determined by the limulus amebocyte 
lysate (LAL) test (BioWhittaker, Walkersville, MD). 
 
Antibodies 
The following monoclonal antirat antibodies were used: anti-intercellular adhesion molecule 1 
(ICAM-1; Endogen, Woburn, MA), anti-β1 (kind gift from K. Löster, Berlin, Germany), 
antimacrophage marker, antigranulocyte marker, and anti–T-cell marker (Serotec, Oxford, United 
Kingdom). In addition, the polyclonal rabbit antibodies SPA895 (antirat-HO-1; Stressgen/Sanbio, 
Uden, The Netherlands) and OSA200 (antirat-HO-2; Stressgen/Sanbio) were used. As secondary 
antibodies, biotin-labeled goat-antimouse IgG or biotin-labeled antirabbit IgG antibodies were used. 
 
Animals 
Male Wistar rats, 5 to 7 weeks of age, were obtained from Harlan (Horst, The Netherlands). The rats 
were kept under specified pathogen-free conditions in the Central Animal Laboratory (University 
Medical Center Nijmegen, The Netherlands). The rats had free access to water and were fed 
standard laboratory chow (Hope Farms, Woerden, The Netherlands). All experiments were 
performed in accordance with the guidelines of the Nijmegen Animal Experiments Committee. 
Human skin material was obtained according to the guidelines of the medical and ethics committee 
of the Radboud University Nijmegen Medical Centre and after informed consent was given. 
 
Experimental wounding protocol  
All rats were anesthetized with an intraperitoneal injection of fentanyl and fluanisone, 0.4 ml/kg 
body weight (Janssen-Cilag, Beerse, Belgium). Full-thickness excisional circular wounds were 
made in the mucoperiosteum of the hard palate between the second molars using a 3-mm biopsy 
punch (Cornelissen et al., 1999; Van Beurden et al., 2003). The day on which this biopsy was taken 
is further referred to as day 0. The initial wounds included the submucosa attached to the midpalatal 
suture (Cornelissen et al., 1999). Wounded rats were medicated postoperatively with a subcutaneous 
injection of buprenorphine, 0.1 mg/kg body weight (Schering-Plough, Maarssen, The Netherlands) 
as an analgesic. Animals were killed with a mixture of CO2/carbogene at 1, 2, 3, 5, 8, 15, 30, 60, or 
90 days after wounding. To ensure the inclusion of the wound margins, 4-mm circular biopsy 
punches of rats (n = 3-6) were then obtained per time point. The tissues were immediately immersed 
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in Tissue-Tek (Sakura Finetek Europe, Zoeterwoude, The Netherlands), frozen in liquid nitrogen, 
and stored at –80°C.  
 In subsequent experiments, 30 µl SnMP (20 µM; day -2) and/or 30 µl heme (750 µM; day -1) 
or 30 µl saline (day -1) was given intradermally with a fine needle (29 gauge) prior to the described 
wounding (n = 6).  
 This mucosal wound-healing model was characterized in time using hematoxylin-eosin staining 
(figure 1). Tissue from day 0 showed the normal mucosa, in which no inflammatory leukocyte 
infiltrates were present. Acute cellular injury and inflammatory reactions and cellular influx are 
evident at days 1 to 5 as exemplified by day 3. From day 5 on, resolution of inflammation started 
resulting in a decreased cell influx (data not shown). From day 8 until day 15, wound contraction by 
myofibroblasts resulted in the closure of the wound. Around day 15 to 30 remodeling started, and at 
day 90 to 120 the wound site was restored, resulting in scar tissue.  
 
 
  
 
 
 
 
 
Figure 1: Wound healing in time. Various stages (days 0, 3, 8, 15, 30, 60) in wound healing are shown. The tissues are 
stained with hematoxylin and eosin. A clear influx of inflammatory cells can be seen at day 3 to 8, whereas from day 15 
remodeling occurs, which was completed at day 60 (original magnification, x 25). 
Primary fibroblast cultures 
For fibroblast isolation, rats were killed with a mixture of CO2/carbogene at 3, 5, 8, 15, 30, 60, and 
90 days after initial wounding (n = 5). Biopsy specimens from the wound area were transported into 
sterile phosphate-buffered saline (PBS), washed extensively, cut into small pieces, and placed into a 
single well of a 24-well culture plate, containing Dulbecco modified Eagle medium (DMEM) with 
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25 mM HEPES (N-2-hydroxyethylpiperazine-N'2-ethanesulfonic acid), sodium pyruvate, 1000 
mg/L glucose, and pyridoxine (Gibco Life Technologies, Paisley, Scotland) supplemented with 10% 
fetal bovine serum (FBS; Gibco Life Technologies) and 100 U/mL penicillin (Gibco Life 
Technologies) and 100 µg/mL streptomycin (Gibco Life Technologies). The tissue explants were 
left undisturbed for 1 week in an incubator (37°C, 5% CO2) to allow the outgrowth of fibroblasts. 
After 7 days, the cultures were trypsinized and transferred to a 25-cm2 culture flask (Nunc, 
Naperville, IL). Cultures were successively passaged to one and three 75-cm2 culture flasks. Finally, 
cell cultures were frozen in 7.5% dimethyl sulfoxide (DMSO; ICN Biomedicals, Aurora, OH) in 
culture medium and stored in liquid nitrogen until use (Schor et al., 1996; Van Beurden et al., 
2003).    
 
FACS analysis of HO-1 expression 
The fibroblasts isolated at the different time points were analyzed for the expression of HO-1 using 
fluorescence-activated cell sorting (FACS) analysis. Cells were fixated for 20 minutes in 1% 
paraformaldehyde on ice. Next, they were permeabilized by incubation with 0.1% saponin/PBA 
(PBAS; PBS containing 0.5% wt/vol bovine serum albumin [Roche Molecular Biochemicals, 
Mannheim, Germany] and 0.01% sodium azide [Merck, Hohenbrunn, Germany]) for 10 minutes on 
ice. Cells were incubated (30 minutes, 4°C) with primary antibody against HO-1. After extensive 
washing (PBAS) cells were incubated with fluorescein isothiocyanate (FITC)–conjugated goat-anti-
rabbit IgG for 30 minutes at 4°C. Cells were washed and the relative fluorescence intensity was 
measured by FACScan analysis (Becton Dickinson, Oxnard, CA).  
 
Heme staining 
Tissue slices, 4 µm thick, were stained with hematoxylin and eosin using standard protocols. The 
presence of heme in the sections was analyzed using a benzidine staining technique as described 
before (Wagener et al., 2001). Tissue was counterstained with hematoxylin. 
 
Immunohistochemistry 
Cryostat sections (4 µm thick) were collected on Superfrost slides (Menzel-Gläser, Braunschweig, 
Germany) and analyzed for the expression of ICAM-1, β1, HO-1 and HO-2, and leukocyte subsets 
using immunohistochemistry.  
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 Immunohistochemical analysis was performed using protocols of the provider (Vector 
Laboratories, Burlingame, CA). AEC (3-amino-9-ethylcarbazole) or diaminobenzidine (DAB) were 
used as chromogens. Slides were microscopically analyzed after counterstaining with hematoxylin.  
 
Results 
Using the wound-healing model as described in "Materials and methods," we first examined the 
effect of injury on heme release using benzidine staining. As demonstrated in figure 2, large 
amounts of free heme/hemoproteins are visible at the site of injury, whereas in the surrounding 
noninjured tissue no heme can be detected. 
 
 
 
 
 
 
 
 
 
Figure 2: Presence of heme. The presence of heme in a fresh wound of a Wistar rat was analyzed using benzidine 
staining. The heme (arrow) has clearly accumulated at the sites of injury. Original magnification, x 100 (left panel) and 
x 265 (right panel). 
Next, expression of adhesion molecules was analyzed in the wound area in time using 
immunohistochemical techniques. Using immunohistochemical analysis, a clear increase in 
expression of β1-integrin was demonstrated on injury, which was localized mainly on fibroblasts and 
infiltrating cells (figure 3A). The β1 integrins are engaged in interactions with extracellular matrix 
components, such as collagen and fibronectin, and cell surface ligands. In parallel studies, it was 
recently found that about 70% of the fibroblasts isolated at day 0 expressed the β1 subunit on their 
cell surface (Van Beurden et al., 2003). Highest amounts of positive cells (90%) were observed at 
30 days after wounding. Peaks in the fluorescence intensity were observed at 5 and 60 days after 
wounding (Van Beurden et al., 2003). In addition, nontreated rats (day 0) hardly showed ICAM-1 
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expression (figure 3B). After injury (day 1-5) ICAM-1 expression was clearly induced. 
Interestingly, activated infiltrating leukocytes also showed intense ICAM-1 staining.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Adhesion molecule expression and the infiltration of leukocytes. Adhesion molecule expression and the 
infiltration of leukocytes subset in the wound shown at 2 different stages in wound healing as determined using 
immunohistochemistry. (A) β1-Integrins are highly up-regulated 5 and 8 days after wounding (arrows; original 
magnification x 100). (B) ICAM-1 expression is clearly up-regulated within the wounded tissue at day 3 compared to 
day 0 (arrow; original magnifications, x 100 and x 250, respectively). (C) Massive infiltrates of macrophages are 
present 1 and 3 days after wounding. Arrows indicate examples of positive staining (original magnification x 250). 
 
 Infiltration of leukocytes into the wound area was investigated using subset-specific antibodies. 
The first infiltrating leukocytes appeared already 1 day after inflicting the wound (figure 3C). They 
consisted mainly of granulocytes (data not shown). After 3 days massive infiltrates of leukocytes, 
consisting of large amounts of macrophages (figure 3C) and granulocytes, were present. T- 
lymphocytes were observed both in normal mucosa and in the wound and did not significantly 
increase. After 15 days most wounds were closed and filled up with new granulation tissue. The 
Day 0 Day 5 Day 1 Day3
C B 
Day 0 Day 3
Day 5 Day 8
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infiltrated granulocytes and macrophages remained only at the initial wound site. Thus, the release 
of heme is followed by adhesion molecule expression and leukocyte recruitment. 
 
Effects of heme administration on adhesion molecule expression and leukocyte infiltration 
Because we observed that after injury large quantities of heme were locally released in conjunction 
with elevated inflammatory adhesion molecules and leukocyte infiltrates, we hypothesized that 
heme is playing an active role in this inflammatory process. To investigate the inflammatory effects 
of heme the rat mucosa was exposed to heme, or saline control, and analyzed for the expression of 
adhesion molecules and leukocytes.  
 The effect of heme on ICAM-1 expression (figure 4) and leukocyte infiltration (figure 4) in the 
mucosa was measured by immunohistochemistry. ICAM-1 expression was highly upregulated on 
endothelial cells and keratinocytes in animals exposed for 24 hours to heme when compared with 
saline controls (figure 4). Moreover, 24 hours after administration of heme the mucosa showed a 
clear increase of granulocyte and macrophage infiltration when compared with saline controls 
(figure 5A-B). Thus, the sheer presence of heme mimics several of the inflammatory effects 
observed on wounding. 
 
 
 
 
 
 
Figure 4: Adhesion molecule expression after administration of saline or heme. Administration of heme prior to injury 
caused a clear increase in ICAM-1 expression in endothelial cells, infiltrating leukocytes, and keratinocytes (arrow; 
original magnification x 100). 
Expression of HO-1 and HO-2 isoforms in the mucosa and skin  
Because HO-1, the heme-degrading enzyme, is up-regulated by a multitude of stress-causing 
conditions, we hypothesized that HO may also play an important function in the response to injury. 
The expression levels of the HO-1 and HO-2 isoforms during wound healing were therefore 
examined using immunohistochemistry. 
Heme Saline 
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SnMP + HemeHemeSaline
SnMP + HemeHemeSaline
 
 
 
 
 
 
 
 
 
Figure 5: The recruitment of leukocytes after administration of heme, saline, or SnMP. Both infiltrated granulocytes 
(A) and macrophages (B) are highly up-regulated after administration of heme (arrows). Inhibition of HO activity using 
SnMP exacerbated heme-induced leukocyte infiltration (original magnification x 100). In some cases HO inhibition 
using SnMP alone already caused leukocyte infiltration (data not shown).  
  Surprisingly, HO-1 protein expression was not only evident in the mucosal epithelium 
throughout the healing process, but also in normal noninjured mucosa (figure 6). High levels of HO-
1 were observed in both keratinocytes and infiltrating leukocytes 1 or 2 days after wounding (data 
not shown). In addition, high HO-1 expression was observed in infiltrated immune cells at day 3 
(data not shown) and day 5 (figure 6).  
 
 
 
 
Figure 6: Expression of HO-1 in the mucosa in time. HO-1 is clearly expressed in the epithelium of the mucosa 
(arrows). Furthermore, at day 5 HO-1 is highly evident in infiltrated leukocytes. At day 15 the expression returned to 
initial levels (in the top and lower panels, original magnifications are x 100 and x 250, respectively). 
 To analyze whether this basal level of HO-1 expression was confined to the epithelium of the 
mucosa, the expression of HO-1 (figure 7A) and HO-2 (figure 7B) was also investigated in different 
sections of the skin.  
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 Although the epidermis in skin sections of the back of the rat is narrow compared with the 
mucosal epithelium, both HO-1 and HO-2 were highly expressed (figure 7). Furthermore, skin 
sections of patients with chronic inflammation of the skin showed expression of HO-1 in the 
epidermis and in infiltrated leukocytes (figure 7). 
 
 
 
 
 
 
 
 
Figure 7: Expression of HO-1 and HO-2 isoforms in mucosa and skin. (A) HO-1 is not exclusively expressed in the 
oral mucosal epithelium, but also present in the epidermis of skin from the back of a rat and in the intestines (original 
magnifications, x 100 and x 250, respectively). Furthermore, HO-1 expression is evident in human epidermis and 
infiltrated leukocytes of a patient suffering from chronic inflammation (arrows; original magnification, x 250). (B) HO-
2 is expressed both in the epithelial as well as the dermal layer of mucosa and skin (mucosal, back of the rat, and 
intestines; arrows; original magnifications, x 100 and x 250, respectively). HO-2 is also expressed in a patient suffering 
from chronic inflammation. 
 Next, cultured rat skin fibroblasts, isolated from the mucosa at several time intervals after 
wounding (day 0 to day 90; see "Materials and methods") were evaluated for the expression of HO-
1 using flow cytometric analysis. It has previously been demonstrated that the phenotype of 
fibroblasts from biopsies remains remarkably stable on prolonged in vitro culturing (Irwin et al., 
1994; Schor et al., 1996). These cultured fibroblasts showed no significant changes in expression of 
Human skin
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a panel of markers (eg, integrins and cytoskeletal markers) and morphology compared to the in vivo 
situation (Schor et al., 1996; Nahm et al., 2002; Van Beurden et al., 2003). Figure 8 shows that 
shortly after wounding (day 1) fibroblasts initially show a small decrease in HO-1 expression, which 
is directly followed by a rise in HO-1 expression, which peaks at day 15. Next, the HO-1 expression 
levels decrease and return at day 90 slowly to day 0 levels. Furthermore, a clear increase in HO-1 
positive fibroblast populations was observed on wounding, which peaks at day 15 (figure 8). Next, 
the percentage of HO-1+ cells returns to day 0 levels at day 60 and then slightly increases again. 
 
 
 
 
 
   
 
 
 
 
Figure 8: Expression of HO-1 in wound fibroblasts in time. Fibroblast populations isolated from the wound area were 
analyzed for HO-1 expression levels (left y-axis; mean fluorescence intensity) and percentage HO-1 positive cells (right 
y-axis) using flow cytometry. After initial decrease, HO-1 expression is elevated and peaks after 15 days, after which it 
decreased and returned to control levels (left y-axis). After wounding, the population of infiltrated HO-1+ cells swiftly 
increased, peaked after 15 days, and returned to control levels at day 60, after which it slowly increased again (right y-
axis). 
The effects of HO activity on leukocyte infiltration 
The layer of HO-1+ and HO-2+ cells in the noninjured mucosa suggests that HO activity may play a 
prominent modulating role in the observed heme-induced leukocyte infiltration. To further 
investigate the effects of HO on wound healing, the mucosa was pretreated with SnMP, an inhibitor 
of HO activity, followed by exposure to heme or saline. Twenty-four hours of incubation with 
SnMP, followed by 24 hours of exposure to heme, resulted in an exacerbated influx of both 
  
Heme, heme oxygenase and wound healing 
 
 
 
 137 
granulocytes as well as macrophages into the mucosa, compared with heme treatment alone (figure 
5). Surprisingly, in some saline control animals (2 of 6) as well as SnMP-treated animals (4 of 6) 
increased numbers of infiltrating leukocytes were observed after injection (data not shown), whereas 
rats receiving no injection never showed inflammatory infiltrates (data not shown). Thus, inhibition 
of HO activity seems to sensitize the tissue for leukocyte infiltration.  
 
Discussion 
In this study, we investigated the effects of heme and the heme-degrading enzyme, HO, on the 
inflammatory response in a mucosal wound-healing model in rats. Cellular injury inflicted upon the 
skin is associated with repair processes involving complex interactions among coagulation, platelet 
aggregation, and the immune response. However, the exact mechanism of wound healing remains 
largely obscure. Wounding is associated with severe hemorrhage and hemolysis, and the injured 
cells get ruptured and release their content resulting in a local accumulation of free heme proteins 
and heme. We postulate that in a wounded area a pro-oxidant microenvironment is created 
providing signals to generate an inflammatory process.  
 We found that large amounts of heme are released at the wound site shortly after wounding, 
which is rapidly followed by the induction of adhesion molecules and the invasion of leukocyte 
subsets into the wounded area, which is indispensable for the elimination of pathogens and for the 
wound-healing process. Moreover, it was demonstrated that exposure of the mucosa to heme 
induces an increased expression of adhesion molecules and results in the recruitment of leukocytes. 
Interestingly, our observation that occasionally the injection of only saline also induces leukocyte 
recruitment, suggests that a minor injury evoked by the injection needle, probably releases sufficient 
amounts of heme to initiate local inflammation.  
 After injury, the life of organisms is at risk and wound repair is crucial, because of blood loss 
and possible influx of bacterial invaders. Previous data support a contribution of heme to this rescue 
operation because hemoglobin/heme can activate a wide array of processes, such as 
vasoconstriction, mononuclear cell-procoagulating effects, the activation of complement, the 
induction of inflammatory cytokines, vascular permeability, and platelet aggregation (Green and 
Ts'ao, 1990; Lavrovsky et al., 2000; Wagener et al., 2001). Therefore, heme and heme proteins are 
likely implicated in initiation of inflammatory processes (Nath et al., 2001; Wagener et al., 2001) 
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and homeostasis (Green and Ts'ao, 1990) and may form an essential link between these important 
systems.  
 Previously, we and others demonstrated that excess of free heme and heme proteins possesses 
potent pro-oxidative and proinflammatory properties (Balla et al., 1991; Wagener et al., 2001). 
Intriguingly, we demonstrate here that administration of solely heme is sufficient to induce 
inflammatory processes as exemplified by the influx of both granulocytes and macrophages.  
 In line with our findings of heme-induced inflammation in the rat model are earlier 
observations that administration of lysed blood, hemoglobin, or heme induced increased adhesion 
molecule expression (Wagener et al., 1997; Wagener et al., 2001), influx of leukocytes 
(F.A.D.T.G.W., A. Eggert, and colleagues, unpublished observations, November 2001), vascular 
permeability (Baldwin, 1999; Wagener et al., 2001), vascular smooth muscle cell contraction 
(Letarte et al., 1993), nuclear factor κB (NF-κB) activation, and chemokine production (Nath et al., 
2001).  
 It was previously demonstrated that heme activates NF-κB, AP-1, and AP-2 responsive 
elements (Lavrovsky et al., 1994; Kanakiriya et al., 2003). These regulatory sites are present on 
various proinflammatory genes (eg, ICAM-1, vascular cell adhesion molecule 1, E-selectin) as well 
as on anti-inflammatory/antioxidative genes (eg, HO-1) (Wagener et al., 1997). Recently, it was 
found that heme further controls gene expression via the transcriptional repressor Bach1 (Ogawa et 
al., 2001). Interestingly, heme increases the nuclear translocation of Nrf2, which has recently been 
implicated in wound-healing processes (Braun et al., 2002), via increased Nrf2 stabilization (Alam 
et al., 2003). On binding of intracellular heme, Bach1 detaches from the MARE sequences, which 
allows binding of Nrf2 and other small maf proteins, resulting in transcriptional activation of target 
genes, such as HO-1, thioredoxin, and keratinocyte growth factor (Kim et al., 2001; Ogawa et al., 
2001; Braun et al., 2002; Sun et al., 2002).  
 The importance of the heme-HO system in wound healing is underscored by the finding that 
HO-1 is associated with keratinocyte proliferation (Hanselmann et al., 2001) and that HO-1 
expression is highly elevated in infiltrated immune cells of patients with psoriasis (Hanselmann et 
al., 2001), who suffer from hyperproliferation of keratinocytes.  
 Surprisingly, we found that both HO-1 and HO-2 were significantly expressed in normal 
mucosa and skin. HO-1 is present mainly near the basal membrane in proliferating keratinocytes 
(Kampfer et al., 2001). HO-2, the HO isoform that is able to bind heme, may therefore function as a 
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first scavenger against heme-induced insults, whereas HO-1, present in the first layers of the 
epidermis and in infiltrating leukocytes, degrades heme to generate its potent cytoprotective 
breakdown products. Therefore, HO seems to form a general protective layer to withstand the 
continuous oxidative and mechanical insults of which the skin daily suffers. This hypothesis is 
supported by experiments of Tyrrell (Tyrrell, 1999), who demonstrated that on UV radiation HO-1 
and therefore ferritin are highly up-regulated in fibroblasts and provide potent cytoprotection. 
Interestingly, many reptiles and amphibians accumulate large amounts of the green antioxidant 
biliverdin, a heme breakdown product, in their skin, which may function as a protective wall as well.  
 The observed increased expression of HO-1 on wounding in fibroblasts seems to be mediated 
mainly by an increased cell population of HO-1+ fibroblasts, which probably represents newly 
recruited cells. The newly arrived fibroblasts and leukocytes in the wound area demonstrate clearly 
elevated HO-1 levels. Thus, by infiltrating, these cells import the HO system into the wounded area 
and cause protection via the immediate generation of the anti-inflammatory and antioxidative heme 
metabolites biliverdin/bilirubin and CO, and the up-regulation of ferritin (Kampfer et al., 2001).  
 When HO activity is inhibited by pharmacological agents such as SnMP, administration of 
heme aggravated influx of granulocytes and macrophages as compared with heme treatment alone. 
HO activity may, via the generation of antioxidants biliverdin/bilirubin and vasodilator CO, function 
as a feedback mechanism by down-regulating adhesion molecules and thereby alleviating 
recruitment of immune cells and the immune response. It is likely that the mechanism by which 
heme-induced leukocyte influx acts, is also mediated by chemokine-triggered pathways. Heme may 
oxidize low-density lipoproteins (ox-LDL) that form potent chemoattractants (Balla et al., 1991) 
(Ishikawa et al., 1997). Moreover, it was recently discovered that heme strongly induces monocyte 
chemoattractant protein 1 (MCP-1) (Nath et al., 2001; Kanakiriya et al., 2003), and that exposure of 
granulocytes to heme induces the expression of the chemokine interleukin 8 (IL-8) (Graca-Souza et 
al., 2002). These heme-mediated inflammatory processes may be counteracted by HO activity. In 
fact, it has been observed that heme breakdown products down-modulate ox-LDL–mediated 
leukocyte chemotaxis (Ishikawa et al., 1997). Moreover, hypoxia-induced proinflammatory 
cytokines and chemokines are significantly suppressed in HO-1 transgenic mice (Minamino et al., 
2001).  
 Matzinger recently described a novel view on immune regulation, in which the immune system 
does not primarily discriminate between "self and non-self", but acts mainly on "danger signals" 
(Gallucci and Matzinger, 2001). The local release of heme and heme proteins may act as a "danger 
  
Chapter 6 
 
 
 
 140 
signal," similar to inflammatory bacterial endotoxins, and alert the immune system to initiate 
inflammatory processes, resulting in the recruitment of leukocytes.  
 Similarly, heme may act as an inducer of inflammatory processes, by cellular activation, the 
formation of ox-LDL, and the induction of adhesion molecules (Balla et al., 1991; Wagener et al., 
1997). This results in signals for recruitment of leukocytes and for antigen processing by dendritic 
cells and macrophages (Ishikawa et al., 1997; Hartgers et al., 2000). This may also explain the vivid 
response of the immune system toward nonopen wounds, such as contusions, despite the absence of 
"foreign" material.  
 Interestingly, Tolosano and coworkers recently described several anti-inflammatory effects of 
hemopexin and haptoglobin, scavengers for, respectively, heme and haemoglobin (Tolosano et al., 
2002). They suggested that these scavengers modulate the inflammatory response by triggering their 
specific receptors (Tolosano et al., 2002). These receptors may also be able to sense and respond to 
the first signs of injury (eg, heme release). In fact, the haptoglobin receptor, CD163, and hemopexin 
receptors have been implicated in cell survival, stress response, and inflammatory processes (Smith 
et al., 1997; Eskew et al., 1999; Gordon, 2001; Kristiansen et al., 2001; Tolosano et al., 2002).  
 On the other hand, we and others previously observed that overexpression of HO-1 down-
regulates adhesion molecule expression and subsequently reduces binding of leukocytes, whereas 
inhibition of HO activity exacerbates adhesion molecule expression and leukocyte infiltration 
mediated by proinflammatory mediators (Hancock et al., 1998; Hayashi et al., 1999; Wagener et 
al., 1999; Vachharajani et al., 2000; Rucker et al., 2001; Wagener et al., 2001). This model of 
heme–HO-mediated modulation of inflammation is further strengthened by the findings of Willis 
and colleagues who demonstrated enhanced levels of HO-1 in monocytes during the resolution 
phase of inflammation (Willis, 1995; Willis et al., 1996). Thus, HO activity probably forms a 
feedback loop by attenuating adhesion and migration and by promoting resolution of inflammation.  
 Thus, the heme-HO system seems tightly integrated in complex wound-healing processes such 
as hemostasis and inflammation (figure 9). This novel view on wound-healing processes may 
provide new tools for therapeutic strategies.  
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Figure 9: Model for heme, HO, and wound healing. We hypothesize that the heme released after injury functions as a 
"danger signal" that can activate a whole range of inflammatory and immune regulatory cascades. Heme activates 
platelet aggregation and causes vasoconstriction, which are important parameters for "thrombus formation." 
Furthermore, heme activates leukocytes, oxidizes LDL, increases adhesion molecule expression, and recruits 
leukocytes. The presence of HO in the skin protects against the heme-mediated pro-oxidative and proinflammatory 
microenvironment that is instantly created on injury, and might play a role in down-regulation of inflammatory cell 
recruitment and resolution of inflammation.  
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Introduction 
Disturbances in maxillary development and dento-alveolar growth after cleft palate repair have been 
a problem for surgeons for a long time (Perko, 1986). In the first half of the 19th century many 
surgeons attempted to optimize cleft palatal closure (Zigiotti et al., 1983), but in spite of all the 
efforts, serious growth problems remained (Millard, 1976). Since that time, some progress has been 
made by modifying surgical techniques. Only in the eighties of the last century it was shown that 
wound contraction and scar tissue formation formed the basis of the inhibition of maxillary 
development and dento-alveolar growth (Kremenak, 1984).  
 Fibroblasts and myofibroblasts are important cells in wound healing. They mediate wound 
contraction and scar formation, and therefore, interference with fibroblast activity might decrease 
the growth disturbances. To achieve this, the wound fibroblasts first have to be characterized. This 
was the main subject of this thesis. More precisely, the aims of this study were: 
 
(1) to characterize fibroblasts at different stages of wound healing in vivo and also after  in vitro 
culture. Accumulating evidence shows that fibroblasts are dynamic cells occurring in 
functionally and morphologically heterogeneous subpopulations. It was proposed that also 
during oral wound healing distinct fibroblast subpopulations occur (Lekic et al., 1997). We 
investigated whether such subpopulations are also present during palatal wound healing. 
Therefore, we analyzed the expression of integrins, cytoskeletal proteins, and the 
cytoprotective enzyme heme oxygenase-1 in vitro and in vivo. Additionally, we investigated 
changes in cell density and apoptosis in vivo. 
 
(2) to relate the fibroblast phenotypes to functional activity in vitro. Fibroblasts migrate into the 
wound and proliferate in response to fibronectin and several growth factors secreted by 
neutrophils and macrophages (Singer and Clark, 1999). Adhesion and migration of these 
cells are essential for the formation of granulation tissue (Singer and Clark, 1999). 
Furthermore, wound contraction is initiated by migrating fibroblasts generating mechanical 
tension (Darby et al., 1990). Therefore, we compared the adhesion and migration of 
fibroblasts from early and late phases of wound healing with age-matched cells from 
unwounded palates. 
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Experimental in vivo models 
Since the breeding of animals with standardized clefts appears to be impossible, animals with 
surgically created clefts have been used. Cats, dogs, rats, rabbits, and primates have been used to 
study the different aspects of a cleft palate (Bardach and Kelly, 1988).  To study the effects of 
surgery on growth, mainly dogs, cats or primates were employed. These animal models, however, 
are very expensive, and species-specific antibodies are often not available. This makes them less 
suitable for cell biological research. Rats provide a more convenient model, since they are relatively 
cheap and many antibodies against rat integrins and cytoskeletal markers are available. Drawbacks 
of the rat as a model are the differences existing between wound healing in rats and humans and that 
rats are too small to perform proper palatal surgery. The latter means that the effect of surgery on 
long term growth cannot be studied in the rat model. Therefore, these aspects have to be studied in 
animals that mimic the human situation more closely. 
 Since the main aim of this thesis is the characterization of the fibroblasts during palatal wound 
healing, a rat model is suitable. Palatal full-thickness wounds made with a biopsy punch are thought 
to mimic the wounds resulting from cleft palate surgery in humans. The feasibility of this method 
has already been demonstrated (Cornelissen et al., 1999). 
 Although the palatal wound healing process is scarcely studied, it appears to be comparable to 
the extensively described dermal wound healing process. Rat dermal wound healing does not 
perfectly mimic human dermal wound healing since the skin morphology is different (Marx and 
Mou, 2002). Rats are described as loose-skinned animals, while humans have a “tight” skin. This 
“loose” skin allows wound contraction to play a more important role in dermal wound closure, 
causing a shorter overall healing time in rats than in humans. This difference complicates the 
comparison between the two species (Davidson, 1998). However, the more fundamental aspects of 
wound healing are largely comparable. In summary, the rat model is suitable to study the more 
fundamental biological aspects of palatal wound healing.  
 
Experimental in vitro models 
The same rat model as described above provides material for the in vitro studies. Fibroblasts are 
cultured from full-thickness wound tissue, obtained with a biopsy punch at different time points 
during wound healing. These cell cultures are used to study the specific characteristics of the 
fibroblasts at different stages. An advantage of cell culture studies is that large numbers of cells are 
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available after propagation. However, a prerequisite is that the phenotype of these cells is stable 
during culture. Since we observed marked differences in fibroblast phenotypes depending on the 
collection time after wounding we conclude that the phenotype of the different fibroblast 
populations remains stable in culture (see chapter 3). Therefore, we assume that the cultured cells 
indeed represent the fibroblastic phenotypes characteristic for different stages of the wound healing 
process. The expression profile of fibroblasts in situ was similar to that found after in vitro culturing 
adding evidence that indeed the different fibroblasts populations are stable in culture. 
 
Study design 
To characterize the fibroblast subpopulations, tissue samples from different phases of the wound 
healing process were used. The sampling protocol is schematized in figure 1. At t=0, biopsies from 
the unwounded tissue were obtained, after which the wounds were allowed to heal. At 3, 5, 8, 15, 
30, 60, or 90 days after wounding biopsies were taken from the healing tissue and either processed 
for western blotting and immunohistochemistry, or for fibroblast culture. For the in vitro 
experiments, biopsies were cut into pieces and the fibroblasts were cultured for four passages. 
These cells were used for flow cytometry (FACS), western blotting of whole cell lysates, 
immunocytochemical analysis, and for adhesion and migration assays.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Sample protocol. 
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Analytical parameters 
The analytical markers used in this study are summarized in table 1. 
 
Integrins 
The α1β1, α2β1 and α5β1 integrins are important for the transmission of forces over the wound and 
for interactions between fibroblasts and collagen during the remodeling phase (Welch et al., 1990; 
Schiro et al., 1991). The αv subunit can combine with several β subunits to serve as receptors for 
vitronectin and fibronectin (Gailit and Clark, 1994). Finally, the α6 subunit is included because it is 
thought to be unique for anchoring basal keratinocytes to the basement membrane (Sonnenberg et 
al., 1991), but whether it is also expressed by fibroblasts is still a matter of debate. 
 
Cytoskeletal markers  
α-Smooth muscle actin (α-SMA) belongs to the actin microfilament system and enables 
myofibroblasts to generate forces during the contraction of granulation tissue (Gabbiani, 1992). The 
intermediate filament vimentin also contributes to the generation of these forces (Coleman and 
Lazarides, 1992). Vinculin, is an important component of focal adhesion complexes (Bailly, 2003). 
 
Enzyme 
Heme oxygenase-1 is an important cytoprotective enzyme during wound healing because it 
neutralizes the toxic heme that is released from heme proteins after wounding  (Willis, 1995; 
Brouard et al., 2000; Duckers et al., 2001). 
 
Cell density 
Apoptosis and DNA content are used as measures for changes in cellularity. 
 
Functional assays 
Migration and adhesion are determined, since both are essential for wound contraction and scar 
tissue formation (Nedelec et al., 2000). 
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Table 1:  Markers included in the study. 
 
Integrin subunits 
α1 
α2 
α6 
αv 
β1 
Cytoskeletal markers 
α-SMA 
vimentin 
vinculin 
Cell density 
DNA 
apoptosis 
Heme-oxygenase HO-1 
 
Functional characteristics 
migration 
adhesion 
All markers which are analyzed in this study. α1 = integrin subunit α1; α2 = integrin 
subunit α2; α6 = integrin subunit α6; αv = integrin subunit αv; β1 = integrin subunit β1; α-
SMA = α-smooth muscle actin; HO-1 = heme oxygenase-1 
 
 
Results 
Analysis of fibroblast parameters in vitro and in vivo 
The expression of integrin subunits was analyzed during palatal wound healing in vivo, and in 
cultured cells from the different stages (chapters 3 and 4). All subunits showed remarkable changes 
in expression both in vitro and in vivo during the first two weeks of palatal wound healing. This 
dynamic period may be related to inflammation, re-epithelialization, wound contraction, and the 
formation of a provisional matrix, since all these processes require rapid changes in integrin 
expression. The integrin subunits α1 and β1 also showed an extended increase in expression later in 
wound healing. Although at that time ”less active” fibroblasts were observed with a more stable 
phenotype, the unwounded situation was never re-established. This indicates that true healing is not 
achieved during the time frame of the present studies, and that scar tissue may remain in the wound. 
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 The expression of some important cytoskeletal markers was also analyzed in the fibroblast 
populations in vitro, and in vivo (chapters 3 and 4). Shortly after wounding, the amount of vimentin 
increased in tissue homogenates. However, the number of vimentin-positive fibroblasts did not 
change during wound healing. This indicates that the amount of vimentin per cell is increased rather 
than the number of vimentin-positive cells. The in vivo expression of α-SMA by fibroblasts also 
showed a maximum around eight days post wounding, after which it decreased to below the level of 
the unwounded control. The in vitro expression of α-SMA in the isolated fibroblast populations 
corresponded highly with these data. Thus, most myofibroblasts are present around eight days post- 
wounding. Thereafter, the myofibroblasts disappear. The early peak in myofibroblast numbers is 
also described by others (Desmouliere and Gabbiani, 1996). The expression of vinculin, which was 
used as a marker for focal adhesions, was high in unwounded tissue, significantly lower early in 
wound healing, and again high later in wound healing. The number of focal adhesions appears to be 
inversely related to the motility of cells (Huttenlocher et al., 1995; Murphy-Ullrich, 2001). Our data 
therefore can be interpreted as a low fibroblast motility in unwounded tissue, a high motility early 
in wound healing, and a reduced motility later on.  
 The results from the functional assays confirm the above findings. Adhesion and migration of 
wound fibroblasts from fibroblast populations isolated in the course of palatal wound healing were 
studied (chapter 5). Sessile fibroblasts obtained from unwounded control tissue showed low 
migration activity and high adhesion in vitro. In contrast, fibroblasts obtained later in wound 
healing showed a much higher migration and less adhesion. Adhesion and migration are indeed 
shown to be inversely related (Couchman and Rees, 1979; Dunlevy and Couchman, 1993). 
 Apart from the changing expression patterns of integrins and cytoskeletal proteins, we also 
observed changes in cell density during palatal wound healing, however none of these changes were 
significant (chapter 4). The maximum cell density was observed between one and two weeks after 
injury which corresponded with the time of maximum granulation tissue formation and wound 
contraction. We also observed a maximum in the number of apoptotic cells around two weeks after 
injury. The decrease in cellularity during wound healing is generally believed to be caused by 
apoptosis (Desmouliere, 1995). Indeed, we observed a maximum in the number of apoptotic cells 
around two weeks after injury, after which the number of apoptotic cells decreased (chapter 4).  
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Heme oxygenase expression of fibroblasts in vitro and in vivo  
During palatal wound healing, fibroblasts showed specific changes in in vivo and in vitro expression 
patterns of the heme degrading enzyme heme oxygenase-1 (HO-1) (chapter 6). Early in wound 
healing the number of HO-1 positive fibroblasts and the average expression per cell was strongly 
increased. Late in wound healing, these levels returned to the normal unwounded levels. HO-1 has a 
cytoprotective role early in wound healing during the inflammatory phase (Kampfer et al., 2001). 
Later in wound healing, when the inflammation subsides, HO-1 expression returns to normal. 
Recent data also indicate antifibrotic activities of HO-1 later in wound healing (Li et al., 2003). 
 
Conclusions  
From these studies we can conclude that heterogeneous populations of fibroblasts are present in the 
course of  palatal wound healing. These different subpopulations can be isolated and cultured, and 
maintain their characteristics up to seven passages. We distinguished two main fibroblast 
phenotypes both during palatal wound healing in vivo, and in vitro: an early “activated” phenotype 
and a late more “quiescent” phenotype. These fibroblast phenotypes were also observed in the 
functional assays for adhesion and migration.  
 The modulation of activity of specific fibroblast phenotypes might offer a good starting point 
for the control of wound contraction and scar formation. 
  
Future Research 
The discovery of specific fibroblast populations during wound healing offers opportunities for 
future manipulation of the wound healing process. As these populations were shown to be 
maintained in culture, further characterization can be carried out in functional wound healing 
models. A first attempt was made in chapter 5 with the study of adhesion and migration of 
fibroblast populations. Further studies, for example in three-dimensional contraction models, should 
focus on myofibroblasts, the main cells responsible for contraction and scarring. In addition, 
functional models can be used to develop methods for the modulation of (myo)fibroblast activity.  
 The emphasis of this study was on the role of fibroblast integrins in palatal wound healing. 
Although we characterized the expression of several integrins on palatal fibroblasts, it will be 
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difficult to modulate palatal wound healing by intervention on the integrin level. The same integrins 
present on other fibroblasts or even on other cell types will also be affected. 
 In chapter 2, we discussed several theoretical options for the modulation of myofibroblasts. 
More feasible options focus on the reduction of myofibroblast numbers, either by inhibition of their 
differentiation, or by stimulation of their apoptosis. The latter might be achieved by the local 
application of certain growth factors but more information on the exact signals inducing 
myofibroblasts apoptosis is required. Inhibition of myofibroblast differentiation might be achieved 
by the blocking of ED-A fibronectin, one of the essential factors for myofibroblast differentiation. 
This protein is specific for the wound healing process, and as such is not expected to induce side 
effects elsewhere in the body.  
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Introductie 
Groeiverstoringen in het orofaciale gebied na de sluiting van een gehemeltespleet vormen al lange 
tijd een probleem. In de eerste helft van de 19e eeuw hebben veel chirurgen geprobeerd om de 
sluiting te optimaliseren. Ondanks alle moeite bleven serieuze problemen bestaan. Sinds die tijd is 
er gelukkig veel vooruitgang geboekt door de verbetering van chirurgische technieken . Echter, pas 
in de jaren tachtig van de afgelopen eeuw werd aangetoond dat wondcontractie en littekenvorming 
de grootste oorzaak vormen van de problemen. 
 Fibroblasten en myofibroblasten zijn belangrijke cellen bij de wondgenezing omdat ze de 
wondcontractie en littekenvorming reguleren. Ingrijpen op de het niveau van de fibroblast zou 
daarom mogelijk tot een afname van de groeiverstoringen kunnen leiden. Ingrijpen is echter pas 
mogelijk als de eigenschappen van de fibroblasten bekend zijn. Dit promotieonderzoek richtte zich 
daarom op twee belangrijke aspecten van de fibroblasten bij de intra-orale wondgenezing, namelijk: 
 
(1) karakterisering van fibroblasten tijdens verschillende stadia in de in vivo wondgenezing en 
na in vitro celkweek. Het wordt steeds duidelijker dat fibroblasten dynamische cellen zijn 
die bestaan uit subpopulaties die functioneel en morfologisch heterogeen zijn. We 
verwachtten dat ook tijdens de palatinale wondgenezing verschillende fibroblast 
subpopulaties ontstaan. Om dit te kunnen onderzoeken, hebben we de in vitro en in vivo 
expressie van integrines, cytoskelet eiwitten en het celbeschermende enzym heme 
oxygenase-1 (HO-1) onderzocht. Bovendien onderzochten we veranderingen in celdichtheid 
en apoptose tijdens de wondgenezing in vivo. 
 
(2) koppeling van fibroblast fenotypes aan de functionele activiteit in vitro. Nadat fibroblasten 
de wond in zijn gemigreerd, scheiden neutrofielen en macrofagen fibronectine en 
verscheidene groeifactoren uit waardoor proliferatie van de fibroblasten plaatsvindt. Adhesie 
en migratie van fibroblasten is van essentieel belang bij de vorming van granulatie weefsel. 
Verder wordt wondcontractie geïnitieerd door migrerende fibroblasten die mechanische 
spanning opbouwen. Daarom hebben we de adhesie en migratie van fibroblasten tijdens de 
vroege en de late fase in wondgenezing vergeleken met controle cellen van vergelijkbare 
leeftijd, die afkomstig van gezond palatumweefsel. 
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In vivo modellen 
Aangezien het onmogelijk is om dieren met een aangeboren gehemeltespleet op een 
gestandaardiseerde wijze te fokken, worden dieren gebruikt waarin de gehemeltespleet chirurgisch 
is aangebracht. Inmiddels zijn er studies uitgevoerd in katten, honden, ratten, konijnen en primaten. 
Om het effect van chirurgie op de groei van de bovenkaak te bepalen, is voornamelijk gebruik 
gemaakt van honden, katten of apen. Deze diermodellen zijn echter zeer duur en soort-specifieke 
antilichamen zijn vaak niet verkrijgbaar. Daarom zijn deze dieren minder geschikt voor 
celbiologisch onderzoek. Een geschikter diermodel is de rat, omdat ratten relatief goedkoop zijn en 
er bovendien veel antilichamen tegen integrines en cytoskeleteiwitten van de rat verkrijgbaar zijn. 
Een nadeel van het gebruik van een rattenmodel is het verschil in wondgenezing tussen ratten en 
mensen. Bovendien zijn ratten te klein om  normale oraal chirurgische technieken op uit te voeren. 
Dit betekent dat de lange termijn effecten van de chirurgische ingreep op de groei van de bovenkaak 
niet bestudeerd kunnen worden. Deze effecten kunnen beter bestudeerd worden in dieren die meer 
overeenkomsten vertonen met de menselijke situatie. 
 Aangezien dit onderzoek zich voornamelijk richtte op de karakterisering  van fibroblasten 
tijdens de palatinale wondgenezing, en niet op het lange termijn effect van wondgenezing op de 
groei van het palatum, is het rattenmodel zeer geschikt. In dit onderzoek werden met bioptpunches 
wonden in het palatum van een rat aangebracht. Deze wonden komen goed overeen met de wonden 
die ontstaan na chirurgische sluiting van het palatum. De bruikbaarheid van het rattenmodel is reeds 
eerder aangetoond. 
 Er is niet veel onderzoek verricht naar de wondgenezing in het palatum, maar de beschikbare 
gegevens wijzen er op dat dit proces grote overeenkomsten vertoont met de dermale wondgenezing. 
De dermale wondgenezing in de mens is uitgebreid beschreven in de literatuur. Toch kunnen we 
deze kennis niet zondermeer vertalen naar ons rattenmodel. De morfologie van een rattenhuid 
verschilt nogal van de mensenhuid. Ratten hebben een ‘losse’ huid, terwijl mensen een ‘vaste’ huid 
hebben. Vanwege de ‘losse’ huid treedt er bij ratten meer wondcontractie op dan bij mensen, en 
daarom neemt de wondgenezing bij ratten minder tijd in beslag. De meer fundamentele aspecten 
van de wondgenezing komen wel sterk overeen en dus is het rattenmodel geschikt om de meer 
fundamentele biologische aspecten van de palatinale wondgenezing te bestuderen. 
 
  
Samenvatting 
 
 
 
 163 
In vitro modellen 
Voor de in vitro studies is hetzelfde rattenmodel gebruikt. Op verschillende tijdstippen in het 
wondgenezingsproces werden biopten van het palatum genomen, waaruit fibroblasten gekweekt 
werden. Deze cellen hebben we gebruikt om de specifieke eigenschappen van de fibroblasten 
tijdens de verschillende fases van de wondgenezing te bestuderen. Het voordeel van 
celkweekstudies is onder andere dat met grote aantallen cellen gewerkt kan worden. Echter, een 
belangrijke voorwaarde voor het gebruik van gekweekte cellen is dat de eigenschappen van deze 
cellen behouden blijven. Omdat de gekweekte cellen fenotypische verschillen vertonen die 
afhankelijk zijn van het tijdstip van de bioptname, kunnen we concluderen dat deze fenotypes 
inderdaad tijdens de kweek aanwezig blijven. Onze aanname is dan ook dat de gekweekte cellen de 
karakteristieken van de wondfibroblast vertonen. Het in vivo expressiepatroon van fibroblasten 
bleek gelijk te zijn aan het patroon dat gevonden wordt na in vitro kweek, wat bewijst dat de 
verschillende fibroblastpopulaties stabiel zijn in kweek.   
 
Het diermodel 
Om de fibroblastsubpopulaties te karakteriseren, hebben we weefselbiopten gebruikt die afkomstig 
zijn van verschillende fases van de wondgenezing. Op t=0 zijn biopten van gezond weefsel 
afgenomen, waarna wondgenezing kon plaatsvinden. Nieuwe biopten werden op dezelfde plek 
afgenomen op 3, 5, 8, 15, 30, 60 of 90 dagen na verwonding. Deze biopten zijn gebruikt voor 
western blotting en immunohistochemie of voor de celkweek. Voor de in vitro experimenten 
werden de biopten in stukjes gesneden, waarna de fibroblasten gedurende 4 passages opgekweekt 
werden. Deze cellen zijn gebruikt voor flow cytometry (FACS), western blotting, 
immunohistochemie en voor enkele functionele testen.  
 
Analytische parameters 
Onderstaande markers zijn in deze studie gebruikt. 
 
Integrines 
De expressie van α1, α2, en β1 integrine-subunits werd bestudeerd als indicatoren voor de 
aanwezigheid van β1-integrines. Deze integrines spelen een belangrijke rol bij de intercellulaire 
overdracht van krachten over de wond, en bij de interactie tussen fibroblasten en collageen tijdens 
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de remodelleringsfase. De αv subunit werd bestudeerd omdat deze, in combinatie met verschillende 
β subunits, als receptor voor vitronectine en fibronectine dient. Tenslotte hebben we ook de 
expressie van de α6 subunit bestudeerd, omdat het uit de literatuur niet duidelijk is of deze subunit 
in fibroblasten tot expressie komt. Wel is bekend dat deze subunit uniek is voor de hechting van 
basale keratinocyten aan het basement membraan.  
 
Cytoskeletale markers 
α-Smooth muscle actine (α-SMA) behoort tot de actine microfilamenten en maakt het mogelijk dat 
myofibroblasten krachten kunnen genereren tijdens de contractie van granulatieweefsel. Ook het 
intermediaire filament vimentine draagt hier aan bij. Tenslotte is vinculine een belangrijke 
component van focale adhesie complexen. 
 
Enzym 
Heem oxygenase-1 is een belangrijk celbeschermend enzym tijdens de wondgenezing omdat het in 
staat is om het toxische heem, dat tijdens de wondgenezing vrijkomt uit heemeiwitten, te 
neutraliseren. 
 
Celdichtheid 
Het aantal apoptotische cellen en het DNA gehalte werden bepaald als maat voor veranderingen in 
celdichtheid. 
 
Functionele testen 
De migratie en adhesie van de wondfibroblasten zijn bepaald omdat beide processen essentieel zijn 
voor de wondcontractie en vorming van littekenweefsel. 
 
Resultaten 
Analyse van fibroblast parameters 
Zowel in wondbiopten als in gekweekte cellen hebben we de expressie van de verschillende 
integrine-subunits bepaald (hoofdstuk 3 en 4). Alle subunits lieten opvallende 
expressieveranderingen zien in de eerste twee weken van de palatinale wondgenezing. Deze 
dynamische periode is waarschijnlijk gerelateerd aan de ontstekingsreactie, de re-epithalisatie, de 
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wondcontractie en de vorming van een tijdelijke matrix, aangezien voor elk van deze processen 
snelle verandering van integrine-expressie noodzakelijk is. De α1 and β1 subunits vertoonden ook 
een sterke toename in expressie later in de wondgenezing. Opvallend is dat de uitgangssituatie niet 
hersteld werd, hetgeen er op duidt dat het remodelleringsproces nog niet is beëindigd.  
 De analyse van de in vivo en in vitro expressie van enkele belangrijke cytoskelet eiwitten 
(hoofdstuk 3 en 4) laat zien dat kort na verwonding de expressie van vimentine in de homogenaten 
toeneemt, hoewel het aantal vimentine-positieve fibroblasten niet verandert tijdens de 
wondgenezing. Dit duidt er op dat de hoeveelheid vimentine per cel is toegenomen. De in vivo 
expressie van α-SMA liet een maximum zien rond de acht dagen na verwonding, waarna het weer 
afnam tot onder het niveau van het normale weefsel. De in vitro expressie van α-SMA in de 
gekweekte fibroblasten. kwam overeen met deze data. De meeste myofibroblasten zijn dus 
aanwezig rond acht dagen na verwonding. Daarna verdwijnen de myofibroblasten, waarschijnlijk 
door apoptose. Dit komt overeen met de literatuur. Vinculine, een marker voor focal adhesion 
complexen komt vooral tot expressie in normaal weefsel. Vlak na verwonding was de expressie van 
dit eiwit laag, maar later in de wondgenezing was de expressie weer hoog. Het aantal focal adhesion 
complexen lijkt omgekeerd evenredig te zijn aan de beweeglijkheid van cellen. In normaal weefsel 
migreren fibroblasten nauwelijks, terwijl vlak na verwonding de migratie sterk toeneemt, om 
tenslotte later in de wondgenezing weer af te nemen. 
  De resultaten van de functionele in vitro testen bevestigen de hierboven vermelde bevindingen 
(hoofdstuk 5). “Rustende” fibroblasten geïsoleerd uit controleweefsel migreerden weinig en 
vertoonden een sterke adhesie. Fibroblasten die op een later tijdstip in de wondgenezing werden 
geïsoleerd, migreerden meer, maar hadden een verminderde adhesie. Ook uit de literatuur is bekend 
dat migratie en adhesie omgekeerd evenredig zijn.  
 Naast een veranderende expressie van integrines en cytoskeleteiwitten lijkt er ook een 
verandering in celdichtheid te zijn tijdens de palatinale wondgenezing. Geen van deze 
veranderingen is echter significant (hoofdstuk 4). De maximale celdichtheid wordt bereikt tussen de 
één en twee weken na verwonding. Dit komt overeen met het tijdstip waarop zowel de vorming van 
granulatieweefsel als de wondcontractie maximaal is. Ook zien we dat het aantal apoptotische 
cellen maximaal is rond twee weken na verwonding, waarna het aantal apoptotische cellen weer 
afneemt (hoofdstuk 4). In het algemeen wordt gedacht dat de afname in cellulariteit tijdens de 
wondgenezing veroorzaakt wordt door apoptose 
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Expressie van heme oxygenase-1 door fibroblasten  
De expressie van het enzym heem oxygenase-1 (HO-1), dat verantwoordelijk is voor de afbraak van 
heem veranderde specifiek tijdens de palatinale wondgenezing (hoofdstuk 6). Vroeg in de 
wondgenezing waren zowel het aantal HO-1 positieve fibroblasten als de gemiddelde expressie per 
cel sterk toegenomen. Later in de wondgenezing daalden deze parameters weer tot het normale 
niveau. Vroeg in de wondgenezing, tijdens de ontstekingsfase, heeft HO-1 een beschermende rol. 
Later in de wondgenezing, wanneer de ontsteking afneemt, wordt de HO-1 expressie weer normaal. 
Recente gegevens lijken er op te wijzen dat, later in de wondgenezing, HO-1 ook antifibrotische 
eigenschappen heeft.  
 
Conclusie  
Uit dit onderzoek kunnen we concluderen dat er heterogene fibroblastpopulaties aanwezig zijn 
tijdens de verschillende fasen van de palatinale wondgenezing. Deze verschillende subpopulaties 
kunnen geïsoleerd en gekweekt worden, zonder dat ze hun specifieke eigenschappen verliezen. Pas 
na zeven passages zien we een verlies aan specifieke eigenschappen. Zowel in vitro als in vivo 
kunnen twee belangrijke fibroblastfenotypes worden onderscheiden. In de vroege fasen van de 
palatinale wondgenezing is er een ‘geactiveerd’ fenotype en in de latere fasen een ‘minder actief’ 
fenotype. Deze fibroblastfenotypes worden ook gevonden in de functionele testen. Modulatie van 
deze fenotypes zou kunnen leiden tot een vermindering van de wondcontractie en littekenvorming.  
 
Toekomstig onderzoek 
De aanwezigheid van specifieke fibroblastpopulaties tijdens de palatinale wondgenezing biedt  
mogelijkheden voor toekomstige manipulatie van het wondgenezingsproces. Aangezien deze 
populaties hun fenotype behouden tijdens kweek, kunnen hun functies verder worden geanalyseerd 
in in vitro modellen. In hoofdstuk 5 hebben we de migratie en de adhesie van fibroblasten 
bestudeerd. Andere modellen kunnen gebruikt worden om de eigenschappen van myofibroblasten 
bij de wondcontractie en littekenvorming verder te onderzoeken. Een voorbeeld van een veel 
toegepast (myo)fibroblastmodel is het drie-dimensionale contractiemodel. Bovendien kunnen deze 
functionele modellen gebruikt worden om methoden te ontwikkelen om (myo)fibroblastactiviteit te 
moduleren. 
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 De nadruk van dit onderzoek lag op fibroblastintegrines in de palatinale wondgenezing. 
Hoewel we de expressie van verschillende integrines gekarakteriseerd hebben, zal het moeilijk 
worden om de palatinale wondgenezing via deze weg te moduleren. Integrines zijn namelijk 
aanwezig op bijna elke menselijk cel en hierdoor is specifieke modulatie bijna niet mogelijk.  
 In hoofdstuk 2 beschrijven we verschillende theoretische mogelijkheden om myofibroblasten te 
moduleren. De beste opties zijn gericht op de afname van het aantal myofibroblasten door remming 
van de differentiatie, of door stimulatie van apoptose. Deze laatste mogelijkheid kan bereikt worden 
door lokale toediening van bepaalde groeifactoren. Hiervoor is het echter noodzakelijk dat er meer 
kennis opgedaan wordt over de exacte signalen die de apoptose induceren.  
 Remming van de myofibroblast differentiatie kan bereikt worden door het blokkeren van ED-A 
fibronectine (ED-A FN). Dit is een van de belangrijkste factoren die nodig zijn bij de differentiatie 
van fibroblasten naar myofibroblasten. Omdat ED-A FN alleen tijdens de wondgenezing tot 
expressie komt, treden er waarschijnlijk elders in het lichaam geen bijwerkingen op. Daarom lijkt 
dit een veelbelovende benadering te zijn..  
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aan Els heb ik veel te danken. Als mede AIO voelden wij elkaar altijd goed aan en dat heb ik altijd 
gewaardeerd. Marc, bedankt dat je mijn paranimf wil zijn. Ik heb je in 2000 al gevraagd en je ziet 
dat ik mijn woord heb gehouden.  
 
Lieve familie, dit proefschrift draag ik mede aan jullie op. Ik mag met recht zeggen dat ik een 
geweldige familie heb. De geboorte van mijn 2 nichtjes Tanya en Marieke behoren ook tot mijn 
hoogtepunten van de afgelopen jaren.  
 
Tot slot mijn vrouw, vriendin, analiste en ex-collega Patricia. Dit proefschrift draag ik 
natuurlijk aan jou op. Simpelweg, omdat er zonder jou geen proefschrift was geweest. Ik ben echt 
heel blij dat je in januari 2001 bij me bent komen werken, ondanks dat onze omgeving het afraadde. 
Nooit is er een moment geweest dat het problemen heeft opgeleverd en daar mogen we beiden trots 
op zijn. Ik ben blij dat we in maart 2003 getrouwd zijn.  
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